[X] Close
You are about to erase all the values you have customized, search history, page format, etc.
Click here to RESET all values       Click here to GO BACK without resetting any value
Items 1 to 100 of about 10099
1. Cheng K, Van de Waal DB, Niu XY, Zhao YJ: Combined Effects of Elevated <i>p</i>CO<sub>2</sub> and Warming Facilitate Cyanophage Infections. Front Microbiol; 2017;8:1096

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Combined Effects of Elevated <i>p</i>CO<sub>2</sub> and Warming Facilitate Cyanophage Infections.
  • At several time points during the 1 year period, and upon re-exposure, we measured various infection characteristics of it associated cyanophage PP, including the burst size, latent period, lytic cycle and the efficiency of plaquing (EOP).
  • Our results demonstrate that adaptation but particularly physiological acclimation to climate change conditions favored viral infections, while limited host plasticity and slow adaptation after re-exposure to control conditions impeded host biomass build-up and viral infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Proc Natl Acad Sci U S A. 2011 Sep 27;108(39):E757-64 [21844365.001]
  • [Cites] Proc Natl Acad Sci U S A. 1979 Sep;76(9):4669-73 [41245.001]
  • [Cites] Biochim Biophys Acta. 2006 Sep;1764(9):1487-92 [16956798.001]
  • [Cites] Proc Natl Acad Sci U S A. 2016 Nov 22;113(47):E7367-E7374 [27830646.001]
  • [Cites] Microbiology. 1997 Jan;143 ( Pt 1):179-85 [9025292.001]
  • [Cites] Nat Rev Microbiol. 2007 Oct;5(10):801-12 [17853907.001]
  • [Cites] Can J Microbiol. 1991 Apr;37(4):270-5 [1913339.001]
  • [Cites] J Mol Biol. 2007 Apr 20;368(1):55-65 [17337002.001]
  • [Cites] FEMS Microbiol Ecol. 2015 Feb;91(2):1-7 [25764544.001]
  • [Cites] Nat Rev Microbiol. 2014 Jul;12(7):519-28 [24931044.001]
  • [Cites] Appl Environ Microbiol. 1997 Apr;63(4):1274-83 [9097424.001]
  • [Cites] Plant Cell Physiol. 2000 Jun;41(6):767-75 [10945347.001]
  • [Cites] Proc Biol Sci. 2013 Jan 08;280(1754):20122598 [23303540.001]
  • [Cites] Physiol Genomics. 2006 Feb 14;24(3):181-90 [16368872.001]
  • [Cites] Food Microbiol. 2007 Oct-Dec;24(7-8):695-702 [17613366.001]
  • [Cites] Ecol Lett. 2014 Aug;17(8):951-60 [24813339.001]
  • [Cites] Eur J Biochem. 1983 Mar 1;131(1):137-41 [6299728.001]
  • [Cites] Appl Environ Microbiol. 1990 Jun;56(6):1875-81 [16348228.001]
  • [Cites] J Virol. 2012 Jan;86(1):236-45 [22031930.001]
  • [Cites] Appl Environ Microbiol. 2014 May;80(10):3119-27 [24610859.001]
  • [Cites] J Gen Appl Microbiol. 2005 Apr;51(2):115-23 [15942872.001]
  • [Cites] FEMS Microbiol Ecol. 2014 Jan;87(1):133-41 [24003947.001]
  • [Cites] J Bacteriol. 2007 Feb;189(4):1417-25 [17012400.001]
  • [Cites] Nature. 2004 Sep 30;431(7008):566-9 [15457260.001]
  • [Cites] Appl Microbiol Biotechnol. 1993 May;39(2):216-20 [7763729.001]
  • [Cites] Acta Histochem. 2011 May;113(3):294-9 [20138651.001]
  • [Cites] Microb Ecol. 2016 Feb;71(2):315-25 [26403721.001]
  • [Cites] Nature. 1999 Jun 10;399(6736):541-8 [10376593.001]
  • [Cites] J Bacteriol. 1979 Jul;139(1):88-92 [110787.001]
  • [Cites] FEMS Microbiol Rev. 2011 Nov;35(6):993-1034 [21204862.001]
  • [Cites] Water Res. 2012 Apr 1;46(5):1394-407 [22217430.001]
  • [Cites] FEMS Microbiol Ecol. 2014 Sep;89(3):495-515 [24754794.001]
  • [Cites] Philos Trans R Soc Lond B Biol Sci. 2008 Aug 27;363(1504):2641-50 [18487130.001]
  • [Cites] BMC Mol Biol. 2009 Jan 27;10:4 [19173723.001]
  • [Cites] J Virol. 1978 Jan;25(1):164-74 [413935.001]
  • [Cites] Microbiology. 2005 Apr;151(Pt 4):1301-11 [15817797.001]
  • [Cites] Science. 1998 Jul 10;281(5374):237-40 [9657713.001]
  • [Cites] Virus Res. 2015 May 4;203:4-9 [25836275.001]
  • [Cites] PLoS One. 2014 Aug 13;9(8):e104325 [25119996.001]
  • [Cites] Appl Environ Microbiol. 2002 Dec;68(12):6388-91 [12450864.001]
  • [Cites] Biol Res. 2013;46(4):373-82 [24510140.001]
  • [Cites] FEMS Microbiol Ecol. 2006 Jan;55(1):136-45 [16420622.001]
  • [Cites] PLoS One. 2014 Nov 18;9(11):e112134 [25405345.001]
  • [Cites] FEMS Microbiol Rev. 2004 May;28(2):127-81 [15109783.001]
  • [Cites] Environ Microbiol Rep. 2009 Feb;1(1):27-37 [23765717.001]
  • [Cites] Appl Environ Microbiol. 1984 May;47(5):979-85 [16346553.001]
  • [Cites] J Exp Bot. 2006;57(2):249-65 [16216846.001]
  • [Cites] Appl Environ Microbiol. 2006 Feb;72(2):1239-47 [16461672.001]
  • (PMID = 28659906.001).
  • [ISSN] 1664-302X
  • [Journal-full-title] Frontiers in microbiology
  • [ISO-abbreviation] Front Microbiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; EOP / climate change / common garden experiment / cyanobacterial virus / infectivity / one-step growth curve
  •  go-up   go-down


2. Slaats J, Ten Oever J, van de Veerdonk FL, Netea MG: IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections. PLoS Pathog; 2016 Dec;12(12):e1005973
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] IL-1β/IL-6/CRP and IL-18/ferritin: Distinct Inflammatory Programs in Infections.
  • The host inflammatory response against infections is characterized by the release of pro-inflammatory cytokines and acute-phase proteins, driving both innate and adaptive arms of the immune response.
  • This review discusses the profiles of acute-phase proteins and circulating cytokines encountered in viral and bacterial infections.
  • We also propose a model in which the inflammatory response to viral (IL-18/ferritin) and bacterial (IL-6/CRP) infections presents with specific plasma patterns of immune biomarkers.
  • [MeSH-major] Acute-Phase Proteins / immunology. Bacterial Infections / immunology. Cytokines / immunology. Inflammation / immunology. Virus Diseases / immunology

  • MedlinePlus Health Information. consumer health - Bacterial Infections.
  • MedlinePlus Health Information. consumer health - Viral Infections.
  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Trends Immunol. 2011 Mar;32(3):110-6 [21333600.001]
  • [Cites] BMB Rep. 2009 Dec 31;42(12):776-87 [20044948.001]
  • [Cites] Clin Chem. 1993 Feb;39(2):293-7 [8381732.001]
  • [Cites] Haematologica. 1994 Mar-Apr;79(2):165-7 [8063264.001]
  • [Cites] Blood. 1989 Jan;73(1):74-9 [2910370.001]
  • [Cites] J Med Virol. 1981;8(3):161-7 [6276502.001]
  • [Cites] Inflamm Res. 2010 Aug;59(8):581-6 [20131075.001]
  • [Cites] Immunology. 2009 Sep;128(1 Suppl):e514-22 [19740312.001]
  • [Cites] Eur J Immunol. 2009 May;39(5):1301-12 [19384872.001]
  • [Cites] Acta Paediatr. 2007 Dec;96(12):1829-31 [18001337.001]
  • [Cites] Ann Clin Lab Sci. 2006 Spring;36(2):144-50 [16682509.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Sep 22;9(9):e0004029 [26394303.001]
  • [Cites] Acta Paediatr. 1999 Jun;88(6):592-4 [10419239.001]
  • [Cites] Acta Paediatr Scand. 1983 Sep;72(5):679-83 [6416019.001]
  • [Cites] J Infect Dis. 2012 Jul 15;206(2):197-201 [22689912.001]
  • [Cites] Crit Care Med. 2006 Apr;34(4):1225-33 [16540967.001]
  • [Cites] J Exp Med. 1999 Aug 16;190(4):585-90 [10449529.001]
  • [Cites] Blood. 2011 Apr 7;117(14):3720-32 [21304099.001]
  • [Cites] Infection. 2015 Feb;43(1):13-9 [25354733.001]
  • [Cites] Mucosal Immunol. 2014 May;7(3):684-93 [24172847.001]
  • [Cites] Nature. 2006 May 11;441(7090):235-8 [16648838.001]
  • [Cites] Mediators Inflamm. 2013;2013:190145 [23690657.001]
  • [Cites] Scand J Clin Lab Invest. 2003;63(4):267-72 [12940634.001]
  • [Cites] J Virol. 2009 Apr;83(8):3719-33 [19176632.001]
  • [Cites] Crit Care Med. 1999 Sep;27(9):1814-8 [10507603.001]
  • [Cites] Am J Physiol Heart Circ Physiol. 2014 Apr 1;306(7):H1025-31 [24531812.001]
  • [Cites] Lancet. 2003 Dec 20;362(9401):2052-8 [14697804.001]
  • [Cites] J Clin Lab Immunol. 1986 May;20(1):11-3 [3735394.001]
  • [Cites] Best Pract Res Clin Haematol. 2005 Jun;18(2):183-201 [15737884.001]
  • [Cites] Ann Clin Biochem. 2001 Sep;38(Pt 5):483-93 [11587126.001]
  • [Cites] J Infect Dis. 1990 Jan;161(1):79-84 [2295861.001]
  • [Cites] Arch Med Res. 2011 Apr;42(3):199-201 [21722815.001]
  • [Cites] Arch Intern Med. 2006 Jan 9;166(1):64-70 [16401812.001]
  • [Cites] Indian J Med Res. 2015 Mar;141(3):315-21 [25963492.001]
  • [Cites] BMC Res Notes. 2014 Jul 17;7:458 [25034373.001]
  • [Cites] Blood. 1986 Dec;68(6):1257-63 [3490884.001]
  • [Cites] J Lab Clin Med. 1995 Jul;126(1):88-94 [7602240.001]
  • [Cites] Science. 2003 Feb 14;299(5609):1033-6 [12532024.001]
  • [Cites] J Immunol. 1984 Aug;133(2):882-5 [6234363.001]
  • [Cites] Blood. 2002 May 1;99(9):3326-34 [11964300.001]
  • [Cites] Arch Med Res. 2014 Apr;45(3):251-6 [24656903.001]
  • [Cites] Blood. 2005 Nov 15;106(10):3483-9 [16020503.001]
  • [Cites] Ann Clin Lab Sci. 2005 Autumn;35(4):415-22 [16254258.001]
  • [Cites] J Leukoc Biol. 2004 Feb;75(2):163-89 [14525967.001]
  • [Cites] Crit Care. 2004 Aug;8(4):R234-42 [15312223.001]
  • [Cites] J Clin Invest. 1993 Apr;91(4):1351-7 [8473487.001]
  • [Cites] Blood. 1997 Dec 15;90(12):4979-86 [9389717.001]
  • [Cites] Annu Rev Immunol. 2001;19:423-74 [11244043.001]
  • [Cites] Clin Exp Immunol. 2003 Jun;132(3):462-6 [12780693.001]
  • [Cites] Clin Infect Dis. 2000 Oct;31 Suppl 5:S178-84 [11113021.001]
  • [Cites] Clin Chim Acta. 1981 Nov 25;117(1):13-23 [7333010.001]
  • [Cites] J Exp Med. 2006 Oct 2;203(10):2271-9 [16982811.001]
  • [Cites] Pediatr Infect Dis J. 1999 Oct;18(10 ):875-81 [10530583.001]
  • [Cites] FEMS Immunol Med Microbiol. 2001 Apr;30(3):229-33 [11335143.001]
  • [Cites] Blood. 1990 Mar 15;75(6):1305-10 [2310829.001]
  • [Cites] J Gen Virol. 2005 Jan;86(Pt 1):185-95 [15604446.001]
  • [Cites] Biomed Res Int. 2015;2015:936062 [26247033.001]
  • [Cites] Pol Arch Med Wewn. 2010 Dec;120(12):491-6 [21178905.001]
  • [Cites] Atherosclerosis. 1995 May;115(1):89-98 [7545398.001]
  • [Cites] J Biol Chem. 2006 Dec 8;281(49):37616-27 [17056593.001]
  • [Cites] Crit Care Med. 2016 Feb;44(2):275-81 [26584195.001]
  • [Cites] Int J Inflam. 2012;2012:156890 [22762008.001]
  • [Cites] Influenza Other Respir Viruses. 2014 Jan;8(1):116-22 [23962134.001]
  • [Cites] Acta Med Iran. 2015 Jul;53(7):408-11 [26520627.001]
  • [Cites] Blood. 1991 Aug 15;78(4):1056-61 [1831058.001]
  • [Cites] Int J Biochem Cell Biol. 1999 Oct;31(10):1139-52 [10582343.001]
  • [Cites] JPEN J Parenter Enteral Nutr. 1990 May-Jun;14(3):287-9 [2352339.001]
  • [Cites] Scand J Infect Dis. 2005;37(1):11-4 [15764184.001]
  • [Cites] J Exp Med. 1975 Sep 1;142(3):709-21 [809531.001]
  • [Cites] J Infect. 2012 Dec;65(6):490-5 [22898387.001]
  • [Cites] Nature. 2001 Mar 22;410(6827):471-5 [11260714.001]
  • [Cites] Blood. 2010 Sep 2;116(9):1574-84 [20472835.001]
  • [Cites] Mediators Inflamm. 2013;2013:434010 [23533306.001]
  • [Cites] Gastroenterology. 2000 Jul;119(1):211-9 [10889171.001]
  • [Cites] J Zhejiang Univ Sci B. 2005 Nov;6(11):1045-56 [16252337.001]
  • [Cites] Clin Infect Dis. 2011 May;52 Suppl 4:S346-50 [21460294.001]
  • [Cites] Br J Pharmacol. 2010 Jan 1;159(2):253-64 [20002097.001]
  • [Cites] J Immunol. 1991 Nov 15;147(10):3445-51 [1834740.001]
  • [Cites] Nat Immunol. 2004 Oct;5(10):987-95 [15454922.001]
  • [Cites] Chest. 1991 Oct;100(4):1133-7 [1914573.001]
  • [Cites] Scand J Immunol. 2000 Jul;52(1):7-12 [10886778.001]
  • [Cites] Eur J Clin Invest. 1996 Jun;26(6):427-35 [8817153.001]
  • [Cites] Ann Trop Paediatr. 2004 Dec;24(4):337-43 [15720891.001]
  • [Cites] Metallomics. 2014 Apr;6(4):748-73 [24549403.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Oct 09;8(10):e3214 [25299654.001]
  • [Cites] Anticancer Res. 1997 Sep-Oct;17(5A):3253-8 [9413156.001]
  • [Cites] Eur J Med Res. 2002 Apr 30;7(4):171-6 [12010652.001]
  • [Cites] Microbes Infect. 2004 Nov;6(14):1273-7 [15555533.001]
  • [Cites] Blood. 2006 Sep 1;108(5):1751-7 [16735604.001]
  • [Cites] J Exp Med. 2009 Feb 16;206(2):313-28 [19204109.001]
  • [Cites] Front Immunol. 2013 Oct 08;4:289 [24115947.001]
  • [Cites] J Immunol. 2008 Aug 1;181(3):1627-31 [18641298.001]
  • [Cites] N Engl J Med. 1999 Feb 11;340(6):448-54 [9971870.001]
  • [Cites] Clin Vaccine Immunol. 2015 Sep;22(9):1025-32 [26135974.001]
  • [Cites] Blood. 2004 Mar 15;103(6):2369-76 [14615366.001]
  • [Cites] Atherosclerosis. 2009 Dec;207(2):374-83 [19535079.001]
  • [Cites] Clin Vaccine Immunol. 2015 Jun;22(6):650-5 [25878254.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Nov 25;105(47):18460-5 [19015529.001]
  • [Cites] J Pathol. 2008 Jan;214(2):149-60 [18161752.001]
  • (PMID = 27977798.001).
  • [ISSN] 1553-7374
  • [Journal-full-title] PLoS pathogens
  • [ISO-abbreviation] PLoS Pathog.
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Acute-Phase Proteins; 0 / Cytokines; 0 / Inflammation Mediators; 0 / Interleukin-18; 0 / Interleukin-1beta; 0 / Interleukin-6; 9007-41-4 / C-Reactive Protein; 9007-73-2 / Ferritins
  •  go-up   go-down


3. Pérot P, Lecuit M, Eloit M: Astrovirus Diagnostics. Viruses; 2017 Jan 12;9(1)
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • With the advent of metagenomics, novel human astrovirus (HAstV) strains have been found in immunocompromised individuals in association with central nervous system (CNS) infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 1975 Jun 7;1(7919):1297 [48925.001]
  • [Cites] Vet Rec. 2013 May 25;172(21):557 [23605075.001]
  • [Cites] J Virol. 2011 Oct;85(19):9909-17 [21795334.001]
  • [Cites] Kansenshogaku Zasshi. 1999 Jun;73(6):578-83 [10423948.001]
  • [Cites] J Virol Methods. 2017 Jan;239:26-33 [27916667.001]
  • [Cites] J Infect Dis. 1990 Feb;161(2):226-9 [2105359.001]
  • [Cites] Arch Virol. 1990;113(1-2):73-81 [2117433.001]
  • [Cites] J Infect Dis. 1988 Jul;158(1):182-5 [3134491.001]
  • [Cites] Emerg Infect Dis. 2013;19(9):1385-92 [23965613.001]
  • [Cites] Emerg Infect Dis. 2009 Mar;15(3):441-4 [19239759.001]
  • [Cites] J Clin Microbiol. 2011 May;49(5):1926-31 [21430103.001]
  • [Cites] J Vet Diagn Invest. 2011 May;23(3):581-4 [21908295.001]
  • [Cites] Viruses. 2015 May 22;7(5):2683-703 [26008707.001]
  • [Cites] PLoS One. 2011;6(8):e22576 [21829634.001]
  • [Cites] J Virol Methods. 2004 Jan;115(1):1-8 [14656455.001]
  • [Cites] Viral Immunol. 2005;18(1):11-6 [15802950.001]
  • [Cites] J Virol. 1994 Sep;68(9):6057-8 [8057481.001]
  • [Cites] Front Vet Sci. 2016 Oct 11;3:91 [27781208.001]
  • [Cites] J Infect Dis. 2001 Jul 1;184(1):10-5 [11398103.001]
  • [Cites] Vet Microbiol. 1989 Feb;19(2):113-25 [2495698.001]
  • [Cites] J Clin Virol. 2014 Jun;60(2):161-4 [24775733.001]
  • [Cites] PLoS Pathog. 2011 Sep;7(9):e1002218 [21909269.001]
  • [Cites] J Clin Microbiol. 1990 Feb;28(2):201-6 [2107200.001]
  • [Cites] J Clin Microbiol. 2013 Feb;51(2):472-80 [23175269.001]
  • [Cites] Pathology. 2014 Jan;46(1):53-9 [24300711.001]
  • [Cites] Emerg Microbes Infect. 2016 Jan 20;5:e5 [26785943.001]
  • [Cites] Transpl Infect Dis. 2016 Dec;18(6):960-964 [27632248.001]
  • [Cites] Avian Dis. 2005 Mar;49(1):86-91 [15839418.001]
  • [Cites] PLoS One. 2016 Jan 29;11(1):e0147832 [26824897.001]
  • [Cites] Epidemiol Infect. 1994 Aug;113(1):153-9 [8062872.001]
  • [Cites] J Microbiol Methods. 2015 Nov;118:93-8 [26342434.001]
  • [Cites] J Clin Microbiol. 2010 Dec;48(12):4392-6 [20926705.001]
  • [Cites] J Clin Virol. 2010 Nov;49(3):205-10 [20829103.001]
  • [Cites] J Gen Virol. 1981 Dec;57(Pt 2):421-4 [6798168.001]
  • [Cites] J Clin Microbiol. 2015 Mar;53(3):915-25 [25588652.001]
  • [Cites] J Gen Virol. 2013 Mar;94(Pt 3):570-82 [23223616.001]
  • [Cites] J Med Virol. 2011 Sep;83(9):1650-6 [21739458.001]
  • [Cites] J Virol. 1997 Nov;71(11):8666-71 [9343224.001]
  • [Cites] Diagn Microbiol Infect Dis. 2015 Jun;82(2):154-7 [25796558.001]
  • [Cites] J Virol. 2009 Oct;83(20):10836-9 [19706703.001]
  • [Cites] Virol J. 2008 Oct 14;5:117 [18854035.001]
  • [Cites] J Gen Virol. 2002 Jun;83(Pt 6):1397-405 [12029155.001]
  • [Cites] J Virol Methods. 1997 Aug;67(1):13-8 [9274813.001]
  • [Cites] Virology. 2016 Jun;493:22-30 [26994586.001]
  • [Cites] Virology. 2013 Feb 5;436(1):8-14 [23084422.001]
  • [Cites] Lancet. 1975 Sep 6;2(7932):451-2 [51251.001]
  • [Cites] Vet Rec. 1980 Jun 28;106(26):561 [6776680.001]
  • [Cites] Epidemiol Infect. 1994 Feb;112(1):187-93 [8119358.001]
  • [Cites] J Virol Methods. 2004 Jun 1;118(1):49-59 [15158068.001]
  • [Cites] Clin Microbiol Rev. 2014 Oct;27(4):1048-74 [25278582.001]
  • [Cites] J Gen Virol. 2015 Dec;96(12):3672-80 [26419604.001]
  • [Cites] Arch Virol. 2014 Dec;159(12):3371-5 [25078389.001]
  • [Cites] Emerg Infect Dis. 2011 Dec;17(12):2391-3 [22172277.001]
  • [Cites] Appl Environ Microbiol. 2014 Dec;80(24):7505-11 [25261510.001]
  • [Cites] J Gen Virol. 2014 Jul;95(Pt 7):1603-11 [24718833.001]
  • [Cites] Can J Microbiol. 2004 Apr;50(4):269-78 [15213751.001]
  • [Cites] Biomed Res Int. 2014;2014:648520 [24711998.001]
  • [Cites] J Virol Methods. 2006 Sep;136(1-2):210-6 [16781784.001]
  • [Cites] Res Microbiol. 2004 Jan-Feb;155(1):11-5 [14759703.001]
  • [Cites] J Virol Methods. 2013 Aug;191(2):141-7 [23159674.001]
  • [Cites] Front Microbiol. 2016 Mar 30;7:386 [27065958.001]
  • [Cites] Microbiol Immunol. 2011 May;55(5):369-72 [21517947.001]
  • [Cites] J Gen Virol. 2010 Jan;91(Pt 1):166-73 [19759240.001]
  • [Cites] Clin Vaccine Immunol. 2014 Jun;21(6):908-11 [24789796.001]
  • [Cites] Infect Genet Evol. 2015 Aug;34:114-21 [26096774.001]
  • [Cites] Vet Microbiol. 2015 Jul 9;178(1-2):70-6 [25979841.001]
  • [Cites] J Clin Microbiol. 1995 Apr;33(4):797-801 [7790440.001]
  • [Cites] J Virol Methods. 2003 Jun 30;110(2):119-27 [12798238.001]
  • [Cites] J Microbiol. 2012 Dec;50(6):970-7 [23104327.001]
  • [Cites] J Clin Microbiol. 1991 Nov;29(11):2390-5 [1774241.001]
  • [Cites] BMC Infect Dis. 2016 Jan 28;16:32 [26822615.001]
  • [Cites] Clin Infect Dis. 2015 Mar 15;60(6):881-8 [25572899.001]
  • [Cites] Expert Rev Mol Diagn. 2015;15(12):1517-9 [26548640.001]
  • [Cites] Vet Microbiol. 2014 Jun 25;171(1-2):102-11 [24793097.001]
  • [Cites] Lett Appl Microbiol. 2005;41(2):103-5 [16033504.001]
  • [Cites] J Infect Dis. 1979 May;139(5):519-23 [438551.001]
  • [Cites] J Gen Virol. 2014 Nov;95(Pt 11):2553-64 [25078300.001]
  • [Cites] J Virol. 2011 Nov;85(22):11697-708 [21900163.001]
  • [Cites] J Mol Biol. 2012 Oct 5;422(5):650-8 [22743104.001]
  • [Cites] Avian Dis. 2004 Sep;48(3):531-9 [15529975.001]
  • [Cites] Arch Virol. 2010 Jun;155(6):977-82 [20376681.001]
  • [Cites] Arch Virol. 2015 Mar;160(3):719-25 [25559674.001]
  • [Cites] Pediatr Infect Dis J. 1999 Mar;18(3):249-54 [10093946.001]
  • [Cites] Arch Virol. 2015 Oct;160(10):2491-501 [26212364.001]
  • [Cites] J Virol Methods. 2008 Jan;147(1):86-92 [17905448.001]
  • [Cites] J Virol Methods. 2007 Dec;146(1-2):36-44 [17644197.001]
  • [Cites] Virology. 1994 Jun;201(2):312-20 [7514320.001]
  • [Cites] J Gen Virol. 2009 Dec;90(Pt 12):2965-72 [19692544.001]
  • [Cites] J Clin Microbiol. 2012 Oct;50(10):3208-15 [22814465.001]
  • [Cites] Arch Virol. 2016 Apr;161(4):887-97 [26965436.001]
  • [Cites] Emerg Infect Dis. 2010 Jun;16(6):918-25 [20507741.001]
  • [Cites] J Gen Virol. 1981 Jul;55(Pt 1):223-7 [6170725.001]
  • [Cites] J Virol Methods. 2013 Mar;188(1-2):126-31 [23274752.001]
  • [Cites] Transbound Emerg Dis. 2016 Jun;63(3):253-9 [26948516.001]
  • [Cites] Clin Infect Dis. 2015 Mar 15;60(6):919-23 [25572898.001]
  • [Cites] J Med Virol. 1999 Mar;57(3):313-21 [10022805.001]
  • [Cites] J Clin Microbiol. 2012 Jul;50(7):2384-9 [22518865.001]
  • [Cites] Clin Diagn Lab Immunol. 1998 Jan;5(1):33-7 [9455876.001]
  • [Cites] J Infect. 2013 Aug;67(2):122-9 [23603249.001]
  • [Cites] Curr Microbiol. 2012 Oct;65(4):361-8 [22711331.001]
  • [Cites] Zhonghua Liu Xing Bing Xue Za Zhi. 2016 Oct 10;37(10 ):1392-1396 [27765132.001]
  • [Cites] J Clin Microbiol. 2015 Jan;53(1):136-45 [25355758.001]
  • [Cites] J Virol Methods. 2006 Jun;134(1-2):190-6 [16490263.001]
  • [Cites] J Clin Microbiol. 2014 Sep;52(9):3318-24 [24989603.001]
  • [Cites] J Pediatr. 2016 Sep;176:50-56.e2 [27329497.001]
  • [Cites] Virol J. 2012 Sep 22;9:216 [22998755.001]
  • [Cites] J Med Virol. 1979;3(3):221-30 [113503.001]
  • [Cites] J Virol. 2008 Sep;82(18):9107-14 [18550669.001]
  • [Cites] J Trop Pediatr. 2010 Apr;56(2):129-31 [19578128.001]
  • [Cites] Infect Genet Evol. 2011 Oct;11(7):1529-44 [21843659.001]
  • [Cites] Diagn Microbiol Infect Dis. 2014 Jun;79(2):149-54 [24656922.001]
  • [Cites] Avian Dis. 2007 Sep;51(3):681-4 [17992926.001]
  • [Cites] J Clin Virol. 2016 May;78:66-70 [26991054.001]
  • [Cites] J Pediatric Infect Dis Soc. 2015 Sep;4(3):e53-7 [26407445.001]
  • [Cites] J Hyg (Lond). 1978 Oct;81(2):279-83 [212477.001]
  • [Cites] J Mol Diagn. 2015 Nov;17(6):715-21 [26321042.001]
  • [Cites] J Hyg (Lond). 1982 Dec;89(3):539-40 [6818278.001]
  • [Cites] J Clin Microbiol. 2010 Sep;48(9):3416-8 [20573860.001]
  • [Cites] Kansenshogaku Zasshi. 2004 Aug;78(8):699-709 [15478645.001]
  • [Cites] J Virol. 2012 Nov;86(22):12161-75 [22933275.001]
  • [Cites] J Clin Microbiol. 2014 Apr;52(4):1266-8 [24478418.001]
  • [Cites] Epidemiol Infect. 1996 Aug;117(1):159-64 [8760964.001]
  • [Cites] Arch Virol Suppl. 1996;12:287-300 [9015126.001]
  • [Cites] J Virol Methods. 2006 Apr;133(1):14-9 [16321452.001]
  • [Cites] Arch Virol. 2016 Sep;161(9):2575-9 [27329081.001]
  • [Cites] J Clin Microbiol. 2000 Sep;38(9):3481-3 [10970410.001]
  • [Cites] Arch Virol. 2000;145(9):1847-56 [11043945.001]
  • [Cites] Arch Virol. 2012 Feb;157(2):323-7 [22033597.001]
  • [Cites] J Clin Pathol. 1978 Oct;31(10):939-43 [101556.001]
  • [Cites] Clin Lab. 2005;51(7-8):429-35 [16122155.001]
  • [Cites] Avian Dis. 2012 Sep;56(3):592-6 [23050480.001]
  • [Cites] Virol Sin. 2014 Jun;29(3):196-8 [24903592.001]
  • [Cites] J Virol Methods. 2011 May;173(2):390-3 [21349292.001]
  • [Cites] J Virol. 2015 May;89(10):5340-9 [25740998.001]
  • [Cites] J Virol Methods. 1988 Feb;19(2):151-9 [3130387.001]
  • [Cites] Pediatr Gastroenterol Hepatol Nutr. 2013 Sep;16(3):162-70 [24224149.001]
  • [Cites] Emerg Infect Dis. 2016 May;22(5):846-53 [27088842.001]
  • [Cites] J Clin Virol. 2013 Dec;58(4):612-8 [24183929.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2014 Oct;33(10):1663-73 [24828003.001]
  • [Cites] Infect Genet Evol. 2016 Oct;44:162-8 [27378415.001]
  • [Cites] Arch Virol. 1989;108(1-2):33-8 [2512894.001]
  • (PMID = 28085120.001).
  • [ISSN] 1999-4915
  • [Journal-full-title] Viruses
  • [ISO-abbreviation] Viruses
  • [Language] eng
  • [Publication-type] Review; Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; astrovirus / detection methods / molecular diagnostics / virology
  •  go-up   go-down


Advertisement
4. Luang-Suarkia D, Ernst T, Alpers MP, Garruto R, Smith D, Imrie A: Serological evidence for transmission of multiple dengue virus serotypes in Papua New Guinea and West Papua prior to 1963. PLoS Negl Trop Dis; 2017 Apr;11(4):e0005488
MedlinePlus Health Information. consumer health - Dengue.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The majority of positive sera demonstrated evidence of multiple previous DENV infections and neutralizing activity against all four serotypes was detected, with anti-DENV-2 responses being most frequent and of greatest magnitude.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Trop Geogr Med. 1975 Dec;27(4):405-8 [1216322.001]
  • [Cites] Bacteriol Rev. 1950 Sep;14(3):225-32 [14772197.001]
  • [Cites] Am J Trop Med Hyg. 1988 Jan;38(1):172-80 [3341519.001]
  • [Cites] Infect Genet Evol. 2009 Jul;9(4):523-40 [19460319.001]
  • [Cites] Emerg Infect Dis. 2007 Feb;13(2):282-6 [17479892.001]
  • [Cites] J Infect Dis. 2015 Feb 15;211(4):590-9 [25336728.001]
  • [Cites] Science. 1945 Jun 22;101(2634):640-2 [17844088.001]
  • [Cites] J Virol. 2007 Sep;81(18):10081-91 [17626101.001]
  • [Cites] Emerg Infect Dis. 2012 Apr;18(4):623-30 [22469290.001]
  • [Cites] BMC Infect Dis. 2014 Jul 26;14:412 [25064368.001]
  • [Cites] Aust N Z J Public Health. 2006 Jun;30(3):220-5 [16800197.001]
  • [Cites] Curr Top Microbiol Immunol. 2010;338:83-98 [19802580.001]
  • [Cites] Annu Rev Microbiol. 2008;62:71-92 [18429680.001]
  • [Cites] Am J Trop Med Hyg. 2011 Apr;84(4):630-6 [21460022.001]
  • [Cites] Am J Trop Med Hyg. 2011 Jul;85(1):132-7 [21734138.001]
  • [Cites] Nature. 2013 Apr 25;496(7446):504-7 [23563266.001]
  • [Cites] Am J Trop Med Hyg. 2003 May;68(5):529-35 [12812338.001]
  • [Cites] Arch Virol. 2013 Jul;158(7):1445-59 [23471635.001]
  • [Cites] J Virol. 2000 Apr;74(7):3227-34 [10708439.001]
  • [Cites] Am J Hyg. 1963 May;77:317-43 [14011049.001]
  • [Cites] PLoS Negl Trop Dis. 2015 Jan 30;9(1):e0003442 [25635775.001]
  • [Cites] Science. 1960 Apr 15;131(3407):1102-3 [14399343.001]
  • [Cites] Am J Trop Med Hyg. 1961 Jan;10:92-109 [13718931.001]
  • [Cites] Clin Microbiol Rev. 1998 Jul;11(3):480-96 [9665979.001]
  • [Cites] Am J Trop Med Hyg. 1952 Jan;1(1):30-50 [14903434.001]
  • [Cites] Am J Trop Med Hyg. 2002 Feb;66(2):208-12 [12135295.001]
  • [Cites] J Infect Dis. 2006 Oct 1;194(7):1023-4; author reply 1024-5 [16960794.001]
  • [Cites] PLoS Negl Trop Dis. 2009;3(4):e423 [19399166.001]
  • [Cites] Am J Trop Med Hyg. 1979 Jul;28(4):717-24 [464193.001]
  • [Cites] J Infect Dis. 1952 Jan-Feb;90(1):1-9 [14888958.001]
  • [Cites] Am J Epidemiol. 1984 Nov;120(5):653-69 [6496446.001]
  • [Cites] Clin Microbiol Rev. 1990 Oct;3(4):376-96 [2224837.001]
  • [Cites] Am J Trop Med Hyg. 2008 Jul;79(1):115-22 [18606774.001]
  • [Cites] Med J Aust. 2005 Jul 4;183(1):35-7 [15992338.001]
  • [Cites] Trends Microbiol. 2014 Mar;22(3):138-46 [24468533.001]
  • [Cites] Emerg Infect Dis. 2012 Nov;18(11):1850-7 [23092682.001]
  • [Cites] Virology. 1990 Feb;174(2):479-93 [2129562.001]
  • [Cites] Am J Trop Med Hyg. 1975 Jul;24(4):664-75 [1155702.001]
  • [Cites] Viral Immunol. 2007 Dec;20(4):672-5 [18158740.001]
  • [Cites] Am J Trop Med Hyg. 1997 Jul;57(1):49-55 [9242317.001]
  • (PMID = 28437465.001).
  • [ISSN] 1935-2735
  • [Journal-full-title] PLoS neglected tropical diseases
  • [ISO-abbreviation] PLoS Negl Trop Dis
  • [Language] eng
  • [Publication-type] Historical Article; Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Antibodies, Neutralizing; 0 / Antibodies, Viral
  •  go-up   go-down


5. Yilema A, Moges F, Tadele S, Endris M, Kassu A, Abebe W, Ayalew G: Isolation of enterococci, their antimicrobial susceptibility patterns and associated factors among patients attending at the University of Gondar Teaching Hospital. BMC Infect Dis; 2017 Apr 17;17(1):276
MedlinePlus Health Information. consumer health - Antibiotics.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Enterococci become clinically important especially in immune compromised patients and important causes of nosocomial infections.
  • Pretested structured questionnaire was used to collect socio-demographic data and possible associated factors of enterococci infections.
  • The commonest sites of infections were urinary tract followed by wound and blood.
  • Forty one point 7 % (10/24) of the enterococci isolates were vancomycin resistant enterococci (VRE).
  • In multivariate analysis, duration of hospital stay for two days and more than two days with infection rate 17/32 (53.1%), previous history of any antibiotics (AOR = 9.13; [95% CI; 2.01-41.51] P = 0.00) and history of urinary catheterization (AOR = 8.80; [95% CI; 1.70-45.64] P = 0.01) were associated with presence of higher enterococci infections than their respective groups.
  • CONCLUSION: The prevalence of enterococci infections among patients with UTIs, wound infections and sepsis were higher than the other infections.
  • Being hospitalized for ≥48 h, having history of any antibiotic administration and catheterization were associated factors for enterococci infections.
  • Therefore, efforts should be made to prevent enterococci infections and emergency of multidrug resistant enterococci.
  • [MeSH-minor] Adolescent. Adult. Blood / microbiology. Child. Child, Preschool. Cross Infection / epidemiology. Cross Infection / microbiology. Cross-Sectional Studies. Drug Resistance, Bacterial / drug effects. Drug Resistance, Multiple / drug effects. Ethiopia / epidemiology. Female. Hospitals, University. Humans. Male. Microbial Sensitivity Tests. Prevalence. Sepsis / epidemiology. Sepsis / microbiology. Surveys and Questionnaires. Urinary Catheterization. Urinary Tract Infections / epidemiology. Urinary Tract Infections / microbiology. Vancomycin-Resistant Enterococci / drug effects. Vancomycin-Resistant Enterococci / isolation & purification. Wounds and Injuries / microbiology. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Bull World Health Organ. 2011 Oct 1;89(10):757-65 [22084514.001]
  • [Cites] Mikrobiyol Bul. 2008 Apr;42(2):245-54 [18697422.001]
  • [Cites] Int J Antimicrob Agents. 2013 Jan;41(1):80-4 [23148985.001]
  • [Cites] Afr J Infect Dis. 2011;5(2):40-6 [23878706.001]
  • [Cites] East Afr Med J. 2010 Mar;87(3):115-9 [23057307.001]
  • [Cites] BMC Public Health. 2014 Feb 20;14:185 [24555580.001]
  • [Cites] Aliment Pharmacol Ther. 2012 May;35(10):1199-208 [22449290.001]
  • [Cites] Indian J Med Res. 2008 Aug;128(2):111-21 [19001673.001]
  • [Cites] Eur Rev Med Pharmacol Sci. 2012 Aug;16(8):1039-44 [22913154.001]
  • [Cites] J Antimicrob Chemother. 2002 Dec;50(6):1003-9 [12461024.001]
  • [Cites] Afr Health Sci. 2012 Jun;12(2):134-9 [23056018.001]
  • [Cites] Lancet. 2011 Jan 15;377(9761):228-41 [21146207.001]
  • [Cites] Clin Microbiol Infect. 2007 Mar;13(3):316-9 [17391388.001]
  • [Cites] J Glob Infect Dis. 2010 Sep;2(3):231-5 [20927283.001]
  • [Cites] Microbiology. 2009 Jun;155(Pt 6):1749-57 [19383684.001]
  • [Cites] Indian J Med Res. 2013 May;137(5):981-5 [23760387.001]
  • [Cites] Braz J Infect Dis. 2009 Aug;13(4):294-6 [20231994.001]
  • [Cites] Ethiop J Health Sci. 2011 Nov;21(3):175-82 [22434997.001]
  • [Cites] Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011 [18947320.001]
  • (PMID = 28412932.001).
  • [ISSN] 1471-2334
  • [Journal-full-title] BMC infectious diseases
  • [ISO-abbreviation] BMC Infect. Dis.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  • [Keywords] NOTNLM ; Antimicrobial susceptibility / Associated factors / Enterococci
  •  go-up   go-down


6. Maheu-Giroux M, Vesga JF, Diabaté S, Alary M, Baral S, Diouf D, Abo K, Boily MC: Population-level impact of an accelerated HIV response plan to reach the UNAIDS 90-90-90 target in Côte d'Ivoire: Insights from mathematical modeling. PLoS Med; 2017 Jun;14(6):e1002321
MedlinePlus Health Information. consumer health - HIV/AIDS Medicines.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Reaching the UNAIDS targets on time would avert 50% (42%-60%) of new HIV infections over 2015-2030 compared to 30% (25%-36%) if the 90-90-90 target is reached in 2025.
  • Attaining the UNAIDS targets in FSW, their clients, and MSM (but not in the rest of the population) would avert a similar fraction of new infections (30%; 21%-39%).
  • A 25-percentage-point drop in condom use from the 2015 levels among FSW and MSM would reduce the impact of reaching the UNAIDS targets, with 38% (26%-51%) of infections averted.
  • [MeSH-major] Acquired Immunodeficiency Syndrome / therapy. Anti-HIV Agents / therapeutic use. Condoms / utilization. HIV Infections / therapy. Models, Theoretical. Sexual Behavior

  • Genetic Alliance. consumer health - HIV.
  • MedlinePlus Health Information. consumer health - HIV/AIDS.
  • MedlinePlus Health Information. consumer health - HIV/AIDS in Women.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS One. 2012;7(3):e32627 [22403685.001]
  • [Cites] Lancet. 2015 Jul 11;386(9989):171-218 [26117719.001]
  • [Cites] Lancet. 2014 Jul 19;384(9939):249-56 [25042235.001]
  • [Cites] AIDS Behav. 2015 Jul;19(7):1305-16 [25662962.001]
  • [Cites] PLoS One. 2015 Apr 24;10(4):e0125218 [25909484.001]
  • [Cites] J Acquir Immune Defic Syndr. 1990;3(12):1193-6 [2173745.001]
  • [Cites] Curr Opin HIV AIDS. 2014 Mar;9(2):115-25 [24356328.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Nov 27;64(46):1287-90 [26605986.001]
  • [Cites] AIDS. 2003 Jul 25;17 (11):1691-4 [12853752.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 1992 Mar;11(3):271-3 [1317802.001]
  • [Cites] PLoS Med. 2015 Nov 24;12(11):e1001907; discussion e1001907 [26599990.001]
  • [Cites] N Engl J Med. 2011 Aug 11;365(6):493-505 [21767103.001]
  • [Cites] J Infect Dis. 2012 Oct;206(8):1299-308 [22926009.001]
  • [Cites] PLoS Med. 2016 May 10;13(5):e1002015 [27163694.001]
  • [Cites] Lancet HIV. 2016 Aug;3(8):e361-87 [27470028.001]
  • [Cites] AIDS. 2014 Jan;28 Suppl 1:S61-72 [24468948.001]
  • [Cites] Lancet HIV. 2016 May;3(5):e221-30 [27126489.001]
  • [Cites] J Acquir Immune Defic Syndr. 2017 Aug 15;75(5):517-527 [28471837.001]
  • [Cites] Lancet. 2010 Jun 12;375(9731):2092-8 [20537376.001]
  • [Cites] AIDS. 2002 Jan 25;16(2):251-8 [11807310.001]
  • [Cites] J Acquir Immune Defic Syndr. 2015 Mar 1;68 Suppl 2:S91-8 [25723996.001]
  • [Cites] Biometrics. 2010 Dec;66(4):1162-73 [20222935.001]
  • [Cites] Nature. 2015 Dec 3;528(7580):S68-76 [26633768.001]
  • [Cites] PLoS Med. 2017 Feb 21;14 (2):e1002240 [28222126.001]
  • [Cites] AIDS. 2017 Apr 24;31(7):1017-1024 [28252526.001]
  • [Cites] Sex Transm Infect. 2008 Aug;84 Suppl 1:i11-i16 [18647860.001]
  • (PMID = 28617810.001).
  • [ISSN] 1549-1676
  • [Journal-full-title] PLoS medicine
  • [ISO-abbreviation] PLoS Med.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-HIV Agents
  •  go-up   go-down


7. Salaheen S, Peng M, Joo J, Teramoto H, Biswas D: Eradication and Sensitization of Methicillin Resistant &lt;i&gt;Staphylococcus aureus&lt;/i&gt; to Methicillin with Bioactive Extracts of Berry Pomace. Front Microbiol; 2017;8:253

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In summary, novel and sustainable prophylactic therapy can be developed with BPE in combination with currently available antibiotics, especially methicillin, against skin and soft tissue infections with MRSA.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Clin Microbiol Infect. 2008 Jan;14(1):29-34 [17986212.001]
  • [Cites] J Agric Food Chem. 2008 Feb 13;56(3):681-8 [18211029.001]
  • [Cites] Curr Microbiol. 2015 May;70(5):698-703 [25586078.001]
  • [Cites] Postgrad Med. 2001 Feb;109(2 Suppl):43-50 [19667557.001]
  • [Cites] Curr Protoc Immunol. 2001 May;Appendix 3:Appendix 3B [18432654.001]
  • [Cites] J Food Prot. 2014 May;77(5):758-64 [24780330.001]
  • [Cites] Ned Tijdschr Geneeskd. 2006 Nov 4;150(44):2442-7 [17131705.001]
  • [Cites] J Agric Food Chem. 2011 May 25;59(10):5312-7 [21469731.001]
  • [Cites] Int J Food Microbiol. 2016 Nov 21;237:128-135 [27565525.001]
  • [Cites] J Food Sci. 2015 Mar;80(3):M635-41 [25627431.001]
  • [Cites] JAMA. 2007 Oct 17;298(15):1803-4 [17940239.001]
  • [Cites] BMC Complement Altern Med. 2012 Aug 16;12:125 [22894560.001]
  • [Cites] J Appl Microbiol. 2005;98 (4):991-1000 [15752346.001]
  • [Cites] PLoS One. 2013 Jul 05;8(7):e69508 [23861974.001]
  • [Cites] J Pharm Biomed Anal. 2002 Jun 15;28(6):1205-13 [12049985.001]
  • [Cites] Pediatr Int. 2011 Jun;53(3):363-7 [20723106.001]
  • [Cites] Antimicrob Agents Chemother. 1994 Nov;38(11):2590-8 [7872753.001]
  • [Cites] Int J Antimicrob Agents. 2004 May;23 (5):462-7 [15120724.001]
  • [Cites] Genet Mol Res. 2003 Mar 31;2(1):63-76 [12917803.001]
  • [Cites] J Appl Microbiol. 2013 Aug;115(2):346-57 [23510516.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 Jan 29;105(4):1327-32 [18216255.001]
  • [Cites] Phytochemistry. 2004 Feb;65(3):331-5 [14751304.001]
  • [Cites] Int J Food Microbiol. 2008 Jul 31;125(3):252-8 [18524407.001]
  • [Cites] Perspect Medicin Chem. 2014 Aug 28;6:25-64 [25232278.001]
  • [Cites] Br J Clin Pharmacol. 2015 Feb;79(2):173-81 [24803175.001]
  • [Cites] Foodborne Pathog Dis. 2004 Winter;1(4):241-6 [15992286.001]
  • [Cites] Can J Infect Dis. 2000 Jul;11(4):202-11 [18159291.001]
  • [Cites] Nat Immunol. 2007 Oct;8(10):1114-22 [17721536.001]
  • [Cites] Appl Environ Microbiol. 2009 Jan;75(1):265-7 [18978079.001]
  • [Cites] PLoS One. 2013;8(4):e60463 [23565251.001]
  • [Cites] Euro Surveill. 2008 Feb 28;13(9):null [18445406.001]
  • [Cites] Science. 2008 Feb 15;319(5865):910-1 [18276877.001]
  • [Cites] Biochem Pharmacol. 2007 Dec 3;74(11):1619-27 [17869225.001]
  • [Cites] J Microbiol. 2016 Jan;54(1):1-8 [26727895.001]
  • [Cites] Lett Appl Microbiol. 2000 Dec;31(6):438-42 [11123552.001]
  • [Cites] Ann Clin Microbiol Antimicrob. 2011 Jun 09;10:25 [21658242.001]
  • [Cites] Microb Drug Resist. 1999 Fall;5(3):163-75 [10566865.001]
  • [Cites] Int J Med Microbiol. 2006 Apr;296(2-3):149-61 [16503194.001]
  • [Cites] J Dairy Sci. 2016 May;99(5):3667-74 [26947297.001]
  • (PMID = 28270804.001).
  • [ISSN] 1664-302X
  • [Journal-full-title] Frontiers in microbiology
  • [ISO-abbreviation] Front Microbiol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Staphylococcus aureus / antibiotic resistance / antimicrobials / gene expression / phenolic compounds
  •  go-up   go-down


8. Delage G, Dubuc S, Grégoire Y, Lowe AM, Bernier F, Germain M: Determining the rate of underrecognition of West Nile virus neurologic disease in the province of Quebec in 2012. Transfusion; 2017 May;57(5):1294-1298
Genetic Alliance. consumer health - West nile virus.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • With data on acute infections detected in blood donors, an estimate of the degree of underrecognition was produced.
  • In the base case, the total number of cases was 16,095 and the expected number of WNND cases was 115.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 AABB.
  • (PMID = 28301049.001).
  • [ISSN] 1537-2995
  • [Journal-full-title] Transfusion
  • [ISO-abbreviation] Transfusion
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / RNA, Viral
  •  go-up   go-down


9. Baswan S, Kasting GB, Li SK, Wickett R, Adams B, Eurich S, Schamper R: Understanding the formidable nail barrier: A review of the nail microstructure, composition and diseases. Mycoses; 2017 May;60(5):284-295
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The topical treatment of nail fungal infections has been a focal point of nail research in the past few decades as it offers a much safer and focused alternative to conventional oral therapy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 Blackwell Verlag GmbH.
  • [Cites] Eur J Pharm Biopharm. 2008 Oct;70(2):684-9 [18582566.001]
  • [Cites] Indian J Med Microbiol. 2008 Apr-Jun;26(2):108-16 [18445944.001]
  • [Cites] J Pharm Pharmacol. 1985 Nov;37(11):771-5 [2867157.001]
  • [Cites] Sci Total Environ. 1991 Apr 15;103(2-3):199-207 [1882232.001]
  • [Cites] Arch Toxicol. 1995;70(1):68-9 [8750909.001]
  • [Cites] J Pharm Sci. 2009 Oct;98(10):3608-16 [19117048.001]
  • [Cites] Br J Dermatol. 2010 Jan;162(1):46-50 [19785609.001]
  • [Cites] Cutis. 2013 May;91(5):237-45 [23772429.001]
  • [Cites] Electron Microsc Rev. 1991;4(1):47-83 [1714783.001]
  • [Cites] Biochim Biophys Acta. 1973 Oct 18;322(2):269-78 [4765091.001]
  • [Cites] Differentiation. 1988 May;37(3):215-30 [2458293.001]
  • [Cites] J Anal Toxicol. 1989 May-Jun;13(3):176-8 [2755090.001]
  • [Cites] J Pharm Pharmacol. 1997 Sep;49(9):866-72 [9306253.001]
  • [Cites] J Dermatol. 1990 Dec;17(12):746-9 [2086619.001]
  • [Cites] Forensic Sci Int. 1984 Jan;24(1):9-16 [6698458.001]
  • [Cites] Analyst. 1995 Mar;120(3):917-24 [7741255.001]
  • [Cites] J Invest Dermatol. 1983 Sep;81(3):220-4 [6411826.001]
  • [Cites] Arch Intern Med. 1974 Sep;134(3):497-502 [4137073.001]
  • [Cites] J Pharm Pharmacol. 1983 Jan;35(1):28-33 [6131961.001]
  • [Cites] J Pharm Sci. 2007 Dec;96(12):3352-62 [17786922.001]
  • [Cites] AMA Arch Derm Syphilol. 1954 Dec;70(6):733-47 [13206419.001]
  • [Cites] Br J Dermatol. 1998 Oct;139(4):665-71 [9892911.001]
  • [Cites] Mycoses. 2014 Dec;57(12):734-40 [25100500.001]
  • [Cites] Trans St Johns Hosp Dermatol Soc. 1960;45:92-3 [13789962.001]
  • [Cites] Cleve Clin J Med. 2003 Feb;70(2):110-4, 117-8 [12636343.001]
  • [Cites] J Pharm Sci. 2009 May;98(5):1788-96 [18781625.001]
  • [Cites] Am J Emerg Med. 2006 Nov;24(7):875-7 [17098113.001]
  • [Cites] J Invest Dermatol. 1981 Feb;76(2):76-9 [7462680.001]
  • [Cites] J Am Acad Dermatol. 1997 Mar;36(3 Pt 1):395-402 [9091470.001]
  • [Cites] Clin Exp Dermatol. 1986 Jan;11(1):54-61 [3708894.001]
  • [Cites] J Pharm Sci. 2010 Jan;99(1):107-18 [19462425.001]
  • [Cites] J Pharm Sci. 2007 Feb;96(2):305-11 [17080425.001]
  • [Cites] J Pharm Pharmacol. 2010 Jun;62(6):721-9 [20636859.001]
  • [Cites] Br J Nutr. 1971 Sep;26(2):233-6 [5571785.001]
  • [Cites] Br J Dermatol. 1960 Apr;72:145-8 [14406356.001]
  • [Cites] J Gerontol. 1955 Oct;10 (4):401-15 [13263542.001]
  • [Cites] Int J Dermatol. 2002 Oct;41(10):647-51 [12390186.001]
  • [Cites] Expert Opin Drug Deliv. 2012 Jan;9(1):91-103 [22149385.001]
  • [Cites] J Invest Dermatol. 1953 Jan;20(1):27-31 [13023027.001]
  • [Cites] J Control Release. 2001 Jan 29;70(1-2):213-7 [11166421.001]
  • [Cites] Drug Dev Ind Pharm. 2011 Oct;37(10):1253-8 [21457120.001]
  • [Cites] J Dermatol Sci. 2007 May;46(2):150-2 [17289349.001]
  • [Cites] J Forensic Sci. 1995 Jul;40(4):634-6 [7595301.001]
  • [Cites] Indian J Dermatol. 1973 Jul;18(4):77-9 [4273104.001]
  • [Cites] J Am Acad Dermatol. 2000 Oct;43(4):641-8 [11004620.001]
  • [Cites] J Pharm Sci. 2012 Jul;101(7):2392-7 [22487899.001]
  • [Cites] Br J Dermatol. 2003 Sep;149 Suppl 65:1-4 [14510968.001]
  • [Cites] Br J Dermatol. 1987 Dec;117(6):765-70 [3322359.001]
  • [Cites] Br J Dermatol. 2003 Sep;149 Suppl 65:5-9 [14510969.001]
  • [Cites] J Pharm Sci. 2016 Mar;105(3):1201-8 [26886342.001]
  • [Cites] J Eur Acad Dermatol Venereol. 2000 Nov;14(6):466-9 [11444267.001]
  • [Cites] Eur J Pharm Sci. 2004 Mar;21(4):471-7 [14998577.001]
  • [Cites] J Am Acad Dermatol. 2014 May;70(5):911-7 [24641985.001]
  • [Cites] Int J Pharm. 2004 Sep 10;282(1-2):95-106 [15336385.001]
  • [Cites] Arch Derm Syphilol. 1946 Jan;53:39-41 [21013473.001]
  • [Cites] J Invest Dermatol. 1970 Aug;55(2):115-22 [5489490.001]
  • [Cites] Arch Dermatol Res. 1980;269(2):197-204 [6161584.001]
  • [Cites] J Ultrastruct Res. 1971 Aug;36(3):391-410 [4106435.001]
  • [Cites] Pharm Dev Technol. 2016;21(2):255-60 [25518727.001]
  • [Cites] Biol Trace Elem Res. 1996 Apr;52(1):11-22 [8860662.001]
  • [Cites] Dermatology. 2001;202(3):220-4 [11385227.001]
  • [Cites] J Am Podiatr Med Assoc. 2012 Jul-Aug;102(4):309-13 [22826329.001]
  • [Cites] Int J Pharm. 2010 Sep 15;397(1-2):67-76 [20620203.001]
  • [Cites] Int J Pharm. 2008 Jun 5;357(1-2):61-9 [18321669.001]
  • [Cites] J Pharm Pharmacol. 1997 Jan;49(1):30-4 [9120766.001]
  • [Cites] J Pharm Pharmacol. 1999 Mar;51(3):271-8 [10344627.001]
  • [Cites] Int J Dermatol. 1997 Oct;36(10):783-7 [9372358.001]
  • [Cites] Pediatr Dermatol. 1988 Aug;5(3):184-6 [3205859.001]
  • [Cites] Int J Dermatol. 1979 Jun;18(5):329-56 [381222.001]
  • [Cites] J Dtsch Dermatol Ges. 2012 Dec;10(12):913-8 [22897199.001]
  • [Cites] Pharm Res. 1998 Jul;15(7):984-7 [9688048.001]
  • [Cites] Acta Derm Venereol. 2001 Jun-Jul;81(3):175-7 [11558871.001]
  • [Cites] J Pharm Sci. 2002 Feb;91(2):312-23 [11835191.001]
  • [Cites] Br J Dermatol. 1996 Jun;134(6):1083-6 [8763429.001]
  • [Cites] Int J Pharm. 2007 Mar 6;332(1-2):196-201 [17097244.001]
  • [Cites] J Pharm Pharmacol. 1985 Jul;37(7):498-9 [2863357.001]
  • [Cites] J Cosmet Laser Ther. 2011 Feb;13(1):2-5 [21250792.001]
  • [Cites] Br J Dermatol. 1989 Oct;121(4):443-6 [2624837.001]
  • [Cites] Nucleic Acids Res. 1992 Oct 25;20(20):5489-90 [1437575.001]
  • [Cites] Dermatologica. 1988;176(1):52-4 [3338603.001]
  • [Cites] Arch Dermatol. 1997 Sep;133(9):1172-3 [9301602.001]
  • [Cites] J Control Release. 2009 Dec 3;140(2):117-25 [19709638.001]
  • [Cites] Arch Dermatol. 2008 Jan;144(1):19-21 [18209164.001]
  • [Cites] J Cell Biol. 1986 Dec;103(6 Pt 2):2593-606 [2432071.001]
  • [Cites] J Invest Dermatol. 1967 Jul;49(1):103-5 [6029454.001]
  • [Cites] Int J Pharm. 2009 Jun 22;375(1-2):22-7 [19481686.001]
  • [Cites] J Invest Dermatol. 1983 Jun;80(6):519-24 [6189921.001]
  • [Cites] Int J Pharm. 2002 Apr 2;236(1-2):1-26 [11891066.001]
  • [Cites] J Invest Dermatol. 1998 Apr;110(4):393-8 [9540981.001]
  • [Cites] Expert Opin Drug Deliv. 2008 Nov;5(11):1267-82 [18976136.001]
  • [Cites] Acta Derm Venereol. 1970;50(3):161-8 [4193212.001]
  • [Cites] Int J Pharm. 2009 Mar 31;370(1-2):61-7 [19071202.001]
  • [Cites] J Exp Biol. 2004 Feb;207(Pt 5):735-41 [14747405.001]
  • [Cites] Curr Probl Dermatol. 1981;9:102-49 [7273840.001]
  • (PMID = 28098391.001).
  • [ISSN] 1439-0507
  • [Journal-full-title] Mycoses
  • [ISO-abbreviation] Mycoses
  • [Language] eng
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM063559
  • [Publication-type] Journal Article; Review
  • [Publication-country] Germany
  • [Chemical-registry-number] 0 / Antifungal Agents
  • [Keywords] NOTNLM ; anti-fungal / iontophoresis / keratin / laser treatment / nails / onychomycosis
  •  go-up   go-down


10. Do J, Zafar H, Saier MH Jr: Comparative genomics of transport proteins in probiotic and pathogenic Escherichia coli and Salmonella enterica strains. Microb Pathog; 2017 Jun;107:106-115

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Pathogenic strains of E. coli cause urinary tract infections, diarrhea, hemorrhagic colitis, and pyelonephritis, while the two known probiotic E. coli strains combat inflammatory bowel disease and play a role in immunomodulation.
  • Taken together, the results reveal the distinguishing features of these strains and provide a starting point for future engineering of beneficial enteric bacteria.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Ltd. All rights reserved.
  • (PMID = 28344124.001).
  • [ISSN] 1096-1208
  • [Journal-full-title] Microbial pathogenesis
  • [ISO-abbreviation] Microb. Pathog.
  • [Language] eng
  • [Grant] United States / NIGMS NIH HHS / GM / R01 GM077402; United States / NIGMS NIH HHS / GM / R01 GM109895
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; E. coli / Pathogens / Physiology / Probiotics / Salmonella enterica / Transport proteins
  •  go-up   go-down


11. El-Aouar Filho RA, Nicolas A, De Paula Castro TL, Deplanche M, De Carvalho Azevedo VA, Goossens PL, Taieb F, Lina G, Le Loir Y, Berkova N: Heterogeneous Family of Cyclomodulins: Smart Weapons That Allow Bacteria to Hijack the Eukaryotic Cell Cycle and Promote Infections. Front Cell Infect Microbiol; 2017;7:208

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Heterogeneous Family of Cyclomodulins: Smart Weapons That Allow Bacteria to Hijack the Eukaryotic Cell Cycle and Promote Infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Nat Rev Microbiol. 2010 Feb;8(2):105-16 [20023663.001]
  • [Cites] Cell Host Microbe. 2013 Jun 12;13(6):759-72 [23768499.001]
  • [Cites] Cytokine. 2005 Apr 21;30(2):56-63 [15804596.001]
  • [Cites] Microb Pathog. 1999 Jan;26(1):45-52 [9973580.001]
  • [Cites] Proc Natl Acad Sci U S A. 2007 Aug 14;104(33):13438-43 [17679696.001]
  • [Cites] DNA Cell Biol. 2008 Dec;27(12):637-48 [18821847.001]
  • [Cites] Front Cell Infect Microbiol. 2012 Mar 27;2:37 [22919629.001]
  • [Cites] Nat Rev Microbiol. 2009 Jan;7(1):50-60 [19079352.001]
  • [Cites] J Am Chem Soc. 2001 Oct 17;123(41):10117-8 [11592899.001]
  • [Cites] Toxins (Basel). 2016 Mar 17;8(3):null [26999205.001]
  • [Cites] Indian J Med Res. 2011 Feb;133:153-63 [21415489.001]
  • [Cites] Clin Microbiol Infect. 2013 Mar;19(3):E149-56 [23331629.001]
  • [Cites] Exp Cell Res. 2013 Sep 10;319(15):2329-36 [23648569.001]
  • [Cites] Nat Prod Rep. 2015 Nov;32(11):1534-40 [26390983.001]
  • [Cites] J Biol Chem. 2013 Sep 20;288(38):27505-16 [23921389.001]
  • [Cites] Mol Biol Cell. 2000 May;11(5):1775-87 [10793151.001]
  • [Cites] Arch Microbiol. 1994;162(3):187-92 [7979873.001]
  • [Cites] Infect Immun. 2016 May 24;84(6):1682-92 [27001539.001]
  • [Cites] FEBS Lett. 2002 Nov 20;531(3):384-8 [12435580.001]
  • [Cites] Toxicon. 2012 Nov;60(6):1085-107 [22960449.001]
  • [Cites] Toxins (Basel). 2010 Jan;2(1):116-27 [22069550.001]
  • [Cites] Infect Immun. 1995 Oct;63(10):3936-44 [7558302.001]
  • [Cites] Cell Microbiol. 2005 Jul;7(7):921-34 [15953025.001]
  • [Cites] Infect Immun. 2001 Jun;69(6):4168-73 [11349094.001]
  • [Cites] J Immunol. 2007 Apr 15;178(8):5099-108 [17404292.001]
  • [Cites] Elife. 2015 Sep 29;4:null [26418746.001]
  • [Cites] Biochemistry. 2009 Mar 24;48(11):2459-67 [19256527.001]
  • [Cites] Semin Cell Dev Biol. 2005 Jun;16(3):311-21 [15840440.001]
  • [Cites] Toxins (Basel). 2010 Feb 1;2(2):215-228 [20871837.001]
  • [Cites] Toxins (Basel). 2016 Mar 10;8(3):null [26978402.001]
  • [Cites] Cell Microbiol. 2015 Jan;17(1):26-34 [25339545.001]
  • [Cites] Mol Microbiol. 2003 Jan;47(2):443-51 [12519194.001]
  • [Cites] Annu Rev Genet. 2009;43:95-118 [19659442.001]
  • [Cites] Int J Med Microbiol. 2014 Mar;304(2):164-9 [24447915.001]
  • [Cites] Cell Microbiol. 2012 May;14(5):622-33 [22289128.001]
  • [Cites] J Mol Biol. 2008 Dec 12;384(2):465-77 [18845161.001]
  • [Cites] Cell Microbiol. 2008 Jul;10(7):1468-77 [18331592.001]
  • [Cites] Future Microbiol. 2010 Mar;5(3):455-69 [20210554.001]
  • [Cites] J Clin Microbiol. 2006 Mar;44(3):1141-4 [16517915.001]
  • [Cites] Front Cell Infect Microbiol. 2012 Jul 12;2:92 [22919683.001]
  • [Cites] PLoS Pathog. 2014 Aug 14;10 (8):e1004255 [25121772.001]
  • [Cites] Cell Microbiol. 2005 Feb;7(2):281-92 [15659071.001]
  • [Cites] J Immunol. 2008 Oct 15;181(8):5587-97 [18832717.001]
  • [Cites] J Med Microbiol. 2008 Mar;57(Pt 3):267-72 [18287287.001]
  • [Cites] J Biol Chem. 2010 Apr 2;285(14):10662-70 [20139088.001]
  • [Cites] Infect Immun. 2006 Jul;74(7):3765-72 [16790748.001]
  • [Cites] Infect Immun. 2009 May;77(5):1835-41 [19237521.001]
  • [Cites] Infect Immun. 1999 Feb;67(2):496-503 [9916051.001]
  • [Cites] Front Cell Infect Microbiol. 2016 Mar 23;6:34 [27047802.001]
  • [Cites] Infect Immun. 2001 Sep;69(9):5925-30 [11500475.001]
  • [Cites] PLoS One. 2009;4(3):e4855 [19308257.001]
  • [Cites] Infect Immun. 2011 Jan;79(1):421-30 [20974825.001]
  • [Cites] Infect Immun. 2003 Feb;71(2):774-83 [12540557.001]
  • [Cites] Clin Microbiol Rev. 1998 Jul;11(3):450-79 [9665978.001]
  • [Cites] Proc Natl Acad Sci U S A. 1982 May;79(10):3162-6 [6285339.001]
  • [Cites] Toxicon. 2003 Nov;42(6):601-11 [14602115.001]
  • [Cites] Cell Microbiol. 2006 Dec;8(12 ):1910-21 [16848790.001]
  • [Cites] J Exp Med. 2004 Jul 5;200(1):35-46 [15226357.001]
  • [Cites] Toxins (Basel). 2011 Jun;3(6):660-71 [22069732.001]
  • [Cites] Nat Rev Microbiol. 2013 Oct;11(10):667-73 [24018382.001]
  • [Cites] Cell Microbiol. 2008 Aug;10(8):1582-90 [18485116.001]
  • [Cites] J Exp Med. 2001 May 7;193(9):1035-44 [11342588.001]
  • [Cites] Nature. 2007 Oct 18;449(7164):827-34 [17943119.001]
  • [Cites] Pediatr Infect Dis J. 1987 Dec;6(12):1135-6 [3324043.001]
  • [Cites] Infect Immun. 2009 Dec;77(12):5471-7 [19786559.001]
  • [Cites] Cells. 2014 Jun 11;3(2):592-615 [24921185.001]
  • [Cites] PLoS Pathog. 2010 Sep 30;6(9):e1001128 [20941356.001]
  • [Cites] PLoS One. 2013 May 23;8(5):e63279 [23717407.001]
  • [Cites] Nature. 2000 Nov 23;408(6811):433-9 [11100718.001]
  • [Cites] Infect Immun. 2014 Nov;82(11):4899-908 [25183729.001]
  • [Cites] Mol Aspects Med. 2009 Dec;30(6):423-30 [19560485.001]
  • [Cites] Science. 2003 Dec 5;302(5651):1775-9 [14657501.001]
  • [Cites] EcoSal Plus. 2016 Jul;7(1):null [27419387.001]
  • [Cites] Cell Microbiol. 2008 Apr;10(4):921-9 [18005237.001]
  • [Cites] Curr Opin Microbiol. 2005 Feb;8(1):83-91 [15694861.001]
  • [Cites] Front Cell Infect Microbiol. 2016 Dec 05;6:168 [27995094.001]
  • [Cites] Nature. 1997 Jun 12;387(6634):729-33 [9192901.001]
  • [Cites] J Cell Physiol. 2008 Mar;214(3):582-7 [17786942.001]
  • [Cites] APMIS. 2008 Jun;116(6):499-506 [18754324.001]
  • [Cites] FEBS Lett. 2005 Dec 5;579(29):6604-10 [16297916.001]
  • [Cites] Mol Biol Cell. 2001 Jul;12 (7):2061-73 [11452003.001]
  • [Cites] World J Gastroenterol. 2014 Jan 21;20(3):630-8 [24574736.001]
  • [Cites] Mol Microbiol. 2000 Aug;37(4):952-63 [10972814.001]
  • [Cites] Proc Natl Acad Sci U S A. 2003 Apr 29;100(9):5170-4 [12700348.001]
  • [Cites] Development. 2013 Aug;140(15):3079-93 [23861057.001]
  • [Cites] J Mol Signal. 2007 Feb 26;2:2 [17319972.001]
  • [Cites] Cold Spring Harb Perspect Biol. 2013 Jan 01;5(1):a011247 [23284045.001]
  • [Cites] EMBO J. 1988 Dec 1;7(12):3997-4004 [2905265.001]
  • [Cites] Biochem Biophys Res Commun. 2010 Oct 15;401(2):268-74 [20850415.001]
  • [Cites] FEMS Microbiol Rev. 2007 Sep;31(5):515-34 [17680807.001]
  • [Cites] J Immunol. 2009 Feb 15;182(4):2194-202 [19201873.001]
  • [Cites] Front Endocrinol (Lausanne). 2015 May 05;6:60 [25999914.001]
  • [Cites] J Cell Biol. 2013 Jun 24;201(7):997-1012 [23775190.001]
  • [Cites] Toxicol In Vitro. 2007 Mar;21(2):235-9 [17064876.001]
  • [Cites] Int J Food Microbiol. 2013 Mar 15;162(2):190-212 [22939912.001]
  • [Cites] Annu Rev Microbiol. 2015;69:185-208 [26195305.001]
  • [Cites] Nat Rev Microbiol. 2013 Jun;11(6):365-9 [23669888.001]
  • [Cites] DNA Repair (Amst). 2004 Aug-Sep;3(8-9):1039-47 [15279791.001]
  • [Cites] FASEB J. 2015 May;29(5):1950-9 [25648996.001]
  • [Cites] Mol Med Rep. 2014 May;9(5):1773-9 [24626525.001]
  • [Cites] Infect Immun. 2005 Jan;73(1):342-51 [15618171.001]
  • [Cites] J Biol Chem. 2001 Feb 16;276(7):5296-302 [11076947.001]
  • [Cites] Biochem Biophys Res Commun. 1984 Jan 30;118(2):587-93 [6367741.001]
  • [Cites] Proc Natl Acad Sci U S A. 2012 Jan 24;109(4):1281-6 [22232686.001]
  • [Cites] Sci Rep. 2015 Sep 08;5:13774 [26346097.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Aug 07;8(8):e3066 [25101965.001]
  • [Cites] Cell Prolif. 2003 Jun;36(3):131-49 [12814430.001]
  • [Cites] Cell Host Microbe. 2013 May 15;13(5):584-94 [23684309.001]
  • [Cites] Science. 2010 Sep 3;329(5996):1215-8 [20688984.001]
  • [Cites] Mol Biol Cell. 2013 Dec;24(23 ):3634-50 [24109597.001]
  • [Cites] Nat Chem Biol. 2011 Dec 15;8(1):36-45 [22173358.001]
  • [Cites] Cell Microbiol. 2010 Jul;12(7):891-905 [20088950.001]
  • [Cites] Infect Immun. 2011 Apr;79(4):1671-9 [21282417.001]
  • [Cites] Trends Microbiol. 2012 Apr;20(4):165-74 [22364673.001]
  • [Cites] J Microbiol. 2010 Jun;48(3):372-7 [20571956.001]
  • [Cites] Biomolecules. 2015 Aug 11;5(3):1762-82 [26270677.001]
  • [Cites] Nat Med. 2007 Dec;13(12):1510-4 [17994102.001]
  • [Cites] Microbiol Spectr. 2014 Aug;2(4):EHEC-0024-2013 [25530917.001]
  • [Cites] Trends Microbiol. 2000 Jul;8(7):306-13 [10878765.001]
  • [Cites] Int J Biochem Cell Biol. 2013 Aug;45(8):1531-7 [23702031.001]
  • [Cites] Cell Microbiol. 2011 Jan;13(1):123-34 [20946259.001]
  • [Cites] Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):3052-7 [11867750.001]
  • [Cites] J Cell Sci. 2002 Feb 15;115(Pt 4):817-26 [11865037.001]
  • [Cites] J Infect Dis. 2009 Dec 1;200(11):1675-84 [19863437.001]
  • [Cites] J Biol Chem. 2007 Dec 14;282(50):36230-9 [17951252.001]
  • [Cites] J Cell Biol. 2011 Dec 26;195(7):1083-92 [22123833.001]
  • [Cites] Nature. 2004 May 27;429(6990):429-33 [15164065.001]
  • [Cites] Cell Host Microbe. 2008 Jan 17;3(1):30-8 [18191792.001]
  • [Cites] Mol Microbiol. 2003 Jun;48(6):1429-49 [12791129.001]
  • [Cites] Toxicon. 2016 Aug;118:27-35 [27105670.001]
  • [Cites] Cell Host Microbe. 2010 Jun 25;7(6):463-73 [20542250.001]
  • [Cites] Cells. 2014 Apr 04;3(2):236-46 [24709959.001]
  • [Cites] Front Cell Infect Microbiol. 2012 Oct 08;2:124 [23061054.001]
  • [Cites] Cell Microbiol. 2008 Aug;10(8):1599-607 [18489725.001]
  • [Cites] Infect Immun. 2006 Apr;74(4):2207-14 [16552051.001]
  • [Cites] Cell Microbiol. 2007 Aug;9(8):2070-80 [17441986.001]
  • [Cites] Cell Microbiol. 2012 Oct;14(10):1513-21 [22747834.001]
  • [Cites] Nature. 2001 Nov 8;414(6860):225-9 [11700562.001]
  • [Cites] FEMS Microbiol Rev. 2004 May;28(2):183-200 [15109784.001]
  • [Cites] Mol Cell. 2009 Sep 24;35(6):841-55 [19782033.001]
  • [Cites] Toxins (Basel). 2010 Jul;2(7):1612-45 [22069653.001]
  • [Cites] Toxins (Basel). 2014 Mar 04;6(3):950-72 [24599233.001]
  • [Cites] J Biol Chem. 2011 Mar 18;286(11):8933-40 [21278255.001]
  • [Cites] PLoS One. 2014 Jan 21;9(1):e87022 [24466317.001]
  • [Cites] FASEB J. 2006 Apr;20(6):606-9 [16581968.001]
  • [Cites] Nat Rev Microbiol. 2014 Apr;12(4):274-88 [24608338.001]
  • [Cites] Trends Microbiol. 2005 Mar;13(3):103-10 [15737728.001]
  • [Cites] J Biol Chem. 1992 May 25;267(15):10570-5 [1587837.001]
  • [Cites] Cold Spring Harb Perspect Biol. 2012 Sep 01;4(9):a006114 [22952390.001]
  • [Cites] Cell Microbiol. 2016 Jan;18(1):17-29 [26572803.001]
  • [Cites] Cell Microbiol. 2004 Mar;6(3):255-67 [14764109.001]
  • [Cites] Toxins (Basel). 2011 Apr;3(4):356-68 [22069713.001]
  • [Cites] Acta Vet Hung. 2015 Mar;63(1):1-10 [25655410.001]
  • [Cites] Int Immunopharmacol. 2014 Nov;23(1):37-45 [25130606.001]
  • [Cites] Curr Opin Microbiol. 2006 Feb;9(1):69-75 [16406775.001]
  • [Cites] Gastroenterology. 2010 Aug;139(2):564-73 [20347814.001]
  • [Cites] Infect Immun. 2000 Feb;68(2):877-83 [10639458.001]
  • [Cites] Infect Immun. 2012 May;80(5):1803-14 [22354021.001]
  • [Cites] Infect Immun. 2006 Apr;74(4):2022-30 [16552031.001]
  • [Cites] J Leukoc Biol. 2000 Oct;68(4):522-8 [11037974.001]
  • [Cites] Toxins (Basel). 2011 Mar;3(3):172-90 [22069704.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2015 Oct 15;309(8):G670-9 [26316590.001]
  • [Cites] Pathog Dis. 2016 Feb;74(1):ftv105 [26534910.001]
  • [Cites] Nature. 2013 Jul 18;499(7458):350-4 [23842500.001]
  • [Cites] Cell Microbiol. 2008 Dec;10(12):2496-508 [18705694.001]
  • [Cites] Infect Immun. 2007 Aug;75(8):4030-9 [17562777.001]
  • [Cites] Gastroenterology. 2007 May;132(5):1820-33 [17484877.001]
  • [Cites] FEMS Immunol Med Microbiol. 2002 Jan 14;32(2):125-31 [11821234.001]
  • [Cites] Infect Immun. 2001 Nov;69(11):6785-95 [11598051.001]
  • [Cites] Nat Rev Immunol. 2010 Mar;10(3):182-92 [20182458.001]
  • [Cites] J Exp Med. 1999 Mar 15;189(6):907-18 [10075974.001]
  • [Cites] Nature. 1997 Jun 12;387(6634):725-9 [9192900.001]
  • [Cites] FEMS Microbiol Lett. 1995 Dec 1;134(1):27-32 [8593951.001]
  • [Cites] Science. 2003 Aug 22;301(5636):1099-102 [12934009.001]
  • [Cites] Future Microbiol. 2009 Sep;4(7):867-77 [19722840.001]
  • [Cites] Science. 1999 Sep 17;285(5435):1920-3 [10489373.001]
  • [Cites] Helicobacter. 2010 Apr;15(2):98-107 [20402812.001]
  • [Cites] J Clin Invest. 2013 Apr;123(4):1501-12 [23549080.001]
  • [Cites] Toxicon. 2010 Dec 15;56(7):1181-5 [19951719.001]
  • [ErratumIn] Front Cell Infect Microbiol. 2017 Aug 14;7:364 [28819588.001]
  • (PMID = 28589102.001).
  • [ISSN] 2235-2988
  • [Journal-full-title] Frontiers in cellular and infection microbiology
  • [ISO-abbreviation] Front Cell Infect Microbiol
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; bacterial toxins / colonization / cyclomodulins / eukaryotic cell cycle alteration / infective efficiency / invasion / reduced host response
  •  go-up   go-down


12. Kearney CJ, Randall KL, Oliaro J: DOCK8 regulates signal transduction events to control immunity. Cell Mol Immunol; 2017 May;14(5):406-411
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • DOCK8 deficiency in humans results in the onset of combined immunodeficiency disease (CID), clinically associated with chronic infections with diverse microbial pathogens, and a predisposition to malignancy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Allergy Clin Immunol. 2017 Mar;139(3):933-949 [27554822.001]
  • [Cites] J Cell Biol. 2000 Sep 18;150(6):1299-310 [10995436.001]
  • [Cites] J Clin Immunol. 2015 Feb;35(2):189-98 [25627830.001]
  • [Cites] J Cell Sci. 2002 Dec 15;115(Pt 24):4901-13 [12432077.001]
  • [Cites] J Clin Invest. 2016 Oct 3;126(10 ):3837-3851 [27599296.001]
  • [Cites] J Biol Chem. 2017 Feb 10;292(6):2191-2202 [28028174.001]
  • [Cites] Immunity. 2004 May;20(5):589-99 [15142527.001]
  • [Cites] JAKSTAT. 2013 Apr 1;2(2):e23435 [24058807.001]
  • [Cites] Blood. 2012 May 10;119(19):4451-61 [22461490.001]
  • [Cites] Nat Immunol. 2009 Dec;10(12):1283-91 [19898472.001]
  • [Cites] Nat Commun. 2014 Aug 05;5:4603 [25091235.001]
  • [Cites] Cancer Immunol Res. 2014 Nov;2(11):1023-33 [25367977.001]
  • [Cites] Nat Rev Immunol. 2013 Jul;13(7):475-86 [23797063.001]
  • [Cites] J Allergy Clin Immunol. 2013 Mar;131(3):840-8 [23380217.001]
  • [Cites] J Cell Sci. 2005 Nov 1;118(Pt 21):4937-46 [16254241.001]
  • [Cites] Cell Rep. 2016 Aug 30;16(9):2472-85 [27545885.001]
  • [Cites] J Immunol. 2013 Apr 1;190(7):3661-9 [23455509.001]
  • [Cites] J Cell Sci. 2008 Jul 15;121(Pt 14):2279-86 [18596256.001]
  • [Cites] Mol Biol Cell. 2008 Sep;19(9):3823-35 [18596235.001]
  • [Cites] Nat Immunol. 2016 Dec;17 (12 ):1361-1372 [27798618.001]
  • [Cites] J Biol Chem. 2011 Jul 15;286(28):25341-51 [21613211.001]
  • [Cites] J Exp Med. 2017 Jan;214(1):209-226 [28028151.001]
  • [Cites] Nat Commun. 2017 Jan 09;8:13946 [28067314.001]
  • [Cites] J Clin Invest. 2002 Jan;109(2):155-60 [11805125.001]
  • [Cites] Crit Rev Immunol. 2015;35(4):325-47 [26757394.001]
  • [Cites] J Exp Med. 2011 Oct 24;208(11):2305-20 [22006977.001]
  • [Cites] FEBS Lett. 2005 Feb 14;579(5):1039-46 [15710388.001]
  • [Cites] Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):3056-61 [25713392.001]
  • [Cites] Nat Cell Biol. 2005 Aug;7(8):797-807 [16025104.001]
  • [Cites] J Allergy Clin Immunol. 2016 Nov;138(5):1384-1394.e2 [27350570.001]
  • [Cites] Nat Rev Immunol. 2008 Sep;8(9):713-25 [19172692.001]
  • [Cites] J Exp Med. 2012 Apr 9;209(4):741-59 [22412158.001]
  • [Cites] Eur J Immunol. 2011 Dec;41(12):3423-35 [21969276.001]
  • [Cites] N Engl J Med. 2009 Nov 19;361(21):2046-55 [19776401.001]
  • [Cites] Oncogene. 2014 Jul 31;33(31):4021-35 [24037532.001]
  • [Cites] Blood. 2013 Sep 19;122(12):2052-61 [23929855.001]
  • [Cites] Immunology. 2012 Apr;135(4):268-75 [22211918.001]
  • [Cites] Nat Immunol. 2012 May 13;13(6):612-20 [22581261.001]
  • [Cites] J Allergy Clin Immunol. 2009 Dec;124(6):1289-302.e4 [20004785.001]
  • [Cites] J Exp Med. 2014 Dec 15;211(13):2549-66 [25422492.001]
  • [Cites] Allergy. 2014 Jul;69(7):943-53 [24898675.001]
  • [Cites] Curr Opin Allergy Clin Immunol. 2010 Dec;10(6):515-20 [20864884.001]
  • [Cites] J Allergy Clin Immunol. 2015 Aug;136(2):402-12 [25724123.001]
  • (PMID = 28366940.001).
  • [ISSN] 2042-0226
  • [Journal-full-title] Cellular & molecular immunology
  • [ISO-abbreviation] Cell. Mol. Immunol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] China
  •  go-up   go-down


13. Septimus EJ, Albrecht HH, Solomon G, Shea T, Guenin EP: Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief in Support of a Wait-and-See Approach for the Treatment of Acute Upper Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Study. Curr Ther Res Clin Exp; 2017;84:54-61

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Extended-Release Guaifenesin/Pseudoephedrine Hydrochloride for Symptom Relief in Support of a Wait-and-See Approach for the Treatment of Acute Upper Respiratory Tract Infections: A Randomized, Double-Blind, Placebo-Controlled Study.
  • Data published at the Oregon Health & Science University demonstrated that a 'wait-and-see' approach, without an AB prescription for the treatment of acute childhood ear infections, was as quick, safe, and effective in resolving the infections as an AB prescription (Spiro DM, Tay KY, Arnold DH, Dziura JD, Baker MD, Shapiro ED.
  • Significant reductions in URTI symptoms were observed for extended-release guaifenesin/pseudoephedrine versus placebo, from Day 1 throughout the study; however, the proportion of patients experiencing overall relief at the Day 4 evening assessment (primary end point) did not reach statistical significance.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Ann Fam Med. 2007 May-Jun;5(3):216-23 [17548849.001]
  • [Cites] Curr Allergy Asthma Rep. 2005 May;5(3):243-51 [15842963.001]
  • [Cites] Laryngoscope. 2005 Jan;115(1):27-30 [15630360.001]
  • [Cites] Postgrad Med. 2008 Jul;120(2):53-9 [18654069.001]
  • [Cites] JAMA. 2016 May 3;315(17):1864-73 [27139059.001]
  • [Cites] Laryngoscope. 1992 Nov;102(11):1225-8 [1357516.001]
  • [Cites] JAMA. 2006 Sep 13;296(10):1235-41 [16968847.001]
  • [Cites] Clin Allergy Immunol. 2007;20:251-62 [17534056.001]
  • [Cites] Chest. 1999 Jul;116(1):195-200 [10424525.001]
  • [Cites] N Engl J Med. 2008 Oct 30;359(18):1932-40 [18971494.001]
  • [Cites] Lung. 2016 Feb;194(1):31-4 [26797018.001]
  • [Cites] Pulm Pharmacol Ther. 2002;15(3):303-8 [12099783.001]
  • [Cites] Ann Intern Med. 2001 Mar 20;134(6):490-4 [11255526.001]
  • [Cites] Am J Rhinol. 2005 Jan-Feb;19(1):25-31 [15794071.001]
  • [Cites] J Clin Epidemiol. 2005 Jun;58(6):609-17 [15878475.001]
  • [Cites] Curr Allergy Asthma Rep. 2009 Mar;9(2):101-6 [19210898.001]
  • [Cites] J Long Term Eff Med Implants. 2003;13(3):195-205 [14516185.001]
  • [Cites] J Gen Intern Med. 2005 Aug;20(8):697-702 [16050877.001]
  • [Cites] Qual Life Res. 2008 Feb;17(1):75-85 [18027107.001]
  • [Cites] Cochrane Database Syst Rev. 2012 Aug 15;(8):CD001831 [22895922.001]
  • [Cites] Chest. 2003 Dec;124(6):2178-81 [14665498.001]
  • [Cites] Cochrane Database Syst Rev. 2007 Jan 24;(1):CD001953 [17253470.001]
  • [Cites] J Clin Epidemiol. 2014 Mar;67(3):267-77 [24275499.001]
  • (PMID = 28761581.001).
  • [ISSN] 0011-393X
  • [Journal-full-title] Current therapeutic research, clinical and experimental
  • [ISO-abbreviation] Curr Ther Res Clin Exp
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; antibiotics / extended-release guaifenesin / pseudoephedrine hydrochloride / upper respiratory tract infection
  •  go-up   go-down


14. Ahmed H, Ali S, Afzal MS, Khan AA, Raza H, Shah ZH, Simsek S: Why more research needs to be done on echinococcosis in Pakistan. Infect Dis Poverty; 2017 Jul 03;6(1):90
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The country has a meagre annual budget for health, which is being spent on known infections such as polio, dengue fever and hepatic viral infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Parasit Dis. 2014 Mar;38(1):73-6 [24505182.001]
  • [Cites] Infect Dis Poverty. 2014 Jan 29;3(1):3 [24475907.001]
  • [Cites] Parasitology. 2002 Oct;125(Pt 4):367-73 [12403325.001]
  • [Cites] Acta Trop. 2015 Jan;141(Pt B):235-43 [24686096.001]
  • [Cites] PLoS Negl Trop Dis. 2009;3(2):e319 [19238190.001]
  • [Cites] Cases J. 2009 Jan 18;2(1):62 [19149905.001]
  • [Cites] Parasit Vectors. 2011 Jun 14;4:106 [21672216.001]
  • [Cites] J Pak Med Assoc. 1989 Dec;39(12):320-1 [2517436.001]
  • [Cites] Niger J Surg. 2012 Jan;18(1):2-7 [24027383.001]
  • [Cites] Parasitol Int. 2006;55 Suppl:S221-5 [16338167.001]
  • [Cites] Surg Neurol Int. 2015 Jul 29;6:125 [26257983.001]
  • [Cites] J Urol. 2000 Mar;163(3):896-8 [10688003.001]
  • [Cites] Vet Parasitol. 2002 Apr 30;105(2):161-71 [11900930.001]
  • [Cites] Infect Dis Poverty. 2013 Aug 01;2(1):16 [23915395.001]
  • [Cites] J Radiol Case Rep. 2009;3(5):25-31 [22470661.001]
  • [Cites] J Ayub Med Coll Abbottabad. 2006 Oct-Dec;18(4):71-3 [17591016.001]
  • [Cites] PLoS One. 2015 Jul 17;10 (7):e0132731 [26186219.001]
  • [Cites] Infect Dis Poverty. 2015 Nov 09;4:48 [26548302.001]
  • [Cites] J Infect Dev Ctries. 2010 May 01;4(4):256-8 [20440066.001]
  • [Cites] J Pak Med Assoc. 1980 Aug;30(8):186-9 [6775112.001]
  • [Cites] BMJ Case Rep. 2013 Nov 15;2013:null [24243503.001]
  • [Cites] World Health Organ Tech Rep Ser. 1979;(637):1-107 [112785.001]
  • [Cites] Singapore Med J. 2010 Apr;51(4):e72-5 [20505900.001]
  • [Cites] Infect Dis Poverty. 2016 Feb 19;5:13 [26895758.001]
  • [Cites] Ecohealth. 2008 Jun;5(2):115-26 [18787915.001]
  • [Cites] Lancet. 2011 Jan 15;377(9761):252-69 [21227500.001]
  • [Cites] PLoS Negl Trop Dis. 2013 Jun 06;7(6):e2249 [23755310.001]
  • [Cites] J Ayub Med Coll Abbottabad. 2009 Jul-Sep;21(3):152-4 [20929036.001]
  • [Cites] Diagn Pathol. 2012 Nov 17;7:157 [23157817.001]
  • [Cites] J Med Case Rep. 2015 Apr 21;9:21 [26187499.001]
  • [Cites] PLoS One. 2015 Apr 27;10(4):e0124813 [25915867.001]
  • [Cites] PLoS Negl Trop Dis. 2011 Jul;5(7):e1146 [21814584.001]
  • [Cites] Chin Med J (Engl). 2002 Aug;115(8):1244-7 [12515272.001]
  • [Cites] Vet Parasitol. 2010 May 28;170(1-2):44-9 [20233639.001]
  • [Cites] J Assoc Physicians India. 2012 Jul;60:12-6 [23405534.001]
  • [Cites] J Pak Med Assoc. 2010 Aug;60(8):687-8 [20726207.001]
  • (PMID = 28669350.001).
  • [ISSN] 2049-9957
  • [Journal-full-title] Infectious diseases of poverty
  • [ISO-abbreviation] Infect Dis Poverty
  • [Language] eng
  • [Publication-type] Letter
  • [Publication-country] England
  • [Keywords] NOTNLM ; Echinococcosis / Neglected tropical diseases / Pakistan / Research
  •  go-up   go-down


15. Jaishankar D, Shukla D: Genital Herpes: Insights into Sexually Transmitted Infectious Disease. Microb Cell; 2016 Jun 27;3(9):438-450

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Etiology, transmission and protection: Herpes simplex virus-2 (HSV-2) is a leading cause of sexually transmitted infections with recurring manifestations throughout the lifetime of infected hosts.
  • Pathology/Symptomatology: Primary and recurrent infections result in lesions and inflammation around the genital area and the latter accounts for majority of genital herpes instances.
  • Immunocompromised patients including neonates are susceptible to additional systemic infections including debilitating consequences of nervous system inflammation.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS Pathog. 2013;9(12):e1003806 [24367260.001]
  • [Cites] Am J Med. 1984 Dec;77(6):1055-60 [6507459.001]
  • [Cites] JAMA. 2006 Aug 23;296(8):964-73 [16926356.001]
  • [Cites] J Infect Dis. 2002 Apr 15;185(8):1019-24 [11930310.001]
  • [Cites] J Virol. 2004 Feb;78(3):1139-49 [14722269.001]
  • [Cites] Mol Biol Cell. 2002 Aug;13(8):2795-809 [12181347.001]
  • [Cites] J Virol. 2005 Jun;79(12):7609-16 [15919913.001]
  • [Cites] J Virol. 2003 May;77(9):5324-32 [12692234.001]
  • [Cites] Nat Commun. 2015 Apr 27;6:6985 [25912399.001]
  • [Cites] J Gen Virol. 2010 Dec;91(Pt 12):3002-9 [20810749.001]
  • [Cites] Trends Biotechnol. 2003 Dec;21(12):556-62 [14624865.001]
  • [Cites] Sex Transm Dis. 2003 Oct;30(10):797-800 [14520181.001]
  • [Cites] J Cell Biol. 1997 Mar 10;136(5):1007-21 [9060466.001]
  • [Cites] J Virol. 1979 Dec;32(3):779-89 [229267.001]
  • [Cites] Cell. 1999 Oct 1;99(1):13-22 [10520990.001]
  • [Cites] Nat Med. 2009 Aug;15(8):886-92 [19648930.001]
  • [Cites] Ann Intern Med. 2005 Nov 15;143(10):707-13 [16287791.001]
  • [Cites] J Pept Sci. 2013 Mar;19(3):148-58 [23389903.001]
  • [Cites] J Neuroimmunol. 1995 Aug;61(1):7-16 [7560014.001]
  • [Cites] J Infect Dis. 2000 Apr;181(4):1454-7 [10762576.001]
  • [Cites] J Acquir Immune Defic Syndr. 2007 Dec 15;46(5):631-42 [18043318.001]
  • [Cites] J Virol. 1996 Sep;70(9):6076-82 [8709231.001]
  • [Cites] J Clin Virol. 1999 May;12(3):243-52 [10382821.001]
  • [Cites] Virol Sin. 2012 Dec;27(6):333-8 [23180288.001]
  • [Cites] J Virol. 1996 Jan;70(1):264-71 [8523535.001]
  • [Cites] Proc Natl Acad Sci U S A. 1997 Feb 4;94(3):843-8 [9023344.001]
  • [Cites] Herpes. 2004 Apr;11 Suppl 1:2A-23A [15115626.001]
  • [Cites] J Ocul Pharmacol Ther. 2010 Dec;26(6):541-7 [21029018.001]
  • [Cites] J Virol. 2010 Oct;84(20):10773-83 [20686018.001]
  • [Cites] Pediatrics. 2005 Apr;115(4):845-51 [15805354.001]
  • [Cites] J Virol. 1995 Mar;69(3):1389-99 [7853471.001]
  • [Cites] J Virol. 2015 Feb;89(3):1932-8 [25428865.001]
  • [Cites] Sex Transm Infect. 2004 Oct;80(5):406-10 [15459412.001]
  • [Cites] J Exp Med. 2007 Mar 19;204(3):595-603 [17325200.001]
  • [Cites] Viruses. 2015 Mar 04;7(3):915-38 [25746217.001]
  • [Cites] J Infect Dis. 1997 Nov;176(5):1129-34 [9359709.001]
  • [Cites] Vaccine. 2011 Nov 3;29(47):8530-41 [21767588.001]
  • [Cites] J Virol. 1992 Apr;66(4):2240-50 [1312629.001]
  • [Cites] Lancet. 2007 Dec 22;370(9605):2127-37 [18156035.001]
  • [Cites] J Gen Virol. 1993 Dec;74 ( Pt 12):2813-7 [8277292.001]
  • [Cites] J Virol. 1987 Jul;61(7):2311-5 [3035230.001]
  • [Cites] Sci Rep. 2015 Aug 07;5:12985 [26248741.001]
  • [Cites] J Virol. 2014 Sep 1;88(17):10026-38 [24942591.001]
  • [Cites] MBio. 2014 Jan 14;5(1):e00958-13 [24425731.001]
  • [Cites] PLoS One. 2014 Apr 02;9(4):e93444 [24695322.001]
  • [Cites] J Virol. 2008 Apr;82(7):3530-7 [18160436.001]
  • [Cites] J Infect Dis. 2011 Mar 1;203(5):602-9 [21220779.001]
  • [Cites] J Virol. 1998 Nov;72(11):8933-42 [9765438.001]
  • [Cites] BMJ. 2002 Jun 8;324(7350):1366-7 [12052804.001]
  • [Cites] Biochem Biophys Res Commun. 2010 Jan 1;391(1):176-81 [19909728.001]
  • [Cites] Ann Intern Med. 1983 Jun;98(6):958-72 [6344712.001]
  • [Cites] J Clin Invest. 2001 Aug;108(4):503-10 [11518721.001]
  • [Cites] J Neurovirol. 1997 Jun;3(3):206-11 [9200068.001]
  • [Cites] J Cell Biol. 2006 Sep 25;174(7):1009-21 [17000878.001]
  • [Cites] Sci Transl Med. 2012 Jun 13;4(138):138ra79 [22700955.001]
  • [Cites] J Virol. 1996 Sep;70(9):6067-70 [8709230.001]
  • [Cites] J Virol. 2013 Jul;87(14):8029-37 [23678175.001]
  • [Cites] J Virol. 2014 Jun;88(12):6599-610 [24672046.001]
  • [Cites] J Antimicrob Chemother. 2005 Apr;55(4):420-3 [15743896.001]
  • [Cites] Antivir Ther. 2014;19(1):15-29 [23813409.001]
  • [Cites] Herpes. 2004 Apr;11 Suppl 1:24A-35A [15115627.001]
  • [Cites] Proc Natl Acad Sci U S A. 2010 Jan 12;107(2):866-71 [20080767.001]
  • [Cites] J Virol. 1987 Jul;61(7):2208-16 [3035221.001]
  • [Cites] Virology. 2000 Dec 5;278(1):207-16 [11112495.001]
  • [Cites] J Virol. 2014 Aug;88(15):8421-32 [24829358.001]
  • [Cites] J Gen Virol. 1987 Jun;68 ( Pt 6):1761-5 [3035069.001]
  • [Cites] Cell Host Microbe. 2007 Mar 15;1(1):23-35 [18005679.001]
  • [Cites] Annu Rev Microbiol. 2013;67:355-74 [24024635.001]
  • [Cites] J Virol. 1993 Apr;67(4):2285-97 [8383241.001]
  • [Cites] J Leukoc Biol. 2001 May;69(5):691-7 [11358975.001]
  • [Cites] Autophagy. 2006 Jan-Mar;2(1):24-9 [16874088.001]
  • [Cites] J Virol. 2009 Feb;83(4):1952-61 [19073735.001]
  • [Cites] J Gen Virol. 2007 Apr;88(Pt 4):1075-9 [17374750.001]
  • [Cites] Science. 2000 Feb 25;287(5457):1500-3 [10688801.001]
  • [Cites] Nat Rev Microbiol. 2008 Mar;6(3):211-21 [18264117.001]
  • [Cites] J Gen Virol. 1994 Jun;75 ( Pt 6):1211-22 [8207388.001]
  • [Cites] J Virol. 2012 Jun;86(12):6434-43 [22491462.001]
  • [Cites] Sex Transm Dis. 2003 Oct;30(10):801-2 [14520182.001]
  • [Cites] Cell. 2008 Mar 21;132(6):935-44 [18358807.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2013 Feb 05;54(2):1070-9 [23341013.001]
  • [Cites] J Virol. 1989 Feb;63(2):943-7 [2536115.001]
  • [Cites] J Exp Med. 2000 May 1;191(9):1459-66 [10790421.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1229-33 [9990006.001]
  • [Cites] Sex Transm Infect. 2006 Jun;82(3):189-90 [16731663.001]
  • [Cites] Appl Microbiol Biotechnol. 2007 Feb;74(2):263-72 [17131147.001]
  • [Cites] Clin Infect Dis. 2006 May 15;42(10):1431-8 [16619156.001]
  • [Cites] Virol Sin. 2014 Jun;29(3):139-47 [24938714.001]
  • [Cites] Nature. 1984 Jun 14-20;309(5969):633-5 [6328323.001]
  • [Cites] J Virol. 2007 Jan;81(2):800-12 [17079321.001]
  • [Cites] Sex Transm Dis. 2004 May;31(5):322-4 [15107637.001]
  • [Cites] J Virol. 2001 Sep;75(18):8803-17 [11507225.001]
  • [Cites] N Engl J Med. 1986 Mar 13;314(11):686-91 [3005858.001]
  • [Cites] AIDS. 2001 Aug;15 Suppl 4:S97-108 [11686471.001]
  • [Cites] J Virol. 2006 Mar;80(5):2358-68 [16474142.001]
  • [Cites] FEBS J. 2009 Dec;276(24):7228-36 [19878306.001]
  • [Cites] J Infect Dis. 2006 Sep 15;194 Suppl 1:S11-8 [16921466.001]
  • [Cites] J Virol. 2009 Dec;83(24):13042-5 [19812165.001]
  • [Cites] J Virol. 2010 Oct;84(19):9889-96 [20631136.001]
  • [Cites] N Engl J Med. 2015 Aug 6;373(6):530-9 [26244306.001]
  • [Cites] Sex Transm Infect. 2000 Jun;76(3):179-82 [10961194.001]
  • [Cites] J Med Virol. 1993;Suppl 1:33-8 [8245890.001]
  • [Cites] J Virol. 2004 Nov;78(22):12508-18 [15507638.001]
  • [Cites] MMWR Recomm Rep. 2015 Jun 5;64(RR-03):1-137 [26042815.001]
  • [Cites] Microbiol Immunol. 2014 Feb;58(2):103-11 [24329555.001]
  • [Cites] J Neurovirol. 2003 Jun;9(3):285-90 [12775412.001]
  • [Cites] N Engl J Med. 2002 Nov 21;347(21):1652-61 [12444179.001]
  • [Cites] J Virol. 1987 Mar;61(3):714-21 [3027398.001]
  • [Cites] J Immunol. 1996 Oct 15;157(8):3542-9 [8871654.001]
  • [Cites] PLoS Pathog. 2010 Jul 08;6(7):e1000991 [20628567.001]
  • [Cites] J Virol. 2010 Apr;84(8):4013-25 [20147400.001]
  • [Cites] J Acquir Immune Defic Syndr. 2004 Apr 15;35(5):435-45 [15021308.001]
  • [Cites] J Virol. 2004 Sep;78(18):10178-86 [15331750.001]
  • [Cites] FEBS Lett. 2007 May 22;581(11):2150-5 [17320081.001]
  • [Cites] Curr Eye Res. 2008 May;33(5):455-67 [18568883.001]
  • [Cites] J Virol. 1988 Apr;62(4):1347-54 [2831396.001]
  • [Cites] Sex Transm Dis. 2004 Jun;31(6):331-6 [15167640.001]
  • [Cites] N Y State J Med. 1983 Apr;83(5):714-6 [6575277.001]
  • [Cites] J Immunol. 2001 Mar 15;166(6):4049-58 [11238653.001]
  • [Cites] J Virol. 2003 Feb;77(4):2686-95 [12552008.001]
  • [Cites] J Virol. 1991 Mar;65(3):1090-8 [1847438.001]
  • [Cites] J Virol. 2001 Nov;75(22):11178-84 [11602757.001]
  • [Cites] Virology. 2000 Sep 15;275(1):1-8 [11017782.001]
  • [Cites] Antiviral Res. 2012 Dec;96(3):363-75 [23047013.001]
  • [Cites] J Virol. 1998 Feb;72(2):1177-85 [9445016.001]
  • [Cites] Med Microbiol Immunol. 2003 Aug;192(3):177-81 [12761673.001]
  • [Cites] Proc Natl Acad Sci U S A. 2015 Jul 21;112(29):E3901-10 [26157134.001]
  • [Cites] PLoS One. 2014 Jun 05;9(6):e99425 [24901434.001]
  • [Cites] J Virol. 1998 Sep;72(9):7476-83 [9696844.001]
  • [Cites] Virol J. 2014 May 12;11:83 [24885431.001]
  • [Cites] J Virol. 2015 Aug;89(16):8497-509 [26041292.001]
  • [Cites] J Clin Microbiol. 1987 Feb;25(2):323-6 [3029166.001]
  • [Cites] FASEB J. 2013 Jul;27(7):2584-99 [23507869.001]
  • [Cites] Nature. 2010 Oct 14;467(7317):859-62 [20944748.001]
  • [Cites] Vaccine. 2011 Nov 3;29(47):8520-9 [21945262.001]
  • [Cites] J Virol. 2002 Apr;76(7):3471-81 [11884571.001]
  • [Cites] J Virol. 1995 Sep;69(9):5401-13 [7636985.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Nov 1;102(44):16055-9 [16247011.001]
  • (PMID = 28357380.001).
  • [ISSN] 2311-2638
  • [Journal-full-title] Microbial cell (Graz, Austria)
  • [ISO-abbreviation] Microb Cell
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] Austria
  • [Keywords] NOTNLM ; antivirals / herpes simplex virus / viral glycoproteins / viral latency / virus entry
  •  go-up   go-down


16. Liu HY, Liu CC, Shen TH, Wang YJ, Liu JY, Chen TJ, Chou LF, Hwang SJ: Pattern of Visits to Older Family Physicians in Taiwan. Int J Environ Res Public Health; 2017 May 08;14(5)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, the proportions of visits for upper respiratory tract infections, hypertension, diabetes mellitus, and dyslipidemia did not differ significantly among different age groups of physicians.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMJ. 2004 Feb 7;328(7435):329 [14764496.001]
  • [Cites] Ann Intern Med. 2005 Feb 15;142(4):260-73 [15710959.001]
  • [Cites] EPMA J. 2010 Dec;1(4):563-85 [23199110.001]
  • [Cites] BMC Health Serv Res. 2012 Dec 18;12:467 [23249631.001]
  • [Cites] J Contin Educ Health Prof. 2010 Summer;30(3):153-60 [20872769.001]
  • [Cites] Ear Nose Throat J. 2016 Apr-May;95(4-5):E35-48 [27140028.001]
  • [Cites] Health Aff (Millwood). 2012 Nov;31(11):2453-63 [23129676.001]
  • [Cites] Am J Obstet Gynecol. 2002 Oct;187(4):1008-12 [12388997.001]
  • [Cites] BMJ Open. 2016 Feb 19;6(2):e010592 [26895989.001]
  • [Cites] JAMA. 2006 Sep 6;296(9):1094-102 [16954489.001]
  • [Cites] J Am Coll Surg. 2008 Jul;207(1):69-78; discussion 78-9 [18589364.001]
  • [Cites] J Am Coll Surg. 2010 Sep;211(3):303-7 [20800185.001]
  • [Cites] Ann Fam Med. 2014 Sep-Oct;12(5):427-31 [25354406.001]
  • [Cites] Hum Resour Health. 2016 Nov 15;14 (1):67 [27846852.001]
  • [Cites] London J Prim Care (Abingdon). 2010 Dec;3(2):115-9 [25949636.001]
  • [Cites] Med Care. 2010 Feb;48(2):95-100 [20057331.001]
  • [Cites] Ann Fam Med. 2016 Jul;14 (4):344-9 [27401422.001]
  • [Cites] Med J Aust. 2008 Dec 1-15;189(11-12):622-4 [19061450.001]
  • [Cites] Int Psychogeriatr. 2007 Oct;19(5):974-84 [17506910.001]
  • [Cites] Fam Pract. 2003 Aug;20(4):474-7 [12876124.001]
  • [Cites] Acad Med. 2006 Oct;81(10):915-8 [16985357.001]
  • [Cites] PeerJ. 2015 Aug 06;3:e1145 [26290798.001]
  • [Cites] BMJ. 2009 Jan 12;338:b97 [19139141.001]
  • (PMID = 28481318.001).
  • [ISSN] 1660-4601
  • [Journal-full-title] International journal of environmental research and public health
  • [ISO-abbreviation] Int J Environ Res Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; Taiwan / aged / ambulatory care / family physicians / national health programs
  •  go-up   go-down


17. Stenger M, Behr-Rasmussen C, Klein K, Grønnemose RB, Andersen TE, Klitgaard JK, Kolmos HJ, Lindholt JS: Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity. PLoS One; 2017;12(3):e0173362

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Systemic thioridazine in combination with dicloxacillin against early aortic graft infections caused by Staphylococcus aureus in a porcine model: In vivo results do not reproduce the in vitro synergistic activity.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Drug Metab Dispos. 2008 Aug;36(8):1689-97 [18505790.001]
  • [Cites] J Bacteriol. 2004 Jul;186(14):4486-91 [15231780.001]
  • [Cites] Appl Environ Microbiol. 2008 Dec;74(23):7376-82 [18836028.001]
  • [Cites] Semin Vasc Surg. 2002 Dec;15(4):268-74 [12478501.001]
  • [Cites] PLoS One. 2015 Aug 12;10(8):e0135571 [26267376.001]
  • [Cites] J Med Microbiol. 2014 Sep;63(Pt 9):1174-80 [24913562.001]
  • [Cites] Vasc Endovascular Surg. 2004 Jan-Feb;38(1):75-82 [14760481.001]
  • [Cites] J Pharmacol Exp Ther. 1984 Mar;228(3):636-9 [6707914.001]
  • [Cites] Intern Med J. 2005 Dec;35 Suppl 2:S72-8 [16271063.001]
  • [Cites] J Antibiot (Tokyo). 2008 Jan;61(1):7-10 [18305353.001]
  • [Cites] Am J Surg. 2010 Jul;200(1):47-52 [20074700.001]
  • [Cites] Eur J Vasc Endovasc Surg. 2010 Apr;39(4):472-7 [20060756.001]
  • [Cites] Semin Vasc Surg. 2011 Dec;24(4):199-204 [22230674.001]
  • [Cites] Nat Chem Biol. 2011 Jun;7(6):348-50 [21516114.001]
  • [Cites] Eur J Pharmacol. 2015 Jan 15;747:7-12 [25449032.001]
  • [Cites] Eur J Vasc Endovasc Surg. 2012 May;43(5):582-7 [22421376.001]
  • [Cites] PLoS One. 2013;8(3):e57493 [23505431.001]
  • [Cites] Forensic Sci Int. 1994 Feb;64(2-3):165-70 [8175087.001]
  • [Cites] Eur J Pharm Sci. 2011 Jun 14;43(3):89-98 [21447389.001]
  • [Cites] PLoS One. 2013 May 17;8(5):e64518 [23691239.001]
  • [Cites] Expert Rev Anti Infect Ther. 2007 Apr;5(2):305-15 [17402845.001]
  • [Cites] JAMA. 2015 Jul 21;314(3):296-7 [26197191.001]
  • [Cites] J Control Release. 2016 Nov 10;241:125-134 [27663229.001]
  • [Cites] PLoS One. 2012;7(11):e48981 [23166602.001]
  • [Cites] In Vivo. 2014 Jan-Feb;28(1):33-8 [24425833.001]
  • [Cites] APMIS. 1988 Dec;96(12):1079-84 [3214583.001]
  • [Cites] Vasc Endovascular Surg. 2006 Jan-Feb;40(1):1-10 [16456600.001]
  • [Cites] Int J Antimicrob Agents. 2003 Sep;22(3):250-3 [13678829.001]
  • [Cites] Int J Antimicrob Agents. 2010 Apr;35(4):322-32 [20149602.001]
  • [Cites] FEMS Microbiol Lett. 2011 May;318(2):168-76 [21375577.001]
  • [Cites] Eur J Vasc Endovasc Surg. 2008 Jan;35(1):41-5 [17719807.001]
  • [Cites] Drug Metab Dispos. 2006 Mar;34(3):471-6 [16272405.001]
  • [Cites] In Vivo. 2004 Nov-Dec;18(6):787-94 [15646821.001]
  • [Cites] Adv Surg. 1996;29:33-9 [8719993.001]
  • [Cites] Toxicol Appl Pharmacol. 1999 Jul 15;158(2):115-24 [10406926.001]
  • [Cites] Int J Antimicrob Agents. 2010 Feb;35(2):174-6 [20005679.001]
  • [Cites] In Vivo. 2007 Sep-Oct;21(5):771-5 [18019410.001]
  • [Cites] J Antimicrob Chemother. 2008 Dec;62(6):1215-21 [18836185.001]
  • [Cites] J Infect. 2000 Mar;40(2):184-7 [10841097.001]
  • [Cites] J Med Chem. 2013 Jun 27;56(12):4975-89 [23710549.001]
  • [Cites] Res Microbiol. 2013 Feb-Mar;164(2):181-8 [23089256.001]
  • [Cites] J Vasc Surg. 2006 Jul;44(1):38-45 [16828424.001]
  • [Cites] In Vivo. 2006 May-Jun;20(3):361-6 [16724671.001]
  • (PMID = 28278183.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


18. Turhan O, Ozhak-Baysan B, Zaragoza O, Er H, Sarıtas ZE, Ongut G, Ogunc D, Colak D, Cuenca-Estrella M: Evaluation of MALDI-TOF-MS for the Identification of Yeast Isolates Causing Bloodstream Infection. Clin Lab; 2017 04 01;63(4):699-703

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Infections due to Candida species are major causes of morbidity and mortality in humans, causing a diverse spectrum of clinical disease ranging from superficial and mucosal infections to invasive disease.
  • The aim of this study was to assess the performance of the matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) system for the correct and rapid identification of yeast isolates causing bloodstream infection.
  • METHODS: Between January 2014 and January 2015, a total of 117 yeast like organisms isolated from blood culture samples of 117 episodes from 102 patients who had blood stream infections were included in the study.
  • RESULTS: One hundred and seventeen yeast isolates including 115 Candida spp and two non-Candida yeasts were analysed.
  • The Biotyper correctly identified 115 (98.3%) isolates to the genus level and 102 (87.2%) isolates to the species level using the manufacturer's recommended cutoff scores.
  • Early identification with MALDI-TOF MS would save time for determination of antifungal susceptibility and proper treatment strategy.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28397475.001).
  • [ISSN] 1433-6510
  • [Journal-full-title] Clinical laboratory
  • [ISO-abbreviation] Clin. Lab.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  •  go-up   go-down


19. Crosby CM, Barry MA: Transgene Expression and Host Cell Responses to Replication-Defective, Single-Cycle, and Replication-Competent Adenovirus Vectors. Genes (Basel); 2017 Feb 18;8(2)
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • While RC-Ad are more potent, they run the real risk of causing adenovirus infections in vector recipients and those that administer them.
  • To gain the benefits of transgene amplification, but avoid the risk of Ad infections, we developed "single cycle" Ad (SC-Ad) vectors.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Virol. 2014 Dec;88(24):14426-39 [25297994.001]
  • [Cites] Adv Virus Res. 2008;72:77-126 [19081489.001]
  • [Cites] Hum Gene Ther. 2010 Jun;21(6):739-49 [20331369.001]
  • [Cites] Curr Gene Ther. 2011 Aug;11(4):241-58 [21453281.001]
  • [Cites] Curr Opin Virol. 2011 Dec;1(6):519-25 [22328912.001]
  • [Cites] Methods Mol Med. 2007;130:169-83 [17401172.001]
  • [Cites] J Virol. 2015 Mar;89(6):3412-6 [25552715.001]
  • [Cites] Biochem Pharmacol. 1990 Nov 15;40(10):2353-62 [2244936.001]
  • [Cites] Br J Cancer. 1972 Aug;26(4):239-57 [4561027.001]
  • [Cites] Nat Med. 1997 Jul;3(7):808-11 [9212113.001]
  • [Cites] J Virol. 2015 Jan;89(1):669-75 [25355873.001]
  • [Cites] Clin Vaccine Immunol. 2012 May;19(5):629-37 [22441384.001]
  • [Cites] PLoS One. 2009;4(3):e5059 [19333387.001]
  • [Cites] J Virol. 2014 Jan;88(2):974-81 [24198409.001]
  • [Cites] Cancer Res. 2008 Jul 15;68(14):5896-904 [18632644.001]
  • [Cites] J Virol. 2006 Apr;80(7):3549-58 [16537623.001]
  • [Cites] J Virol. 2017 Jan 3;91(2):null [27807231.001]
  • [Cites] J Virol. 2012 Apr;86(8):4644-57 [22345466.001]
  • [Cites] J Immunol. 1975 Sep;115(3):844-7 [807647.001]
  • [Cites] Hepatology. 2006 Feb;43(2 Suppl 1):S54-62 [16447271.001]
  • [Cites] Virology. 2014 Aug;462-463:158-65 [24996029.001]
  • [Cites] J Virol. 2013 Apr;87(7):3678-86 [23325678.001]
  • [Cites] Virology. 2009 Nov 25;394(2):311-20 [19765790.001]
  • (PMID = 28218713.001).
  • [ISSN] 2073-4425
  • [Journal-full-title] Genes
  • [ISO-abbreviation] Genes (Basel)
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI096967; United States / NCI NIH HHS / CA / R01 CA136945
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; adenovirus / animal models / cancer therapy / genome replication / replication-competent / replication-defective / vaccines
  •  go-up   go-down


20. Zilm PS, Butnejski V, Rossi-Fedele G, Kidd SP, Edwards S, Vasilev K: D-amino acids reduce Enterococcus faecalis biofilms in vitro and in the presence of antimicrobials used for root canal treatment. PLoS One; 2017;12(2):e0170670

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Enterococcus faecalis is the most frequent species present in post-treatment disease and plays a significant role in persistent periapical infections following root canal treatment.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Oral Microbiol Immunol. 1992 Oct;7(5):257-62 [1494447.001]
  • [Cites] Trends Microbiol. 2001 Jan;9(1):9-10 [11252255.001]
  • [Cites] Aust Dent J. 2007 Mar;52(1 Suppl):S64-82 [17546863.001]
  • [Cites] Science. 2009 Sep 18;325(5947):1552-5 [19762646.001]
  • [Cites] Int Endod J. 2006 Apr;39(4):249-81 [16584489.001]
  • [Cites] World J Microbiol Biotechnol. 2012 Oct;28(10):3067-74 [22806745.001]
  • [Cites] Int J Antimicrob Agents. 2007 Sep;30(3):236-41 [17574822.001]
  • [Cites] J Microbiol Methods. 2011 Feb;84(2):167-73 [21081140.001]
  • [Cites] Int Endod J. 2015 Mar;48(3):210-9 [24749689.001]
  • [Cites] Appl Environ Microbiol. 2001 Oct;67(10):4538-45 [11571153.001]
  • [Cites] Antimicrob Agents Chemother. 2002 Jun;46(6):1845-50 [12019099.001]
  • [Cites] J Bacteriol. 2013 Dec;195(23):5391-5 [24097941.001]
  • [Cites] J Microbiol Methods. 2008 Feb;72 (2):157-65 [18155789.001]
  • [Cites] Science. 1988 Jun 3;240(4857):1302-9 [3287616.001]
  • [Cites] Int Endod J. 1998 Jan;31(1):1-7 [9823122.001]
  • [Cites] BMC Microbiol. 2006 Jul 11;6:60 [16834772.001]
  • [Cites] World J Microbiol Biotechnol. 2012 Apr;28(4):1641-6 [22805946.001]
  • [Cites] Oral Microbiol Immunol. 2000 Oct;15(5):309-12 [11154422.001]
  • [Cites] J Dent Res. 1987 Aug;66(8):1375-9 [3114347.001]
  • [Cites] Int Endod J. 2003 Jan;36(1):1-11 [12656508.001]
  • [Cites] Int Endod J. 2014 Nov;47(11):1003-11 [25298127.001]
  • [Cites] APMIS. 2007 Aug;115(8):891-9 [17696944.001]
  • [Cites] FEBS Open Bio. 2016 May 19;6(6):586-93 [27419061.001]
  • [Cites] Science. 2010 Apr 30;328(5978):627-9 [20431016.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2001 Jul;20(7):502-4 [11561809.001]
  • [Cites] J Microbiol Methods. 2000 Apr;40(2):175-9 [10699673.001]
  • [Cites] J Microbiol Methods. 2004 Sep;58(3):351-60 [15279939.001]
  • [Cites] Front Microbiol. 2016 Jun 13;7:896 [27379039.001]
  • [Cites] Int Endod J. 1997 Sep;30(5):297-306 [9477818.001]
  • [Cites] PLoS One. 2015 Feb 06;10(2):e0117613 [25658642.001]
  • [Cites] Int Endod J. 2001 Sep;34(6):429-34 [11556508.001]
  • [Cites] Infect Immun. 2015 Feb;83(2):470-81 [25385795.001]
  • [Cites] J Med Microbiol. 2014 Oct;63(Pt 10):1369-76 [25001104.001]
  • (PMID = 28151960.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


21. Heydarpour F, Rahmani Y, Heydarpour B, Asadmobini A: Nosocomial infections and antibiotic resistance pattern in open-heart surgery patients at Imam Ali Hospital in Kermanshah, Iran. GMS Hyg Infect Control; 2017;12:Doc07

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Nosocomial infections and antibiotic resistance pattern in open-heart surgery patients at Imam Ali Hospital in Kermanshah, Iran.
  • <b>Background:</b> Patients undergoing open heart surgery have a relatively high risk of acquiring nosocomial infections.
  • The development of antibiotic-resistant infections is associated with prolonged hospital stays and mortalities.
  • <b>Objectives:</b> The present study was conducted to investigate nosocomial infections and the antibiotic resistance pattern in bacteria causing these infections in open heart surgery patients at Imam Ali Hospital in Kermanshah in the west of Iran over a 4-year period from March 2011 to March 2014.
  • <b>Results:</b> Out of the 6,000 patients who underwent open heart surgery during this 4-year period at the selected hospital, nosocomial infections developed in 135 patients (2.25%), 59.3% of whom were female and 40.7% male.
  • <i>E.coli</i>, <i>Klebsiella</i> spp. and <i>S. aureus</i> were the most common bacteria causing the nosocomial infections. <i>E. coli</i> was most frequently resistant to imipenem (23.3%) <i>Klebsiella</i> spp. to gentamicin (38.5%) <i>S. aureus</i> to co-trimoxazole (54.2%).
  • Der Anteil von Surgery Site Infections (SSI), Pneumonien, Harnweg- und Blutstrominfektionen betrug 52,6%, 37%, 9,6% bzw. 0,8%. <i>E. coli</i>, <i>Klebsiella</i> spp. and <i>S. aureus</i> waren die häufigsten Erreger. <i>E. coli</i> war am häufigsten gegen Imipenem (23,3%) resistent, <i>Klebsiella</i> spp. am häufigsten gegen Gentamicin (38,5%) und <i>S. aureus</i> am häufigsten gegen Cotrimoxazol (54,2%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2010 May 13;362(19):1804-13 [20463340.001]
  • [Cites] JAMA. 2006 Nov 22;296(20):2460-6 [17119142.001]
  • [Cites] Ann Ig. 2004 Nov-Dec;16(6):735-43 [15697003.001]
  • [Cites] J Cardiothorac Surg. 2011 Nov 14;6:151 [22082355.001]
  • [Cites] Ann Intern Med. 1991 Oct 15;115(8):585-90 [1892329.001]
  • [Cites] East Mediterr Health J. 2008 May-Jun;14(3):556-63 [18720619.001]
  • [Cites] Biomed Res Int. 2015;2015:309478 [26064896.001]
  • [Cites] BMC Pediatr. 2010 Sep 10;10:66 [20831797.001]
  • [Cites] Infect Control Hosp Epidemiol. 2006 Dec;27(12):1393-6 [17152040.001]
  • [Cites] Anesth Analg. 2000 Nov;91(5):1176-81 [11049905.001]
  • [Cites] Georgian Med News. 2010 Jan;(178):7-11 [20157198.001]
  • [Cites] BMC Infect Dis. 2009 Jul 25;9:115 [19630992.001]
  • [Cites] Infect Control Hosp Epidemiol. 2000 Apr;21(4):260-3 [10782588.001]
  • [Cites] Chest. 1997 Sep;112(3):666-75 [9315799.001]
  • [Cites] JAMA. 1996 Jan 17;275(3):234-40 [8604178.001]
  • [Cites] JAMA. 2000 Jul 26;284(4):483-5 [10904513.001]
  • [Cites] Eur J Cardiothorac Surg. 2001 Dec;20(6):1168-75 [11717023.001]
  • [Cites] Infect Control Hosp Epidemiol. 2006 Sep;27(9):958-63 [16941323.001]
  • [Cites] Ann Thorac Surg. 1996 Mar;61(3):1030-6 [8619682.001]
  • [Cites] Indian J Pathol Microbiol. 2015 Apr-Jun;58(2):195-200 [25885133.001]
  • [Cites] Diabet Med. 2007 Oct;24(10):1168-71 [17888136.001]
  • [Cites] J Card Surg. 1998 Jul;13(4):252-9 [10225180.001]
  • [Cites] Chest. 2000 Aug;118(2):397-402 [10936131.001]
  • [Cites] Saudi J Anaesth. 2014 Nov;8(Suppl 1):S84-8 [25538530.001]
  • [Cites] Chest. 1995 May;107(5):1395-401 [7750337.001]
  • [Cites] Ann Thorac Surg. 2010 Mar;89(3):843-50 [20172141.001]
  • [Cites] Circulation. 2005 Aug 30;112(9 Suppl):I358-65 [16159846.001]
  • [Cites] Caspian J Intern Med. 2014 Fall;5(4):227-31 [25489435.001]
  • [Cites] J Microbiol Immunol Infect. 2010 Oct;43(5):378-85 [21075704.001]
  • [Cites] J Prev Med Hyg. 2012 Dec;53(4):204-6 [23469589.001]
  • [Cites] Eur J Cardiothorac Surg. 2003 Jan;23(1):97-102 [12493512.001]
  • [Cites] Glob J Health Sci. 2015 Aug 06;8(2):288-97 [26383221.001]
  • [Cites] J Hosp Infect. 1994 Jun;27(2):139-47 [7930541.001]
  • [Cites] Eur J Cardiothorac Surg. 2006 Apr;29(4):456-60 [16481186.001]
  • [Cites] Infect Control Hosp Epidemiol. 2003 Jan;24(1):17-25 [12558231.001]
  • [Cites] Infect Control Hosp Epidemiol. 2005 May;26(5):466-72 [15954485.001]
  • [Cites] Am J Infect Control. 2005 Oct;33(8):450-4 [16216658.001]
  • [Cites] Clin Microbiol Infect. 2015 Jul;21(7):674.e11-8 [25882356.001]
  • [Cites] Iran Red Crescent Med J. 2014 Feb;16(2):e14562 [24719744.001]
  • (PMID = 28584733.001).
  • [ISSN] 2196-5226
  • [Journal-full-title] GMS hygiene and infection control
  • [ISO-abbreviation] GMS Hyg Infect Control
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Germany
  • [Keywords] NOTNLM ; Iran / SSI / antibiotic resistance / nosocomial infection / open heart surgery
  •  go-up   go-down


22. Girardi A, Galletti S, Raschi E, Koci A, Poluzzi E, Faldella G, De Ponti F: Pattern of drug use among preterm neonates: results from an Italian neonatal intensive care unit. Ital J Pediatr; 2017 Apr 17;43(1):37

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Drug use in preterm neonates admitted to Neonatal Intensive Care Unit (NICU) has been investigated, so far, in terms of unauthorized or off-label use; very little is known on the use of combinations of different active substances, which is frequently required in this population (prophylaxis of infections, treatment of concomitant diseases).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] N Engl J Med. 2007 Jun 14;356(24):2483-95 [17568029.001]
  • [Cites] Pediatrics. 2015 May;135(5):826-33 [25896845.001]
  • [Cites] Acta Paediatr. 2014 Apr;103(4):e139-42 [24397831.001]
  • [Cites] Pediatr Int. 2014 Feb;56(1):57-9 [23937449.001]
  • [Cites] Semin Fetal Neonatal Med. 2005 Apr;10(2):115-22 [15701577.001]
  • [Cites] Int J Clin Pharm. 2015 Aug;37(4):645-55 [25832676.001]
  • [Cites] Int J Risk Saf Med. 2015;27 Suppl 1:S9-S10 [26639729.001]
  • [Cites] J Perinatol. 2011 Mar;31(3):199-205 [20651693.001]
  • [Cites] Drug Saf. 2015 Jun;38(6):535-51 [25863473.001]
  • [Cites] Acta Paediatr. 2013 Nov;102(11):1067-74 [23855971.001]
  • [Cites] Clin Dev Immunol. 2013;2013:586076 [23762094.001]
  • [Cites] Pediatrics. 2015 May;135(5):928-9 [25896842.001]
  • [Cites] Arch Dis Child. 2015 Apr;100(4):394-8 [25628457.001]
  • [Cites] Pediatr Res. 2011 Apr;69(4):354-8 [21178824.001]
  • [Cites] Early Hum Dev. 2011 Mar;87 Suppl 1:S31-3 [21251768.001]
  • [Cites] Pediatr Crit Care Med. 2013 Mar;14(3):318-22 [23392363.001]
  • [Cites] Eur J Clin Pharmacol. 2010 Jan;66(1):87-95 [19756556.001]
  • [Cites] Eur J Clin Pharmacol. 2016 Jan;72 (1):117-23 [26490354.001]
  • [Cites] N Engl J Med. 2001 Dec 6;345(23):1660-6 [11759644.001]
  • [Cites] Pharmaceuticals (Basel). 2013 Sep 05;6(9):1094-129 [24276421.001]
  • [Cites] Pediatr Nephrol. 2013 Mar;28(3):477-84 [23070277.001]
  • [Cites] Pediatrics. 2006 Jun;117(6):1979-87 [16740839.001]
  • [Cites] Pediatrics. 2013 Aug;132(2):e372-80 [23878051.001]
  • [Cites] Eur J Clin Pharmacol. 2014 Apr;70(4):445-52 [24398969.001]
  • [Cites] Eur J Pediatr. 2012 Mar;171(3):439-45 [21912893.001]
  • [Cites] Pediatr Nephrol. 2013 Apr;28(4):661-6 [23224224.001]
  • [Cites] BMC Pediatr. 2013 Jan 07;13:5 [23294560.001]
  • [Cites] Arch Dis Child Fetal Neonatal Ed. 2011 Jul;96(4):F290-5 [21173011.001]
  • [Cites] J Clin Pharm Ther. 2016 Dec;41(6):612-620 [27578606.001]
  • [Cites] Expert Opin Drug Saf. 2008 Nov;7(6):679-90 [18983215.001]
  • [Cites] Pediatr Nephrol. 2012 Sep;27(9):1575-82 [22532328.001]
  • (PMID = 28412957.001).
  • [ISSN] 1824-7288
  • [Journal-full-title] Italian journal of pediatrics
  • [ISO-abbreviation] Ital J Pediatr
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Drug use / Neonatal intensive care unit / Nephrotoxicity / Preterm neonates
  •  go-up   go-down


23. Kim GS, Lee KS, Park CK, Kang SK, Kim DW, Oh SG, Oh BS, Jung Y, Kim S, Yun JS, Song SY, Na KJ, Jeong IS, Ahn BH: Nosocomial Infection in Adult Patients Undergoing Veno-Arterial Extracorporeal Membrane Oxygenation. J Korean Med Sci; 2017 Apr;32(4):593-598

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Data on the frequency of nosocomial infections during extracorporeal membrane oxygenation (ECMO) in adult populations remain scarce.
  • We investigated the risk factors for nosocomial infections in adult patients undergoing venoarterial ECMO (VA-ECMO) support.
  • Mean patient age was 60.6 ± 14.3 years and 21 (34.4%) patients were female.
  • There were 18 nosocomial infections in 14 (23.0%) patients.
  • These included respiratory tract infections in 9 cases and bloodstream infections in a further 9.
  • Therefore, to avoid the development of nosocomial infections, strategies to shorten the length of ECMO support should be applied whenever possible.
  • [MeSH-minor] Adult. Aged. Creatinine / blood. Female. Gram-Negative Bacteria / isolation & purification. Humans. Incidence. Male. Middle Aged. Multivariate Analysis. Odds Ratio. Proportional Hazards Models. Respiratory Tract Infections / diagnosis. Respiratory Tract Infections / therapy. Risk Factors. Shock, Cardiogenic / etiology. Time Factors. Young Adult

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] © 2017 The Korean Academy of Medical Sciences.
  • [Cites] ASAIO J. 2005 Sep-Oct;51(5):487-9 [16322701.001]
  • [Cites] Clin Infect Dis. 2012 Dec;55(12):1633-41 [22990851.001]
  • [Cites] Semin Respir Crit Care Med. 2011 Apr;32(2):115-38 [21506049.001]
  • [Cites] Pediatr Crit Care Med. 2006 Nov;7(6):546-50 [17006389.001]
  • [Cites] JAMA. 1995 Aug 23-30;274(8):639-44 [7637145.001]
  • [Cites] J Am Soc Nephrol. 2008 Mar;19(3):547-58 [18235097.001]
  • [Cites] Infect Control Hosp Epidemiol. 2013 Jan;34(1):24-30 [23221189.001]
  • [Cites] J Hosp Infect. 2014 Jul;87(3):152-8 [24856114.001]
  • [Cites] ASAIO J. 2013 May-Jun;59(3):202-10 [23644605.001]
  • [Cites] Am J Infect Control. 1988 Jun;16(3):128-40 [2841893.001]
  • [Cites] Clin Nephrol. 2011 Sep;76(3):165-73 [21888852.001]
  • [Cites] J Trauma Acute Care Surg. 2013 Apr;74(4):1005-13 [23511138.001]
  • [Cites] J Pediatr Surg. 1995 Jun;30(6):809-12 [7666312.001]
  • [Cites] N Engl J Med. 1972 Mar 23;286(12 ):629-34 [5060491.001]
  • [Cites] Artif Organs. 2013 Dec;37(12):1080-1 [24329546.001]
  • [Cites] Pediatr Crit Care Med. 2011 May;12(3):277-81 [20495508.001]
  • [Cites] Contrib Nephrol. 2011;174:56-64 [21921609.001]
  • [Cites] Clin Infect Dis. 1999 Apr;28(4):828-33 [10825046.001]
  • [Cites] Lancet. 2009 Oct 17;374(9698):1351-63 [19762075.001]
  • [Cites] ASAIO J. 2016 Jan-Feb;62(1):80-6 [26579980.001]
  • [Cites] Clin Infect Dis. 2009 Mar 1;48(5):503-35 [19191635.001]
  • (PMID = 28244284.001).
  • [ISSN] 1598-6357
  • [Journal-full-title] Journal of Korean medical science
  • [ISO-abbreviation] J. Korean Med. Sci.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Korea (South)
  • [Chemical-registry-number] AYI8EX34EU / Creatinine
  • [Keywords] NOTNLM ; Extracorporeal Membrane Oxygenation Support / Infection
  •  go-up   go-down


24. Beccari MV, Meaney CJ: Clinical utility of patiromer, sodium zirconium cyclosilicate, and sodium polystyrene sulfonate for the treatment of hyperkalemia: an evidence-based review. Core Evid; 2017;12:11-24

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Electrolyte abnormalities occurred with patiromer and SPS, whereas urinary tract infections, edema, and corrected QT-interval prolongations were reported with ZS9.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Curr Med Res Opin. 2016;32(1):155-64 [26456884.001]
  • [Cites] Am J Med. 2000 Sep;109(4):307-14 [10996582.001]
  • [Cites] J Am Soc Nephrol. 1998 Oct;9(10):1924-30 [9773794.001]
  • [Cites] N Engl J Med. 1961 Jan 19;264:115-9 [13747532.001]
  • [Cites] Clin J Am Soc Nephrol. 2010 Oct;5(10):1723-6 [20798253.001]
  • [Cites] Burns. 2002 Mar;28(2):189-90 [11900946.001]
  • [Cites] N Engl J Med. 2015 Apr 16;372(16):1577-8 [25875277.001]
  • [Cites] J Am Soc Nephrol. 2010 May;21(5):733-5 [20167700.001]
  • [Cites] Kidney Int. 2015 Aug;88(2):404-11 [25651363.001]
  • [Cites] Circ Heart Fail. 2010 Mar;3(2):253-60 [20103777.001]
  • [Cites] N Engl J Med. 2015 Jan 15;372(3):222-31 [25415807.001]
  • [Cites] Eur J Heart Fail. 2015 Oct;17(10):1050-6 [26011677.001]
  • [Cites] Eur Heart J. 2011 Apr;32(7):820-8 [21208974.001]
  • [Cites] Kidney Int. 2015 Dec;88(6):1427-1433 [26376130.001]
  • [Cites] J Am Soc Nephrol. 1998 Aug;9(8):1535-43 [9697678.001]
  • [Cites] Am J Kidney Dis. 1992 Aug;20(2):159-61 [1496969.001]
  • [Cites] Am J Cardiol. 2012 May 15;109(10):1510-3 [22342847.001]
  • [Cites] Eur J Heart Fail. 2015 Oct;17(10):1057-65 [26459796.001]
  • [Cites] Am J Med. 2013 Mar;126(3):264.e9-24 [23321430.001]
  • [Cites] PLoS One. 2014 Dec 22;9(12):e114686 [25531770.001]
  • [Cites] Gastroenterology. 1995 Mar;108(3):752-60 [7875477.001]
  • [Cites] JAMA. 2014 Dec 3;312(21):2223-33 [25402495.001]
  • [Cites] Circulation. 2013 Oct 15;128(16):e240-327 [23741058.001]
  • [Cites] Clin J Am Soc Nephrol. 2015 Jun 5;10(6):1050-60 [24721891.001]
  • [Cites] Drug Saf. 2014 Sep;37(9):677-92 [25047526.001]
  • [Cites] Exp Clin Cardiol. 2010 Winter;15(4):e96-9 [21264075.001]
  • [Cites] N Engl J Med. 2004 Aug 5;351(6):585-92 [15295051.001]
  • [Cites] J Intensive Care Med. 2005 Sep-Oct;20(5):272-90 [16145218.001]
  • [Cites] N Engl J Med. 2015 Jan 15;372(3):211-21 [25415805.001]
  • [Cites] J Ayub Med Coll Abbottabad. 2014 Oct-Dec;26(4):455-8 [25672163.001]
  • [Cites] Clin J Am Soc Nephrol. 2015 Dec 7;10 (12 ):2136-42 [26576619.001]
  • [Cites] JAMA. 2015 Jul 14;314(2):151-61 [26172895.001]
  • (PMID = 28356904.001).
  • [ISSN] 1555-1741
  • [Journal-full-title] Core evidence
  • [ISO-abbreviation] Core Evid
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] New Zealand
  • [Keywords] NOTNLM ; evidence-based review / hyperkalemia / patiromer / sodium polystyrene sulfonate / sodium zirconium cyclosilicate
  •  go-up   go-down


25. Russell CJ, Mack WJ, Schrager SM, Wu S: Care Variations and Outcomes for Children Hospitalized With Bacterial Tracheostomy-Associated Respiratory Infections. Hosp Pediatr; 2017 01;7(1):16-23
MedlinePlus Health Information. consumer health - Health Screening.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Care Variations and Outcomes for Children Hospitalized With Bacterial Tracheostomy-Associated Respiratory Infections.
  • OBJECTIVES: Identify hospital-level care variations and association with length of stay (LOS) and hospital revisit in children with tracheostomies hospitalized for bacterial respiratory tract infections (bRTIs).
  • After adjusting for patient and hospital characteristics, compared with low test utilization hospitals, there were no differences in 30-day all-cause revisit rates in moderate (adjusted odds ratio: 1.19; 95% confidence interval [CI]: 0.93-1.52) or high (adjusted odds ratio: 1.07; 95% CI: 0.82-1.39) utilization hospitals.
  • [MeSH-major] Anti-Bacterial Agents / therapeutic use. Diagnostic Tests, Routine / utilization. Length of Stay / statistics & numerical data. Patient Readmission / statistics & numerical data. Tracheostomy / adverse effects
  • [MeSH-minor] California / epidemiology. Child. Child, Preschool. Cohort Studies. Female. Humans. Infant. Male. Odds Ratio. Outcome and Process Assessment (Health Care). Patient Care Management / methods. Patient Care Management / statistics & numerical data. Pseudomonas Infections / diagnosis. Pseudomonas Infections / drug therapy. Respiratory Tract Infections / diagnosis. Respiratory Tract Infections / drug therapy. Retrospective Studies

  • MedlinePlus Health Information. consumer health - Antibiotics.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 by the American Academy of Pediatrics.
  • [Cites] Pediatr Crit Care Med. 2008 Jan;9(1):96-100 [18477921.001]
  • [Cites] JAMA. 2013 Jan 23;309(4):372-80 [23340639.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 2003 May;129(5):523-9 [12759264.001]
  • [Cites] J Pediatr. 2014 Sep;165(3):585-91 [24973795.001]
  • [Cites] JAMA Pediatr. 2013 Sep;167(9):851-8 [23896966.001]
  • [Cites] Int J Pediatr Otorhinolaryngol. 1996 Apr;35(2):171-7 [8735413.001]
  • [Cites] Chest. 1998 Jun;113(6):1549-54 [9631792.001]
  • [Cites] JAMA Pediatr. 2013 Oct;167(10):911-8 [23921627.001]
  • [Cites] J Asthma. 2013 Oct;50(8):821-7 [23789734.001]
  • [Cites] Otolaryngol Head Neck Surg. 2014 Aug;151(2):232-9 [24788698.001]
  • [Cites] Laryngoscope. 2015 Feb;125(2):462-8 [24986601.001]
  • [Cites] Pediatrics. 2000 Jul;106(1 Pt 2):205-9 [10888693.001]
  • [Cites] Clin Infect Dis. 2011 Oct;53(7):e25-76 [21880587.001]
  • [Cites] Chest. 2012 Mar;141(3):625-631 [21436240.001]
  • [Cites] Arch Dis Child. 2010 Sep;95(9):703-10 [20522454.001]
  • [Cites] Pediatr Emerg Care. 2011 Jul;27(7):606-10 [21712748.001]
  • [Cites] Pediatrics. 2005 Apr;115(4):878-84 [15805359.001]
  • [Cites] J Pediatr. 2013 Oct;163(4):1034-8.e1 [23683748.001]
  • [Cites] Clin Infect Dis. 2016 Sep 1;63(5):e61-e111 [27418577.001]
  • [Cites] Pediatr Infect Dis J. 2012 Oct;31(10):1036-41 [22653486.001]
  • [Cites] J Pediatr. 2014 Oct;165(4):786-92.e1 [25015578.001]
  • [Cites] Hosp Pediatr. 2015 Apr;5(4):185-92 [25832973.001]
  • [Cites] Semin Pediatr Infect Dis. 2006 Jan;17(1):11-3 [16522500.001]
  • [Cites] Pediatrics. 2009 Aug;124(2):563-72 [19596736.001]
  • [Cites] Laryngoscope. 2013 Oct;123(10):2560-6 [23907959.001]
  • (PMID = 27998905.001).
  • [ISSN] 2154-1663
  • [Journal-full-title] Hospital pediatrics
  • [ISO-abbreviation] Hosp Pediatr
  • [Language] eng
  • [Grant] United States / NCATS NIH HHS / TR / KL2 TR000131
  • [Publication-type] Journal Article; Multicenter Study; Research Support, N.I.H., Extramural
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Bacterial Agents
  •  go-up   go-down


26. Truong DT, Bui MT, Memon P, Cavanagh HD: Microbial Keratitis at an Urban Public Hospital: A 10-Year Update. J Clin Exp Ophthalmol; 2015 Dec;6(6)
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the past ten years, epidemiology has shifted towards greater contact lens wear with more Pseudomonal infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Refract Surg. 1997 Jul-Aug;13(4):388-91 [9268940.001]
  • [Cites] Cornea. 1998 May;17(3):282-7 [9603384.001]
  • [Cites] Am J Ophthalmol. 2002 Apr;133(4):463-6 [11931779.001]
  • [Cites] Ophthalmology. 2015 May;122(5):918-24 [25600200.001]
  • [Cites] Lancet. 1991 Sep 14;338(8768):650-3 [1679472.001]
  • [Cites] Cornea. 2005 Mar;24(2):201-5 [15725889.001]
  • [Cites] Arch Ophthalmol. 1997 Apr;115(4):462-5 [9109753.001]
  • [Cites] Cornea. 2010 Oct;29(10):1131-5 [20595899.001]
  • [Cites] Cornea. 2008 Jan;27(1):22-7 [18245962.001]
  • [Cites] Br J Ophthalmol. 1987 Feb;71(2):96-101 [3103672.001]
  • [Cites] Eye (Lond). 2011 Apr;25(4):489-93 [21252952.001]
  • [Cites] Ophthalmology. 1997 Nov;104(11):1902-9 [9373124.001]
  • [Cites] Int Ophthalmol Clin. 1973 Winter;13(4):1-29 [4784000.001]
  • [Cites] Eye Contact Lens. 2010 Jul;36(4):195-200 [20626115.001]
  • [Cites] Ophthalmology. 1996 Mar;103(3):479-84 [8600426.001]
  • [Cites] Ophthalmology. 2000 Aug;107(8):1497-502 [10919897.001]
  • [Cites] Indian J Ophthalmol. 2009 Jul-Aug;57(4):273-9 [19574694.001]
  • [Cites] Arch Ophthalmol. 2003 Sep;121(9):1229-33 [12963604.001]
  • [Cites] Graefes Arch Clin Exp Ophthalmol. 1996 Dec;234(12):731-8 [8986444.001]
  • [Cites] Ophthalmology. 2012 Sep;119(9):1785-90 [22627118.001]
  • [Cites] Clin Exp Ophthalmol. 2011 Jul;39(5):393-7 [21176039.001]
  • [Cites] J Ocul Pharmacol Ther. 2013 Apr;29(3):339-44 [23289847.001]
  • [Cites] MMWR Morb Mortal Wkly Rep. 2015 Aug 21;64(32):865-70 [26292204.001]
  • [Cites] Eye Contact Lens. 2007 Jan;33(1):45-9 [17224678.001]
  • (PMID = 28540138.001).
  • [ISSN] 2155-9570
  • [Journal-full-title] Journal of clinical & experimental ophthalmology
  • [ISO-abbreviation] J Clin Exp Ophthalmol
  • [Language] eng
  • [Grant] United States / NEI NIH HHS / EY / P30 EY020799
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; Antibiotic resistance / Corneal ulcer / Keratitis / Microbial keratitis
  •  go-up   go-down


27. Siren PM: SIDS-CDF Hypothesis Revisited: Cause vs. Contributing Factors. Front Neurol; 2016;7:244
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • There are several known SIDS factors, such as the prone sleeping position, non-lethal infections, deep sleep, gestational prematurity, low birth weight, cigarette smoke, male gender, and altitude, but of these, some such as the prone sleeping position more significantly both impact diaphragm function and correlate with SIDS.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Lancet. 1984 Nov 24;2(8413):1199-201 [6150244.001]
  • [Cites] Magnesium. 1984;3(2):57-62 [6503356.001]
  • [Cites] Ups J Med Sci. 2014 Mar;119(1):55-6 [24151935.001]
  • [Cites] Clin Exp Pharmacol Physiol. 1995 Aug;22(8):527-32 [7586708.001]
  • [Cites] Forensic Sci Med Pathol. 2016 Mar;12 (1):33-9 [26662848.001]
  • [Cites] Am J Clin Nutr. 2014 Sep;100(3):974-81 [25008857.001]
  • [Cites] Magnes Res. 2005 Mar;18(1):12-8 [15945612.001]
  • [Cites] J Basic Clin Physiol Pharmacol. 1992 Apr-Jun;3(2):139-51 [1295571.001]
  • [Cites] Physiol Rev. 2015 Jan;95(1):1-46 [25540137.001]
  • [Cites] Magnes Res. 1991 Sep-Dec;4(3-4):137-52 [1799550.001]
  • [Cites] Am J Respir Crit Care Med. 2005 Oct 1;172(7):861-8 [15994462.001]
  • [Cites] Eur J Pediatr. 1980 Sep;134(3):239-43 [7428773.001]
  • [Cites] Magnes Res. 2001 Mar;14(1-2):39-50 [11300621.001]
  • [Cites] Thorax. 1981 Mar;36(3):164-8 [7281080.001]
  • [Cites] J Appl Physiol (1985). 2004 Aug;97(2):669-74 [15247199.001]
  • [Cites] Lancet. 1973 May 26;1(7813):1176 [4123554.001]
  • [Cites] Lancet. 1990 Nov 3;336(8723):1104 [1977987.001]
  • [Cites] Lancet. 1979 Jan 27;1(8109):220 [84247.001]
  • [Cites] Am Rev Respir Dis. 1984 Mar;129(3):497-8 [6703506.001]
  • [Cites] Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L994-L1001 [19376888.001]
  • [Cites] Magnes Res. 2001 Dec;14(4):291-303 [11794637.001]
  • [Cites] Lancet. 1972 Aug 5;2(7771):258-62 [4114510.001]
  • [Cites] Temperature (Austin). 2016 Feb 18;3(1):146-60 [27227102.001]
  • [Cites] Lancet. 1968 Jul 6;2(7558):18-21 [4172684.001]
  • [Cites] Acta Med Scand. 1977;201(4):273-80 [851037.001]
  • [Cites] Respir Physiol Neurobiol. 2013 Nov 1;189(2):301-14 [23851109.001]
  • [Cites] J Hyg (Lond). 1905 Oct;5(4):494-513 [20474239.001]
  • [Cites] Dev Med Child Neurol. 1976 Aug;18(4):480-92 [955312.001]
  • [Cites] Innate Immun. 2011 Feb;17(3):321-6 [20472613.001]
  • [Cites] J Neuropathol Exp Neurol. 2014 Feb;73(2):115-22 [24423636.001]
  • [Cites] Ups J Med Sci. 2011 May;116(2):115-23 [21222555.001]
  • [Cites] Ups J Med Sci. 2013 May;118(2):143-4 [23570456.001]
  • [Cites] BMJ. 1992 Feb 1;304(6822):277-82 [1739826.001]
  • [Cites] Ups J Med Sci. 2016 Aug;121(3):199-201 [27460606.001]
  • [Cites] Acta Med Scand Suppl. 1981;647:125-37 [7020347.001]
  • [Cites] Magnes Res. 2010 Sep;23(3):138-41 [20860960.001]
  • [Cites] BMJ. 1990 Jul 14;301(6743):85-9 [2390588.001]
  • [Cites] Magnes Res. 2001 Sep;14(3):227-38 [11599557.001]
  • [Cites] J Forensic Sci. 2014 Nov;59(6):1650-3 [24975687.001]
  • [Cites] Int J Legal Med. 1996;109(3):139-42 [8956988.001]
  • [Cites] Pediatrics. 1979 Sep;64(3):369-74 [481982.001]
  • [Cites] Ups J Med Sci. 2011 Aug;116(3):220 [21671726.001]
  • [Cites] Epidemiol Rev. 1997;19(2):258-72 [9494787.001]
  • [Cites] Pediatr Res. 1983 Oct;17(10):784-7 [6634242.001]
  • [Cites] Ups J Med Sci. 2013 Mar;118(1):62-4 [23153369.001]
  • [Cites] Lancet. 1972 Oct 21;2(7782):871 [4116568.001]
  • [Cites] BMC Med. 2011 May 27;9:64 [21619576.001]
  • (PMID = 28138321.001).
  • [ISSN] 1664-2295
  • [Journal-full-title] Frontiers in neurology
  • [ISO-abbreviation] Front Neurol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; SIDS / diaphragm / hyperthermia / magnesium deficiency / respiratory failure
  •  go-up   go-down


28. Courjon J, Demonchy E, Degand N, Risso K, Ruimy R, Roger PM: Patients with community-acquired bacteremia of unknown origin: clinical characteristics and usefulness of microbiological results for therapeutic issues: a single-center cohort study. Ann Clin Microbiol Antimicrob; 2017 May 19;16(1):40

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Eleven patients had polymicrobial infections.
  • The leading bacterial species involved were Escherichia coli 25/115 (22%), group D Streptococci 12/115 (10%), viridans Streptococci 12/115 (10%) and Staphylococcus aureus 11/115 (9%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virulence. 2016 Apr 2;7(3):248-51 [26890622.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2014 Nov;33(11):1973-80 [24907852.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Jun;163(7):1584-90 [11401878.001]
  • [Cites] J Infect. 2014 Feb;68(2):149-55 [24429297.001]
  • [Cites] Clin Microbiol Infect. 2003 Aug;9(8):793-802 [14616699.001]
  • [Cites] Clin Microbiol Rev. 2014 Oct;27(4):870-926 [25278577.001]
  • [Cites] J Infect. 2017 Feb;74(2):131-141 [27838521.001]
  • [Cites] Infection. 2011 Dec;39(6):549-54 [21898120.001]
  • [Cites] Crit Care. 2015 Aug 27;19:302 [26307060.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2007 Jul;26(7):453-7 [17541655.001]
  • [Cites] Chest. 2003 May;123(5):1615-24 [12740282.001]
  • [Cites] Clin Microbiol Infect. 2011 Oct;17(10):1581-6 [21073629.001]
  • [Cites] Clin Infect Dis. 2002 Jul 15;35(2):156-61 [12087521.001]
  • [Cites] Clin Microbiol Infect. 2008 Jan;14 Suppl 1:144-53 [18154538.001]
  • [Cites] Clin Infect Dis. 1992 Feb;14(2):436-43 [1445517.001]
  • [Cites] Crit Care. 2016 Nov 6;20(1):360 [27816060.001]
  • [Cites] Med Mal Infect. 2008 Sep;38(9):457-64 [18707833.001]
  • [Cites] Crit Care. 2015 Feb 16;19:63 [25888181.001]
  • [Cites] Clin Infect Dis. 1997 Apr;24(4):584-602 [9145732.001]
  • (PMID = 28526094.001).
  • [ISSN] 1476-0711
  • [Journal-full-title] Annals of clinical microbiology and antimicrobials
  • [ISO-abbreviation] Ann. Clin. Microbiol. Antimicrob.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Antimicrobial resistance / Bacteremia / Bacteremia of unknown origin / Empirical antibiotic treatment / Primary bacteremia / Severe sepsis
  •  go-up   go-down


29. Boyce KJ, Wang Y, Verma S, Shakya VPS, Xue C, Idnurm A: Mismatch Repair of DNA Replication Errors Contributes to Microevolution in the Pathogenic Fungus &lt;i&gt;Cryptococcus neoformans&lt;/i&gt;. MBio; 2017 May 30;8(3)

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • <b>IMPORTANCE</b> Fungi account for a large number of infections that are extremely difficult to treat; superficial fungal infections affect approximately 1.7 billion (25%) of the general population worldwide, and systemic fungal diseases result in an unacceptably high mortality rate.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Boyce et al.
  • [Cites] Eukaryot Cell. 2004 Apr;3(2):420-9 [15075272.001]
  • [Cites] Mol Biol Evol. 2012 Aug;29(8):1987-2000 [22334577.001]
  • [Cites] G3 (Bethesda). 2017 Apr 3;7(4):1165-1176 [28188180.001]
  • [Cites] J Infect Dis. 1998 Dec;178(6):1761-6 [9815230.001]
  • [Cites] Cell. 2008 Oct 3;135(1):174-88 [18854164.001]
  • [Cites] Eukaryot Cell. 2013 Jan;12(1):12-22 [23087368.001]
  • [Cites] J Bacteriol. 2013 Feb;195(3):615-28 [23204459.001]
  • [Cites] Genetics. 2013 Apr;193(4):1025-64 [23547164.001]
  • [Cites] PLoS Pathog. 2012;8(10):e1002936 [23055925.001]
  • [Cites] AIDS. 2009 Feb 20;23(4):525-30 [19182676.001]
  • [Cites] Science. 2006 Jul 21;313(5785):367-70 [16857942.001]
  • [Cites] G3 (Bethesda). 2013 Apr 9;3(4):675-686 [23550133.001]
  • [Cites] J Med Vet Mycol. 1992;30(1):61-9 [1573522.001]
  • [Cites] PLoS Pathog. 2010 Apr 01;6(4):e1000848 [20368972.001]
  • [Cites] G3 (Bethesda). 2013 Sep 04;3(9):1453-65 [23821616.001]
  • [Cites] Eur J Clin Microbiol Infect Dis. 2001 Aug;20(8):535-43 [11681432.001]
  • [Cites] J Clin Microbiol. 1996 Jul;34(7):1739-44 [8784580.001]
  • [Cites] Proc Natl Acad Sci U S A. 2014 Feb 4;111(5):1897-902 [24449905.001]
  • [Cites] Semin Cell Dev Biol. 2013 Apr;24(4):339-46 [23380396.001]
  • [Cites] MBio. 2014 Jul 29;5(4):e01494-14 [25073643.001]
  • [Cites] FEMS Yeast Res. 2007 Jan;7(1):152-64 [17311593.001]
  • [Cites] Diagn Microbiol Infect Dis. 2014 Dec;80(4):294-8 [25277745.001]
  • [Cites] Science. 1996 Nov 15;274(5290):1208-11 [8895473.001]
  • [Cites] Bioinformatics. 2009 Jun 15;25(12):1564-5 [19369502.001]
  • [Cites] Mol Microbiol. 2008 May;68(3):624-41 [18363649.001]
  • [Cites] Curr Opin Chem Biol. 2011 Oct;15(5):620-6 [21862387.001]
  • [Cites] Infect Immun. 2003 Sep;71(9):4831-41 [12933823.001]
  • [Cites] Prog Nucleic Acid Res Mol Biol. 2006;81:1-49 [16891168.001]
  • [Cites] Microbiology. 2008 Aug;154(Pt 8):2446-56 [18667577.001]
  • [Cites] Mutat Res. 1998 May 25;400(1-2):99-115 [9685598.001]
  • [Cites] J Biol Chem. 2005 Aug 19;280(33):29980-7 [15964835.001]
  • [Cites] Mol Microbiol. 2006 May;60(4):820-7 [16677295.001]
  • [Cites] PLoS Genet. 2012;8(10):e1003016 [23071460.001]
  • [Cites] J Bacteriol. 1993 Mar;175(5):1405-11 [8444802.001]
  • [Cites] PLoS Genet. 2014 Apr 17;10(4):e1004261 [24743168.001]
  • [Cites] Nat Commun. 2016 Mar 29;7:11128 [27020939.001]
  • [Cites] Infect Immun. 2009 Aug;77(8):3188-95 [19487475.001]
  • [Cites] Acc Chem Res. 2010 Feb 16;43(2):280-7 [19938827.001]
  • [Cites] Science. 2000 May 19;288(5469):1251-4 [10818002.001]
  • [Cites] Curr Biol. 2003 Apr 29;13(9):744-8 [12725731.001]
  • [Cites] Antimicrob Agents Chemother. 2009 Jul;53(7):2804-15 [19414582.001]
  • (PMID = 28559486.001).
  • [ISSN] 2150-7511
  • [Journal-full-title] mBio
  • [ISO-abbreviation] MBio
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; microevolution / mismatch repair / pathogens
  •  go-up   go-down


30. de Wolf ACMT, van Aalst S, Ludwig IS, Bodinham CL, Lewis DJ, van der Zee R, van Eden W, Broere F: Regulatory T cell frequencies and phenotypes following anti-viral vaccination. PLoS One; 2017;12(6):e0179942

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, these cells may also interfere with resolution of infections or with immune reactions following vaccination.
  • Taken together, we showed that vaccination with vaccines with an already established safe profile have only minimal impact on frequencies and characteristics of Treg over time.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Arch Virol. 2013 Nov;158(11):2267-72 [23728719.001]
  • [Cites] PLoS One. 2016 Mar 17;11(3):e0151717 [26986976.001]
  • [Cites] BMC Immunol. 2012 Apr 11;13:17 [22489829.001]
  • [Cites] Curr Opin Immunol. 2014 Apr;27:1-7 [24413387.001]
  • [Cites] Nat Rev Immunol. 2014 May;14(5):343-9 [24722479.001]
  • [Cites] Dig Dis Sci. 2014 Jul;59(7):1475-83 [24442238.001]
  • [Cites] Ann N Y Acad Sci. 2016 Feb 25;:null [26918796.001]
  • [Cites] Clin Exp Immunol. 2007 Apr;148(1):90-100 [17309541.001]
  • [Cites] Hum Immunol. 2012 Apr;73(4):335-41 [22342871.001]
  • [Cites] J Immunol. 2013 Mar 1;190(5):2150-8 [23338234.001]
  • [Cites] Pediatr Res. 2015 Nov;78(5):483-91 [26267154.001]
  • [Cites] Virol J. 2011 May 10;8:215 [21569236.001]
  • [Cites] Vaccine. 2016 Apr 12;34(17 ):2027-34 [26768126.001]
  • [Cites] Am J Transplant. 2010 Nov;10(11):2410-20 [20977632.001]
  • [Cites] Immunol Lett. 2009 Feb 21;122(2):108-11 [19100777.001]
  • [Cites] Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2011 Nov;36(11):1046-51 [22169715.001]
  • [Cites] Front Microbiol. 2014 Sep 11;5:477 [25309517.001]
  • [Cites] J Autoimmun. 2013 Dec;47:1-16 [24238833.001]
  • [Cites] PLoS One. 2009 Dec 23;4(12):e8393 [20037642.001]
  • [Cites] Expert Opin Biol Ther. 2010 Nov;10(11):1563-72 [20932226.001]
  • [Cites] Clin Immunol. 2010 Feb;134(2):113-20 [19846344.001]
  • [Cites] Immunity. 2009 Jun 19;30(6):899-911 [19464196.001]
  • [Cites] Microb Biotechnol. 2012 Mar;5(2):260-9 [21951341.001]
  • [Cites] J Immunol Res. 2015;2015:909406 [26380327.001]
  • [Cites] PLoS One. 2016 Jun 23;11(6):e0157066 [27336786.001]
  • [Cites] Vaccine. 2012 Aug 17;30(38):5595-602 [22781305.001]
  • [Cites] Front Immunol. 2015 Sep 14;6:471 [26441976.001]
  • [Cites] Cell Transplant. 2011;20(11-12):1747-58 [21457615.001]
  • [Cites] Hemodial Int. 2016 Apr;20(2):242-52 [26104830.001]
  • [Cites] Hepatology. 2012 Sep;56(3):873-83 [22487943.001]
  • [Cites] J Leukoc Biol. 2001 Dec;70(6):849-60 [11739546.001]
  • [Cites] Nat Rev Immunol. 2010 Jul;10(7):490-500 [20559327.001]
  • [Cites] Nat Rev Immunol. 2014 Mar;14(3):154-65 [24481337.001]
  • [Cites] Viral Immunol. 2015 Dec;28(10 ):580-9 [26501792.001]
  • [Cites] Virusdisease. 2014 Jan;25(1):18-25 [24426307.001]
  • [Cites] Nature. 1999 Oct 14;401(6754):708-12 [10537110.001]
  • [Cites] J Clin Invest. 2005 Jul;115(7):1953-62 [16007258.001]
  • [Cites] Immunology. 2012 May;136(1):1-10 [22211994.001]
  • [Cites] Immunol Rev. 2006 Aug;212:8-27 [16903903.001]
  • [Cites] Blood. 2007 Aug 15;110(4):1225-32 [17449799.001]
  • [Cites] J Exp Med. 2007 Jun 11;204(6):1257-65 [17502665.001]
  • [Cites] Immunology. 2009 Apr;126(4):466-74 [19278420.001]
  • [Cites] J Virol. 2012 Mar;86(5):2817-25 [22205730.001]
  • [Cites] J Exp Med. 2001 Sep 17;194(6):847-53 [11560999.001]
  • (PMID = 28658271.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


31. Al-Azri MH, Al-Belushi R, Al-Mamari M, Davidson R, Mathew AC: Knowledge and Health Beliefs Regarding Sickle Cell Disease Among Omanis in a Primary Healthcare Setting: Cross-sectional study. Sultan Qaboos Univ Med J; 2016 Nov;16(4):e437-e444

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Few participants were aware that SCD can be very painful (20.2%) and can cause strokes, infections and organ damage (20.0%).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] J Trop Pediatr. 2003 Jul;49 Suppl 1:i1-20 [12934793.001]
  • [Cites] Ann Hum Biol. 2000 May-Jun;27(3):321-6 [10834296.001]
  • [Cites] J Pediatr Psychol. 2013 Sep;38(8):809-28 [23843630.001]
  • [Cites] Health Educ Q. 1988 Summer;15(2):175-83 [3378902.001]
  • [Cites] J Pediatr Hematol Oncol. 2007 Nov;29(11):752-60 [17984693.001]
  • [Cites] J Natl Med Assoc. 2009 Nov;101(11):1163-72 [19998646.001]
  • [Cites] Arch Intern Med. 2005 Dec 12-26;165(22):2618-24 [16344419.001]
  • [Cites] Am J Prev Med. 2011 Dec;41(6 Suppl 4):S376-83 [22099361.001]
  • [Cites] Niger Postgrad Med J. 2000 Sep;7(3):120-3 [11257917.001]
  • [Cites] J Natl Med Assoc. 2015 Feb;107(1):4-10 [27282522.001]
  • [Cites] J Genet Couns. 2011 Dec;20(6):572-92 [21748660.001]
  • [Cites] Sultan Qaboos Univ Med J. 2011 Nov;11(4):462-9 [22087394.001]
  • [Cites] Ann Saudi Med. 2010 Jul-Aug;30(4):284-8 [20622345.001]
  • [Cites] Blood. 2010 Jun 3;115(22):4331-6 [20233970.001]
  • [Cites] Cochrane Database Syst Rev. 2009 Jul 08;(3):CD001431 [19588325.001]
  • [Cites] Genet Med. 2007 May;9(5):303-10 [17505208.001]
  • [Cites] J Natl Med Assoc. 2005 Jan;97(1):62-7 [15719873.001]
  • [Cites] J Natl Med Assoc. 2005 Mar;97(3):405-8 [15779507.001]
  • [Cites] J Community Genet. 2012 Jul;3(3):185-92 [22109912.001]
  • [Cites] Trends Parasitol. 2011 Jul;27(7):315-20 [21429801.001]
  • [Cites] Bull World Health Organ. 2008 Jun;86(6):480-7 [18568278.001]
  • [Cites] Reprod Health. 2009 Oct 08;6:17 [19811666.001]
  • [Cites] East Mediterr Health J. 2001 Nov;7(6):1004-11 [15332742.001]
  • [Cites] BMC Public Health. 2014 Apr 17;14:380 [24742222.001]
  • [Cites] ANS Adv Nurs Sci. 1984 Apr;6(3):73-85 [6426380.001]
  • [Cites] J Natl Med Assoc. 2006 May;98(5):704-10 [16749645.001]
  • [Cites] Oman Med J. 2012 Jul;27(4):291-6 [23071880.001]
  • [Cites] Pediatr Blood Cancer. 2012 Aug;59(2):386-90 [22535620.001]
  • [Cites] BMJ. 2006 Oct 21;333(7573):831-4 [17053236.001]
  • (PMID = 28003889.001).
  • [ISSN] 2075-0528
  • [Journal-full-title] Sultan Qaboos University medical journal
  • [ISO-abbreviation] Sultan Qaboos Univ Med J
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Oman
  • [Keywords] NOTNLM ; Awareness / Genetic Screening / Oman / Primary Health Care / Sickle Cell Disease
  •  go-up   go-down


32. Schiavone MB, Moukarzel L, Leong K, Zhou QC, Afonso AM, Iasonos A, Roche KL, Leitao MM Jr, Chi DS, Abu-Rustum NR, Zivanovic O: Surgical site infection reduction bundle in patients with gynecologic cancer undergoing colon surgery. Gynecol Oncol; 2017 Jul 19;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • OBJECTIVE: Surgical site infections (SSIs) can lead to substantial morbidity, prolonged hospitalization, increased costs, and death in patients undergoing colorectal procedures.
  • METHODS: We identified all gynecologic cancer patients who underwent colon resection at our institution from 2014 to 2016, during which time a service-wide SSI reduction bundle was introduced.
  • RESULTS: Of 233 identified patients, 115 had undergone colon surgery prior to (PRE) and 118 after (POST) the implementation of the intervention.
  • The incidence of SSI within 30days of surgery was 43/115 (37%) in the PRE and 14/118 (12%) in the POST cohorts (p≤0.001).
  • Wound dehiscence was noted in 30/115 (26%) and 2/118 (2%) patients, respectively (p≤0.001).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 Elsevier Inc. All rights reserved.
  • (PMID = 28734498.001).
  • [ISSN] 1095-6859
  • [Journal-full-title] Gynecologic oncology
  • [ISO-abbreviation] Gynecol. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


33. Culakova E, Khorana A, Kuderer NM, Crawford J, Dale DC, Lyman GH, Anc Study Group: Hospitalization with febrile neutropenia in colorectal cancer patients. J Clin Oncol; 2004 Jul 15;22(14_suppl):3706

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • METHODS: Hospitalization of colorectal cancer patients with FN at 115 academic medical centers between 1995 and 2000 was studied using the discharge database of the University HealthSystem Consortium.
  • Clinical infection was reported in 57% of patients with microbiologically documented infection reported in 31% including gram-negative sepsis in 8.5%, gram-positive in 2.7% and other bacterial infections in 17.5%.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28013684.001).
  • [ISSN] 1527-7755
  • [Journal-full-title] Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • [ISO-abbreviation] J. Clin. Oncol.
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


34. Peetoom KKB, Crutzen R, Bohnen JMHA, Verhoeven R, Nelissen-Vrancken HJMG, Winkens B, Dinant GJ, Cals JWL: Optimising decision making on illness absenteeism due to fever and common infections within childcare centres: development of a multicomponent intervention and study protocol of a cluster randomised controlled trial. BMC Public Health; 2017 Jul 26;18(1):61

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Optimising decision making on illness absenteeism due to fever and common infections within childcare centres: development of a multicomponent intervention and study protocol of a cluster randomised controlled trial.
  • BACKGROUND: Evidence has shown that children 0-4 year-old attending childcare are prone to acquire infections compared to children cared for at home, with fever being the most common symptom.
  • Illness absenteeism due to fever and common infections is substantial and mostly driven by unrealistic concerns and negative attitude towards fever of both childcare staff and parents, resulting in illness absenteeism from childcare, work absenteeism among parents and healthcare service use.
  • The objective of this study is to optimise decision making among childcare staff on illness absenteeism due to fever and common infections in childcare.
  • 4) an information booklet regarding childhood fever, common infections, and self-management strategies for childcare staff and parents.
  • Secondary outcome measures are: incidence rate and duration of illness episodes, knowledge, attitude, self-efficacy, and risk perception on fever and common infections of childcare staff and parents, healthcare service use in general and paracetamol use, and work absenteeism of parents.
  • DISCUSSION: This study aims to develop a multicomponent intervention and to evaluate to what extent illness absenteeism due to fever and common infections can be affected by implementing a multicomponent intervention addressing decision making and underlying determinants among childcare staff and parents of children attending daycare.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] BMJ. 2013 Jan 08;346:e7586 [23303884.001]
  • [Cites] Infection. 1991 Jul-Aug;19(4):230-6 [1917034.001]
  • [Cites] Am J Infect Control. 2005 Jun;33(5):276-85 [15947744.001]
  • [Cites] BMC Pediatr. 2012 Jul 13;12:97 [22794080.001]
  • [Cites] Ann Intern Med. 2013 Feb 5;158(3):200-7 [23295957.001]
  • [Cites] Pediatrics. 2003 Apr;111(4 Pt 1):e371-5 [12671154.001]
  • [Cites] Acta Paediatr. 2008 Dec;97(12):1672-80 [18945282.001]
  • [Cites] Fam Pract. 2003 Dec;20(6):717-23 [14701898.001]
  • [Cites] Am J Respir Crit Care Med. 1997 Jan;155(1):156-61 [9001305.001]
  • [Cites] Fam Pract. 2015 Aug;32(4):449-55 [25914101.001]
  • [Cites] Arch Dis Child. 2015 Sep;100(9):818-20 [25977564.001]
  • [Cites] Stat Methods Med Res. 2008 Aug;17(4):439-58 [17698940.001]
  • [Cites] J Adv Nurs. 2005 Mar;49(5):453-64 [15713177.001]
  • [Cites] Pediatrics. 1984 Nov;74(5 Pt 2):929-36 [6333668.001]
  • [Cites] Am J Dis Child. 1980 Feb;134(2):176-81 [7352443.001]
  • [Cites] Pediatrics. 1988 May;81(5):662-7 [3357726.001]
  • [Cites] J Pediatr (Rio J). 2007 Jul-Aug;83(4):299-312 [17632670.001]
  • [Cites] Rev Infect Dis. 1986 Jul-Aug;8(4):521-6 [3529307.001]
  • [Cites] Int J Clin Pharm. 2016 Aug;38(4):761-70 [27315082.001]
  • [Cites] J Pediatr Health Care. 1996 Jul-Aug;10(4):167-73 [8920378.001]
  • [Cites] BMC Health Serv Res. 2016 Jul 08;16:240 [27393615.001]
  • [Cites] Br J Gen Pract. 2014 May;64(622):e302-12 [24771845.001]
  • [Cites] Fam Pract. 1998 Dec;15(6):513-8 [10078789.001]
  • [Cites] Am J Trop Med Hyg. 2007 Jun;76(6):1166-73 [17556631.001]
  • [Cites] BMC Fam Pract. 2015 Oct 07;16:131 [26446754.001]
  • [Cites] PLoS One. 2012;7(1):e30334 [22299036.001]
  • [Cites] Fam Pract. 2005 Aug;22(4):367-74 [15897210.001]
  • [Cites] CJEM. 2002 Nov;4(6):394-400 [17637156.001]
  • [Cites] Pediatrics. 2000 Apr;105(4 Pt 1):738-42 [10742313.001]
  • [Cites] BMC Infect Dis. 2012 Oct 15;12:259 [23066727.001]
  • [Cites] Br J Gen Pract. 2014 Jan;64(618):e10-6 [24567577.001]
  • [Cites] Pediatr Infect Dis J. 1999 Aug;18(8):672-7 [10462334.001]
  • [Cites] Fam Pract. 2006 Dec;23(6):618-23 [17035288.001]
  • [Cites] J Am Assoc Nurse Pract. 2015 Apr;27(4):222-9 [25066313.001]
  • [Cites] Arch Pediatr Adolesc Med. 2001 Apr;155(4):481-8 [11296076.001]
  • [Cites] Health Psychol Rev. 2017 Jun;11(2):103-121 [28110627.001]
  • [Cites] Patient Educ Couns. 2002 Jan;46(1):61-5 [11804771.001]
  • [Cites] Influenza Other Respir Viruses. 2013 Nov;7(6):1103-12 [23829670.001]
  • [Cites] PLoS One. 2014 Aug 20;9(8):e104940 [25141226.001]
  • [Cites] J Clin Epidemiol. 2004 Aug;57(8):785-94 [15485730.001]
  • [Cites] BMJ. 1996 Oct 19;313(7063):983-6 [8892420.001]
  • [Cites] Arch Dis Child. 2017 Mar;102(3):261-267 [27432451.001]
  • [Cites] Acta Paediatr. 2016 Jul;105(7):829-33 [26998922.001]
  • [Cites] Infection. 2004 Feb;32(1):2-7 [15007735.001]
  • [Cites] Pediatrics. 2005 May;115(5):1273-82 [15867035.001]
  • [Cites] J Gen Intern Med. 2008 Oct;23(10):1615-20 [18622651.001]
  • [Cites] Clin Pediatr (Phila). 2014 Feb;53(2):145-50 [24137024.001]
  • [Cites] Epidemiol Infect. 2015 Sep;143(12):2494-502 [25566827.001]
  • [Cites] Br J Gen Pract. 1998 Jan;48(426):880-4 [9604409.001]
  • [Cites] Trials. 2016 Nov 17;17 (1):547 [27855719.001]
  • [Cites] Scand J Prim Health Care. 2006 Mar;24(1):44-9 [16464814.001]
  • [Cites] BMC Fam Pract. 2013 Jul 28;14 :106 [23890343.001]
  • [Cites] Pediatrics. 2001 Jun;107(6):1241-6 [11389237.001]
  • [Cites] Arch Dis Child. 2016 Jan;101(1):42-50 [26471110.001]
  • [Cites] Pediatrics. 1994 Dec;94(6 Pt 2):991-4 [7971087.001]
  • [Cites] J Clin Nurs. 2007 Dec;16(12):2331-40 [17419783.001]
  • [Cites] Arch Pediatr Adolesc Med. 2000 Feb;154(2):180-3 [10665606.001]
  • (PMID = 28747169.001).
  • [ISSN] 1471-2458
  • [Journal-full-title] BMC public health
  • [ISO-abbreviation] BMC Public Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Childcare centres / Common infections / Fever / Illness absenteeism / Intervention mapping
  •  go-up   go-down


35. Er İ, Günlemez A, Uyan ZS, Aydoğan M, Oruç M, Işık O, Arısoy AE, Baydemir C, Gökalp AS: Evaluation of pulmonary functions in preschool children born late-preterm. Turk Pediatri Ars; 2017 Jun;52(2):72-78

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • In the postdischarge period, 54.1% were hospitalized for pulmonary infections at least once, and 57.8% were passive smoking currently.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Respir Crit Care Med. 2006 Feb 15;173(4):442-7 [16322648.001]
  • [Cites] Ann Allergy Asthma Immunol. 2011 Mar;106(3):191-9 [21354020.001]
  • [Cites] Pediatrics. 2011 Oct;128(4):e830-8 [21911345.001]
  • [Cites] Am J Respir Crit Care Med. 2007 Dec 15;176(12):1269-73 [17885265.001]
  • [Cites] J Allergy Clin Immunol Pract. 2013 Mar;1(2):152-6 [24187656.001]
  • [Cites] Eur J Pediatr. 1993 Jan;152(1):55-8 [8444206.001]
  • [Cites] BMJ. 1991 Sep 21;303(6804):671-5 [1912913.001]
  • [Cites] Semin Fetal Neonatal Med. 2012 Apr;17(2):77-81 [22277112.001]
  • [Cites] Early Hum Dev. 2011 Mar;87 Suppl 1:S47-9 [21276672.001]
  • [Cites] J Pediatr. 2014 Feb;164(2):295-9.e1 [24210922.001]
  • [Cites] Thorax. 2012 Jan;67(1):54-61 [21953066.001]
  • [Cites] Pediatrics. 2010 Jul;126(1):115-28 [20530073.001]
  • [Cites] Am Rev Respir Dis. 1991 Nov;144(5):1202-18 [1952453.001]
  • [Cites] Thorax. 1998 Jul;53(7):549-53 [9797752.001]
  • [Cites] Chest. 2005 Sep;128(3):1266-73 [16162717.001]
  • [Cites] Pediatr Int. 2016 Apr;58(4):274-8 [26455505.001]
  • [Cites] Pediatrics. 2006 Sep;118(3):1207-14 [16951017.001]
  • [Cites] Eur Respir J. 1995 Mar;8(3):483-91 [7789502.001]
  • [Cites] Eur J Epidemiol. 2000;16(8):693-9 [11142496.001]
  • [Cites] J Pediatr. 2000 Dec;137(6):865-70 [11113845.001]
  • [Cites] Pediatr Pulmonol. 2006 Oct;41(10):978-84 [16871596.001]
  • (PMID = 28747837.001).
  • [ISSN] 1306-0015
  • [Journal-full-title] Turk pediatri arsivi
  • [ISO-abbreviation] Turk Pediatri Ars
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Turkey
  • [Keywords] NOTNLM ; Impulse oscillometric study / late-premature / preschool period / pulmonary functions
  •  go-up   go-down


36. Dull B, Conant L, Myckatyn T, Tenenbaum M, Cyr A, Margenthaler JA: Nipple-sparing mastectomies: Clinical outcomes from a single academic institution. Mol Clin Oncol; 2017 May;6(5):737-742

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Charts were reviewed for demographic data and patient characteristics.
  • The mean patient age was 44.4 years (range, 20-77).
  • A total of 34 (17.2%) complications occurred, including infections, hematomas and nipple necrosis, with 9 requiring removal of the NAC and 13 requiring removal of the tissue expander or implant.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Plast Reconstr Surg. 1977 Apr;59(4):535-7 [847031.001]
  • [Cites] Ann Surg Oncol. 2015 Oct;22(10):3241-9 [26242363.001]
  • [Cites] Ann Surg Oncol. 2016 Aug;23(8):2665-72 [27038458.001]
  • [Cites] Plast Reconstr Surg. 2013 Nov;132(5):1043-54 [23924650.001]
  • [Cites] Eur J Surg Oncol. 2006 Nov;32(9):937-40 [16829015.001]
  • [Cites] Ann Plast Surg. 2005 Sep;55(3):240-4 [16106159.001]
  • [Cites] Cancer. 1985 May 15;55(10):2459-63 [2985236.001]
  • [Cites] Ann Surg Oncol. 2012 Apr;19(4):1174-80 [22006374.001]
  • [Cites] Plast Reconstr Surg. 2013 May;131(5):969-84 [23629079.001]
  • [Cites] Ann Surg Oncol. 2011 Oct;18(11):3123-8 [21861222.001]
  • [Cites] Eur J Surg Oncol. 2008 Feb;34(2):143-8 [17709228.001]
  • [Cites] Ann Plast Surg. 2016 Jun;76(6):629-34 [25003437.001]
  • [Cites] J Plast Surg Hand Surg. 2012 Oct;46(5):344-8 [22931106.001]
  • [Cites] Breast. 2016 Feb;25:75-81 [26612083.001]
  • [Cites] J Am Coll Surg. 2016 Jun;222(6):1149-55 [27118712.001]
  • [Cites] Aesthetic Plast Surg. 1989 Winter;13(1):15-21 [2728994.001]
  • [Cites] Ann Surg Oncol. 2016 Jan;23 (1):257-64 [26193963.001]
  • [Cites] N Engl J Med. 1985 Mar 14;312(11):665-73 [3883167.001]
  • [Cites] Ann Surg. 2009 Mar;249(3):461-8 [19247035.001]
  • [Cites] Cancer. 1980 Jul 1;46(1):1-13 [6992972.001]
  • [Cites] Scand J Surg. 2010;99(3):115-8 [21044925.001]
  • [Cites] N Engl J Med. 1999 Jan 14;340(2):77-84 [9887158.001]
  • [Cites] Plast Reconstr Surg. 2013 Sep;132(3):330e-8e [23985644.001]
  • [Cites] JAMA Surg. 2014 Oct;149(10):1015-21 [25141939.001]
  • [Cites] Plast Reconstr Surg. 1991 Jun;87(6):1048-53 [1852020.001]
  • [Cites] Ann Oncol. 2012 Aug;23(8):2053-8 [22231025.001]
  • [Cites] Arch Surg. 2008 Jan;143(1):38-45; discussion 45 [18209151.001]
  • [Cites] Plast Reconstr Surg Transplant Bull. 1962 Dec;30:676-82 [13959443.001]
  • [Cites] Plast Reconstr Surg. 2014 Mar;133(3):496-506 [24572843.001]
  • [Cites] Ann Surg Oncol. 2011 Jun;18(6):1665-70 [21174155.001]
  • [Cites] Pathol Res Pract. 1980;166(4):515-35 [6253967.001]
  • [Cites] Ann Surg. 2009 Jan;249(1):26-32 [19106672.001]
  • [Cites] J Surg Oncol. 2011 Mar 15;103(4):313-6 [21337564.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2010 Feb;148(2):177-81 [19926200.001]
  • [Cites] Cancer. 1977 Jun;39(6 Suppl):2827-39 [326381.001]
  • [Cites] Ann Surg Oncol. 2008 Feb;15(2):438-42 [18004629.001]
  • [Cites] J Reconstr Microsurg. 2015 Jul;31(6):434-41 [25910179.001]
  • (PMID = 28515925.001).
  • [ISSN] 2049-9450
  • [Journal-full-title] Molecular and clinical oncology
  • [ISO-abbreviation] Mol Clin Oncol
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; breast cancer / nipple-sparing mastectomy / reconstruction
  •  go-up   go-down


37. Ashley SL, Pretto CD, Stier MT, Kadiyala P, Castro-Jorge L, Hsu TH, Doherty R, Carnahan KE, Castro MG, Lowenstein PR, Spindler KR: Matrix Metalloproteinase Activity in Infections by an Encephalitic Virus, Mouse Adenovirus Type 1. J Virol; 2017 Mar 15;91(6)
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Matrix Metalloproteinase Activity in Infections by an Encephalitic Virus, Mouse Adenovirus Type 1.
  • We show for the first time that astrocytes and microglia are also infected <i>in vivo</i> by MAV-1.
  • [MeSH-major] Adenoviridae Infections / pathology. Encephalitis, Viral / pathology. Mastadenovirus / pathogenicity. Matrix Metalloproteinase 2 / analysis. Matrix Metalloproteinase 9 / analysis

  • Mouse Genome Informatics (MGI). Mouse Genome Informatics (MGI) .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017 American Society for Microbiology.
  • [Cites] Methods Mol Biol. 2012;814:221-33 [22144310.001]
  • [Cites] J Neuroimmunol. 2005 Dec;169(1-2):116-25 [16146656.001]
  • [Cites] Nature. 1970 Aug 15;227(5259):680-5 [5432063.001]
  • [Cites] Cell Tissue Res. 2014 Mar;355(3):687-99 [24590145.001]
  • [Cites] Exp Cell Res. 1992 Apr;199(2):330-40 [1347502.001]
  • [Cites] MBio. 2012 May 29;3(3):null [22647790.001]
  • [Cites] Nat Rev Neurosci. 2005 Dec;6(12):931-44 [16288297.001]
  • [Cites] J Immunol. 2010 Mar 15;184(6):3055-62 [20164425.001]
  • [Cites] Lab Invest. 2005 May;85(5):597-607 [15711567.001]
  • [Cites] Br J Pharmacol. 2014 Mar;171(5):1210-30 [24641185.001]
  • [Cites] J Exp Med. 2006 Apr 17;203(4):1007-19 [16585265.001]
  • [Cites] Semin Cell Dev Biol. 2008 Feb;19(1):34-41 [17707664.001]
  • [Cites] Front Microbiol. 2012 Jun 20;3:201 [22723794.001]
  • [Cites] Virology. 1996 Oct 1;224(1):184-97 [8862413.001]
  • [Cites] J Virol. 1999 Oct;73(10):8640-6 [10482617.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2001 Mar;42(3):853-9 [11222550.001]
  • [Cites] J Virol. 2001 Dec;75(24):12039-46 [11711594.001]
  • [Cites] J Virol. 2005 Sep;79(17):11517-22 [16103204.001]
  • [Cites] Neuroscience. 2009 Feb 6;158(3):983-94 [18621108.001]
  • [Cites] J Virol. 1995 Dec;69(12):7674-81 [7494276.001]
  • [Cites] J Virol. 1998 Jul;72(7):5699-706 [9621028.001]
  • [Cites] Prog Mol Biol Transl Sci. 2011;99:241-63 [21238938.001]
  • [Cites] Pharmacol Rev. 2005 Jun;57(2):173-85 [15914466.001]
  • [Cites] Am J Physiol Cell Physiol. 2000 Oct;279(4):C935-44 [11003573.001]
  • [Cites] J Cell Biol. 1991 Dec;115(6):1725-35 [1661734.001]
  • [Cites] Virology. 2009 Aug 1;390(2):307-14 [19540545.001]
  • [Cites] Nat Methods. 2012 Jul;9(7):671-5 [22930834.001]
  • [Cites] Neurobiol Dis. 2006 Jul;23(1):87-96 [16624562.001]
  • [Cites] Trends Microbiol. 2012 Jun;20(6):282-90 [22564250.001]
  • [Cites] J Leukoc Biol. 2001 Jun;69(6):851-9 [11404367.001]
  • [Cites] J Neurochem. 1990 May;54(5):1798-801 [2182777.001]
  • [Cites] Brain Res. 1997 Sep 12;768(1-2):10-8 [9369295.001]
  • [Cites] J Virol. 1995 Dec;69(12):8084-8 [7494327.001]
  • [Cites] J Virol. 2009 Sep;83(18):9398-410 [19570856.001]
  • [Cites] Cell Mol Neurobiol. 2005 Feb;25(1):59-127 [15962509.001]
  • [Cites] J Cell Sci. 2004 Apr 15;117(Pt 10):2097-107 [15054114.001]
  • [Cites] J Neuroinflammation. 2012 Jun 28;9:147 [22742584.001]
  • [Cites] mSphere. 2016 Apr 20;1(2):null [27303733.001]
  • [Cites] Methods Mol Med. 2007;130:41-59 [17401163.001]
  • [Cites] J Cell Physiol. 2009 Mar;218(3):612-22 [19016245.001]
  • [Cites] Virology. 1998 Jun 5;245(2):216-28 [9636361.001]
  • [Cites] J Virol. 2009 Apr;83(8):3450-62 [19193803.001]
  • [Cites] J Virol. 1998 Feb;72(2):1219-23 [9445021.001]
  • [Cites] Virology. 1995 Apr 20;208(2):457-66 [7747418.001]
  • [Cites] Virology. 1991 Jan;180(1):257-65 [1845825.001]
  • (PMID = 28053109.001).
  • [ISSN] 1098-5514
  • [Journal-full-title] Journal of virology
  • [ISO-abbreviation] J. Virol.
  • [Language] eng
  • [Grant] United States / NIAID NIH HHS / AI / R01 AI068645; United States / NINDS NIH HHS / NS / R01 NS082311; United States / NCI NIH HHS / CA / P30 CA046592; United States / NINDS NIH HHS / NS / R01 NS074387; United States / NIAID NIH HHS / AI / R56 AI023762; United States / NIAID NIH HHS / AI / R01 AI091721; United States / NINDS NIH HHS / NS / R21 NS084275; United States / NIAID NIH HHS / AI / R01 AI023762; United States / NINDS NIH HHS / NS / R37 NS094804; United States / NINDS NIH HHS / NS / R01 NS057711; United States / NINDS NIH HHS / NS / R01 NS096756; United States / NINDS NIH HHS / NS / R21 NS091555
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] EC 3.4.24.24 / Matrix Metalloproteinase 2; EC 3.4.24.24 / Mmp2 protein, mouse; EC 3.4.24.35 / Matrix Metalloproteinase 9; EC 3.4.24.35 / Mmp9 protein, mouse
  • [Keywords] NOTNLM ; astrocytes / encephalitis / endothelial / endothelial cells / matrix metalloproteinase / microglia
  •  go-up   go-down


38. Garimella PS, Bartz TM, Ix JH, Chonchol M, Shlipak MG, Devarajan P, Bennett MR, Sarnak MJ: Urinary Uromodulin and Risk of Urinary Tract Infections: The Cardiovascular Health Study. Am J Kidney Dis; 2017 Jun;69(6):744-751

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Urinary Uromodulin and Risk of Urinary Tract Infections: The Cardiovascular Health Study.
  • [MeSH-major] Urinary Tract Infections / urine. Uromodulin / urine

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2016 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
  • [Cites] Kidney Int. 2015 Nov;88(5):1126-34 [26154925.001]
  • [Cites] J Clin Invest. 2005 Feb;115(2):468-75 [15650774.001]
  • [Cites] J Am Soc Nephrol. 2016 Oct;27(10 ):2983-2996 [26966016.001]
  • [Cites] J Urol. 2009 May;181(5):2332-8 [19303096.001]
  • [Cites] PLoS One. 2008 Apr 30;3(4):e2040 [18446213.001]
  • [Cites] Nephrol Dial Transplant. 2014 Jan;29(1):136-45 [24097801.001]
  • [Cites] J Biol Chem. 1990 Dec 5;265(34):20784-9 [2249987.001]
  • [Cites] Am J Kidney Dis. 2008 Mar;51(3):395-406 [18295055.001]
  • [Cites] Eur J Clin Invest. 2005 Apr;35(4):227-35 [15816991.001]
  • [Cites] BMC Med Genet. 2012 Sep 05;13:78 [22947327.001]
  • [Cites] Diabetes Care. 2012 Mar;35(3):549-55 [22238279.001]
  • [Cites] Transplantation. 2006 Sep 15;82(5):603-11 [16969281.001]
  • [Cites] J Infect Dis. 2001 Mar 1;183 Suppl 1:S1-4 [11171002.001]
  • [Cites] Am J Physiol Renal Physiol. 2004 Apr;286(4):F795-802 [14665435.001]
  • [Cites] Sci Transl Med. 2011 Nov 16;3(109):109ra115 [22089451.001]
  • [Cites] Urol Clin North Am. 2015 Nov;42(4):561-8 [26475952.001]
  • [Cites] Am J Nephrol. 2005 Nov-Dec;25(6):570-8 [16244464.001]
  • [Cites] Kidney Blood Press Res. 2010;33(5):393-8 [20948228.001]
  • [Cites] J Clin Invest. 1992 Sep;90(3):965-72 [1522244.001]
  • [Cites] Nephrol Dial Transplant. 2007 Feb;22(2):347-9 [17035368.001]
  • [Cites] Lancet. 1980 Apr 19;1(8173):887 [6103253.001]
  • [Cites] J Biol Chem. 2001 Mar 30;276(13):9924-30 [11134021.001]
  • [Cites] N Engl J Med. 2005 May 19;352(20):2049-60 [15901858.001]
  • [Cites] Clin J Am Soc Nephrol. 2016 Jan 7;11(1):62-9 [26683887.001]
  • [Cites] Vital Health Stat 13. 2011 Apr;(169):1-38 [21614897.001]
  • [Cites] Am J Kidney Dis. 2012 Mar;59(3):356-63 [21906862.001]
  • [Cites] J Am Soc Nephrol. 2015 Oct;26(10 ):2494-503 [25655067.001]
  • [Cites] Pediatrics. 2011 Aug;128(2):323-30 [21768320.001]
  • [Cites] Kidney Int. 2004 Mar;65(3):791-7 [14871399.001]
  • [Cites] J Am Soc Nephrol. 2014 Aug;25(8):1869-82 [24578125.001]
  • [Cites] Infect Dis Clin North Am. 2014 Mar;28(1):1-13 [24484571.001]
  • [Cites] Ann Epidemiol. 1991 Feb;1(3):263-76 [1669507.001]
  • [Cites] Am J Nephrol. 2011;34(5):445-51 [21968132.001]
  • (PMID = 28029393.001).
  • [ISSN] 1523-6838
  • [Journal-full-title] American journal of kidney diseases : the official journal of the National Kidney Foundation
  • [ISO-abbreviation] Am. J. Kidney Dis.
  • [Language] eng
  • [Grant] United States / NIDDK NIH HHS / DK / T32 DK007777; United States / NIDDK NIH HHS / DK / R01 DK098234; United States / NHLBI NIH HHS / HL / U01 HL080295; United States / NHLBI NIH HHS / HL / HHSN268200800007C; United States / NHLBI NIH HHS / HC / N01 HC015103; United States / NHLBI NIH HHS / HC / N01 HC085085; United States / NHLBI NIH HHS / HL / N01HC55222; United States / NHLBI NIH HHS / HL / N01HC85086; United States / NHLBI NIH HHS / HL / HHSN268201200036C; United States / NIDDK NIH HHS / DK / P50 DK096418; United States / NIA NIH HHS / AG / R01 AG027002; United States / NHLBI NIH HHS / HC / N01 HC085084; United States / NHLBI NIH HHS / HL / N01HC85082; United States / NHLBI NIH HHS / HL / N01HC75150; United States / NHLBI NIH HHS / HL / N01HC85083; United States / NHLBI NIH HHS / HL / N01HC85079; United States / NIA NIH HHS / AG / R01 AG023629; United States / NHLBI NIH HHS / HL / N01HC85080; United States / NHLBI NIH HHS / HC / N01 HC035129; United States / NHLBI NIH HHS / HL / N01HC85081
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / UMOD protein, human; 0 / Uromodulin; AYI8EX34EU / Creatinine
  • [Keywords] NOTNLM ; Tamm-Horsfall protein / Uromodulin (UMOD) / bacterial infection / elderly / geriatric / hospitalization / urinary tract infection (UTI)
  •  go-up   go-down


39. Aykac K, Ozsurekci Y, Tanir Basaranoglu S, Akin MS, Cengiz AB, Bicakcigil A, Sancak B, Kara A, Ceyhan M: Current epidemiology of resistance among Gram-negative bacilli in pediatric patients in Turkey. J Glob Antimicrob Resist; 2017 Aug 10;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: The increasing incidence of infections caused by drug-resistant Gram-negative organisms has led to a reemergence in worldwide.
  • This study attempted to investigate the changes in resistance of Gram-negative bacteria to different classes of antibiotics and treatment options in invasive infections.
  • Totally, 115 (38.1%) multidrug-resistance (MDR), 63 (20.9%) extensively drug-resistant (XDR), and 6 (2%) pandrug-resistance (PDR) bacteria were detected.
  • Therefore, the active surveillance of resistance pattern of microorganisms is needed for better management of infections caused by highly resistant bacteria.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Copyright] Copyright © 2017. Published by Elsevier Ltd.
  • (PMID = 28803838.001).
  • [ISSN] 2213-7173
  • [Journal-full-title] Journal of global antimicrobial resistance
  • [ISO-abbreviation] J Glob Antimicrob Resist
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Netherlands
  • [Keywords] NOTNLM ; Gram-negative bacteria / child / resistance
  •  go-up   go-down


40. Veeraraghavan B, Shankar C, Karunasree S, Kumari S, Ravi R, Ralph R: Carbapenem resistant Klebsiella pneumoniae isolated from bloodstream infection: Indian experience. Pathog Glob Health; 2017 Jul;111(5):240-246

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • A total of 115 K. pneumoniae from January 2015 to September 2016 were included in the study which comprised of phenotypically identified ESBL and carbapenem resistant (CR) isolates.
  • Co-expression of bla<sub>SHV</sub>, bla<sub>TEM</sub> and bla<sub>CTX-M</sub> was predominant with 64% (74/115) prevalence.
  • AmpC was uncommon, seen in 5% of the isolates (6/115).
  • Among the carbapenemases co-expression of bla<sub>NDM</sub> and bla<sub>OXA48-like</sub> was observed in 28% (32/115) and bla<sub>NDM</sub> in 19% (22/115) and bla<sub>OXA48-like</sub> in 13% (15/115).
  • Prevalence of community acquired and nosocomial infections were 5% (4/73) and 95% (69/73) respectively among CRKp.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28670975.001).
  • [ISSN] 2047-7732
  • [Journal-full-title] Pathogens and global health
  • [ISO-abbreviation] Pathog Glob Health
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; K. pneumoniae / NDM / OXA-48-like / bacteremia / carbapenem resistance / mortality
  •  go-up   go-down


41. Wegener JT, Kraal T, Stevens MF, Hollmann MW, Kerkhoffs GMMJ, Haverkamp D: Low-dose dexamethasone during arthroplasty: What do we know about the risks? EFORT Open Rev; 2016 Aug;1(8):303-309
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • However, conflicting views of orthopaedic surgeons and anaesthesiologists regarding the use of dexamethasone raise questions about risks of impaired wound healing and surgical site infections (SSI).The aim of this systematic review is to determine the level of evidence for the safety of a peri-operative single low dose of dexamethasone in hip and knee arthroplasty.We systematically reviewed literature in PubMed, EMBASE and Cochrane databases and cited references in articles found in the initial search from 1980 to 2013 based on predefined inclusion criteria.

  • NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Br J Anaesth. 2008 Oct;101(4):535-41 [18653493.001]
  • [Cites] Eur J Anaesthesiol. 2010 Apr;27(4):324-30 [19734790.001]
  • [Cites] Clin Ther. 2005 Jun;27(6):740-5 [16117980.001]
  • [Cites] Cochrane Database Syst Rev. 2006 Jul 19;(3):CD004125 [16856030.001]
  • [Cites] Eur J Anaesthesiol. 2009 Apr;26(4):318-21 [19401661.001]
  • [Cites] J Bone Joint Surg Am. 2009 Jul;91(7):1621-9 [19571084.001]
  • [Cites] Eur J Anaesthesiol. 2010 Feb;27(2):192-5 [19915480.001]
  • [Cites] Anesthesiology. 2011 Sep;115(3):575-88 [21799397.001]
  • [Cites] Anaesth Intensive Care. 2010 Jul;38(4):661-6 [20715728.001]
  • [Cites] J Clin Pharm Ther. 2010 Dec;35(6):679-84 [21054459.001]
  • [Cites] Acta Orthop Suppl. 2012 Oct;83(346):1-39 [23205862.001]
  • [Cites] Acta Anaesthesiol Scand. 2004 Nov;48(10):1223-31 [15504180.001]
  • [Cites] Clin Orthop Relat Res. 2008 Nov;466(11):2617-27 [18704616.001]
  • [Cites] Ann Pharmacother. 2006 May;40(5):856-72 [16670360.001]
  • [Cites] Br J Dermatol. 2002 Nov;147(5):859-68 [12410694.001]
  • [Cites] Anesth Analg. 2000 Jan;90(1):186-94 [10625002.001]
  • [Cites] Anesth Analg. 2003 Nov;97(5):1377-80 [14570655.001]
  • [Cites] J Arthroplasty. 2013 Mar;28(3):385-9 [23142444.001]
  • [Cites] Clin Orthop Relat Res. 2009 Jun;467(6):1463-7 [19224304.001]
  • [Cites] J Am Coll Surg. 2002 Nov;195(5):694-712 [12437261.001]
  • [Cites] Am J Orthop (Belle Mead NJ). 2004 Feb;33(2):85-92; discussion 92 [15005598.001]
  • [Cites] Anesth Analg. 2008 Apr;106(4):1253-7, table of contents [18349202.001]
  • [Cites] J Invest Dermatol. 1997 Mar;108(3):285-9 [9036926.001]
  • [Cites] Reg Anesth Pain Med. 2011 Jan-Feb;36(1):36-40 [21455087.001]
  • [Cites] Ann Surg. 1973 Feb;177(2):222-7 [4572787.001]
  • [Cites] Br J Anaesth. 2011 Feb;106(2):230-8 [21131371.001]
  • [Cites] Acta Anaesthesiol Scand. 2009 Sep;53(8):1073-83 [19572933.001]
  • [Cites] Br J Anaesth. 2013 Jan;110(1):66-73 [22986420.001]
  • [Cites] Pain Pract. 2010 May-Jun;10(3):245-8 [20230453.001]
  • [Cites] J Arthroplasty. 2013 Sep;28(8 Suppl):11-7 [23937923.001]
  • [Cites] N Engl J Med. 2004 Jun 10;350(24):2441-51 [15190136.001]
  • [Cites] J Obstet Gynaecol Res. 2011 Dec;37(12):1807-12 [21794004.001]
  • [Cites] Anaesth Intensive Care. 2010 Jul;38(4):654-60 [20715727.001]
  • [Cites] J Int Med Res. 2006 Nov-Dec;34(6):603-11 [17294992.001]
  • [Cites] PLoS Med. 2009 Jul 21;6(7):e1000097 [19621072.001]
  • (PMID = 28461961.001).
  • [ISSN] 2058-5241
  • [Journal-full-title] EFORT open reviews
  • [ISO-abbreviation] EFORT Open Rev
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; PONV / SSI / arthroplasty / hip / knee / post-operative nausea and vomiting / surgical site infections
  •  go-up   go-down


42. Rineh A, Dolla NK, Ball AR, Magana M, Bremner JB, Hamblin MR, Tegos GP, Kelso MJ: Attaching the NorA Efflux Pump Inhibitor INF55 to Methylene Blue Enhances Antimicrobial Photodynamic Inactivation of Methicillin-Resistant Staphylococcus aureus in Vitro and in Vivo. ACS Infect Dis; 2017 Aug 17;

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The study supports a new approach for treating localized multidrug-resistant MRSA infections and paves the way for wider exploration of the EPI-PS hybrid strategy in aPDI.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • (PMID = 28799332.001).
  • [ISSN] 2373-8227
  • [Journal-full-title] ACS infectious diseases
  • [ISO-abbreviation] ACS Infect Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  • [Keywords] NOTNLM ; antimicrobial photodynamic inactivation / bioluminescence wound infection model / methicilllin resistant Staphylococcus aureus / photosensitizer-efflux pump inhibitor hybrid / reactive oxygen species
  •  go-up   go-down


43. Saha D, Koli S, Patgaonkar M, Reddy KV: Expression of hemoglobin-α and β subunits in human vaginal epithelial cells and their functional significance. PLoS One; 2017;12(2):e0171084
NCI CPTC Antibody Characterization Program. NCI CPTC Antibody Characterization Program .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The results of EMSA revealed the presence of putative binding sites of NF-κB in the human Hb-α promoter region (nt-115 to -106).
  • In conclusion, the present findings revealed for the first time that hPVECs synthesized Hb-α and Hb-β and the expression is comparable with the expression of VK2/E6E7 cells.
  • The identification of NF-κB regulatory sequences in Hb-α promoter, whose activation is associated with immune response of hPVECs, indicating Hb-α and Hb-β may act as an endogenous antimicrobial defense protein against vaginal inflammation/infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Exp Neurol. 2007 Feb;203(2):568-78 [17126834.001]
  • [Cites] J Reprod Immunol. 2002 Oct-Nov;57(1-2):61-79 [12385834.001]
  • [Cites] Respir Res. 2010 Sep 13;11:123 [20836851.001]
  • [Cites] J Immunol. 2005 Dec 1;175(11):7560-7 [16301665.001]
  • [Cites] Nat Immunol. 2010 May;11(5):373-84 [20404851.001]
  • [Cites] Proc Natl Acad Sci U S A. 1999 Jun 8;96(12):6643-7 [10359765.001]
  • [Cites] Hum Reprod. 2008 Mar;23 (3):635-41 [18216035.001]
  • [Cites] Biol Reprod. 1997 Oct;57(4):847-55 [9314589.001]
  • [Cites] Proc Natl Acad Sci U S A. 2009 Sep 8;106(36):15454-9 [19717439.001]
  • [Cites] J Exp Biol. 1998 Apr;201(Pt 8):1099-117 [9510523.001]
  • [Cites] Methods. 2001 Dec;25(4):402-8 [11846609.001]
  • [Cites] Am J Respir Cell Mol Biol. 2011 Apr;44(4):439-47 [20508070.001]
  • [Cites] Peptides. 2004 Nov;25(11):1839-47 [15501514.001]
  • [Cites] Eur J Biochem. 2003 Apr;270(8):1855-62 [12694199.001]
  • [Cites] PLoS One. 2013;8(1):e54342 [23349856.001]
  • [Cites] Int J Inflam. 2014;2014:803237 [25431740.001]
  • [Cites] Front Biosci. 2008 May 01;13:6859-71 [18508700.001]
  • [Cites] Biochim Biophys Acta. 1997 Mar 20;1351(1-2):51-72 [9116045.001]
  • [Cites] Curr Top Microbiol Immunol. 2006;306:199-230 [16909923.001]
  • [Cites] Immunol Rev. 2005 Aug;206:306-35 [16048557.001]
  • [Cites] EMBO J. 2010 Feb 3;29(3):632-42 [20019665.001]
  • [Cites] J Mol Cell Biol. 2011 Jun;3(3):190-6 [21059732.001]
  • [Cites] Physiol Rev. 2012 Oct;92(4):1543-76 [23073626.001]
  • [Cites] Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):5987-91 [8016102.001]
  • [Cites] PLoS One. 2014 Jan 07;9(1):e83882 [24409285.001]
  • [Cites] Hum Reprod. 2009 Jan;24(1):211-8 [18786935.001]
  • [Cites] PLoS One. 2015 Apr 27;10(4):e0124839 [25915507.001]
  • [Cites] Mol Vis. 2003 Aug 22;9:360-96 [12942050.001]
  • [Cites] J Am Soc Nephrol. 2008 Aug;19(8):1440-1 [18614770.001]
  • [Cites] Mucosal Immunol. 2011 May;4(3):335-42 [21048705.001]
  • [Cites] Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1911-9 [19060278.001]
  • [Cites] Rev Physiol Biochem Pharmacol. 1986;103:61-203 [2421388.001]
  • [Cites] Clin Vaccine Immunol. 2011 Oct;18(10):1632-43 [21865417.001]
  • [Cites] Cell. 1982 Nov;31(1):11-24 [6186379.001]
  • [Cites] Antioxid Redox Signal. 2013 Jun 10;18(17):2274-83 [23025272.001]
  • [Cites] Mediators Inflamm. 2013;2013:165974 [23853427.001]
  • [Cites] J Biol Chem. 2006 Mar 3;281(9):5668-76 [16407281.001]
  • [Cites] Cytokine. 2008 Jul;43(1):63-70 [18513989.001]
  • [Cites] Am J Reprod Immunol. 2014 Feb;71(2):137-53 [24405266.001]
  • [Cites] Biochem Biophys Res Commun. 2005 Aug 12;333(4):1348-52 [15979582.001]
  • [Cites] Eur J Obstet Gynecol Reprod Biol. 2007 Mar;131(1):97-100 [16675092.001]
  • [Cites] J Am Soc Nephrol. 2008 Aug;19(8):1500-8 [18448584.001]
  • [Cites] Med Mycol. 2000 Dec;38(6):419-31 [11204879.001]
  • [Cites] PLoS One. 2011;6(9):e24363 [21931690.001]
  • (PMID = 28178273.001).
  • [ISSN] 1932-6203
  • [Journal-full-title] PloS one
  • [ISO-abbreviation] PLoS ONE
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] United States
  •  go-up   go-down


44. Ngobeni R, Samie A: PREVALENCE OF &lt;i&gt;TOXOPLASMA GONDII&lt;/i&gt; IGG AND IGM AND ASSOCIATED RISK FACTORS AMONG HIV-POSITIVE AND HIV-NEGATIVE PATIENTS IN VHEMBE DISTRICT OF SOUTH AFRICA. Afr J Infect Dis; 2017;11(2):1-9

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • CONCLUSIONS: The present study has shown a high prevalence of <i>T. gondii</i> (IgG) among patients attending different HIV clinics in the Vhembe district with no current infections among pregnant women.
  • In addition to the sero-positive status of the patient to HIV, other significant risk factors for toxoplasmosis included high viral load, non-adherence to ARV therapy and age (>25 years).

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Korean J Parasitol. 2014 Dec;52(6):581-93 [25548409.001]
  • [Cites] Rev Soc Bras Med Trop. 2015 May-Jun;48(3):338-42 [26108015.001]
  • [Cites] Korean J Parasitol. 2016 Feb;54(1):93-6 [26951986.001]
  • [Cites] Pathog Glob Health. 2016 Mar;110(2):62-7 [27092763.001]
  • [Cites] Asian Pac J Trop Med. 2011 Apr;4(4):271-4 [21771468.001]
  • [Cites] Am J Trop Med Hyg. 2008 Mar;78(3):504-8 [18337350.001]
  • [Cites] Int J STD AIDS. 2007 Aug;18(8):555-8 [17686219.001]
  • [Cites] Am J Trop Med Hyg. 2016 Jul 6;95(1):168-74 [27139453.001]
  • [Cites] Pathog Glob Health. 2015 ;109 (8):377-82 [26924348.001]
  • [Cites] BMC Infect Dis. 2016 Apr 16;16:157 [27083153.001]
  • [Cites] J Parasitol. 2012 Aug;98(4):871-2 [22360636.001]
  • [Cites] Adv Food Nutr Res. 2010;60:1-19 [20691951.001]
  • [Cites] East Afr J Public Health. 2008 Dec;5(3):211-4 [19374326.001]
  • [Cites] Pediatr Infect Dis J. 2014 Jan;33(1):5-10 [24064557.001]
  • [Cites] East Mediterr Health J. 2009 Sep-Oct;15(5):1278-84 [20214142.001]
  • [Cites] BMC Infect Dis. 2012 Dec 05;12:337 [23216887.001]
  • [Cites] Parasitol Res. 2016 Apr;115(4):1627-34 [26762861.001]
  • [Cites] Protist. 2006 Jun;157(2):173-83 [16621694.001]
  • [Cites] Acta Trop. 2016 Jun;158:160-9 [26952970.001]
  • [Cites] Parasitol Int. 2016 Oct;65(5 Pt A):363-6 [27155133.001]
  • (PMID = 28670634.001).
  • [ISSN] 2006-0165
  • [Journal-full-title] African journal of infectious diseases
  • [ISO-abbreviation] Afr J Infect Dis
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Nigeria
  • [Keywords] NOTNLM ; ELISA / HIV / Opportunistic infections / Sero-prevalence / Toxoplasma gondii
  •  go-up   go-down


45. Hamid PH, Prastowo J, Widyasari A, Taubert A, Hermosilla C: Knockdown resistance (kdr) of the voltage-gated sodium channel gene of Aedes aegypti population in Denpasar, Bali, Indonesia. Parasit Vectors; 2017 Jun 05;10(1):283

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • BACKGROUND: Aedes aegypti is the main vector of several arthropod-borne viral infections in the tropics profoundly affecting humans, such as dengue fever (DF), West Nile (WN), chikungunya and more recently Zika.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] PLoS Negl Trop Dis. 2015 Jan 08;9(1):e3332 [25569164.001]
  • [Cites] PLoS Negl Trop Dis. 2013 Sep 19;7(9):e2438 [24069492.001]
  • [Cites] PLoS Negl Trop Dis. 2013 Nov 14;7(11):e2503 [24244765.001]
  • [Cites] Insect Biochem Mol Biol. 2013 Apr;43(4):407-16 [23123179.001]
  • [Cites] Parasit Vectors. 2014 Jan 15;7:25 [24428880.001]
  • [Cites] Parasit Vectors. 2015 Mar 25;8:181 [25888775.001]
  • [Cites] Insect Mol Biol. 2007 Dec;16(6):785-98 [18093007.001]
  • [Cites] J Agromedicine. 2004;9(2):329-45 [19785227.001]
  • [Cites] Med Vet Entomol. 2003 Mar;17(1):87-94 [12680930.001]
  • [Cites] Am J Trop Med Hyg. 2015 Jan;92(1):201-9 [25371186.001]
  • [Cites] Parasit Vectors. 2015 Jun 12;8:325 [26068925.001]
  • [Cites] Nat Rev Dis Primers. 2016 Aug 18;2:16055 [27534439.001]
  • [Cites] Parasit Vectors. 2011 Jan 12;4:5 [21226942.001]
  • [Cites] Trop Med Int Health. 2011 Apr;16(4):501-9 [21342372.001]
  • [Cites] Pest Manag Sci. 2015 Jun;71(6):863-9 [24935645.001]
  • [Cites] PLoS Negl Trop Dis. 2009 Oct 13;3(10):e531 [19829709.001]
  • [Cites] Insect Biochem Mol Biol. 2004 Jul;34(7):653-65 [15242706.001]
  • [Cites] Heredity (Edinb). 2015 Sep;115(3):243-52 [25899013.001]
  • [Cites] Evolution. 2002 Dec;56(12):2435-44 [12583584.001]
  • [Cites] Am J Trop Med Hyg. 2010 Aug;83(2):277-84 [20682868.001]
  • [Cites] PLoS Negl Trop Dis. 2009 Oct 06;3(10):e527 [19806205.001]
  • [Cites] PLoS One. 2016 Mar 03;11(3):e0150577 [26939002.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Aug 28;8(8):e3085 [25166902.001]
  • [Cites] Parasit Vectors. 2016 Jul 26;9(1):417 [27460671.001]
  • [Cites] Proc Natl Acad Sci U S A. 2013 Jan 15;110(3):994-9 [23277539.001]
  • [Cites] Parasit Vectors. 2013 Aug 30;6(1):253 [24059267.001]
  • [Cites] Insects. 2015 Jul 23;6(3):658-85 [26463408.001]
  • [Cites] Evol Med Public Health. 2013 Jan;2013(1):197-207 [24481199.001]
  • [Cites] Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):11785-90 [23821746.001]
  • [Cites] Southeast Asian J Trop Med Public Health. 2012 Nov;43(6):1380-6 [23413701.001]
  • [Cites] PLoS Negl Trop Dis. 2013;7(1):e1913 [23326609.001]
  • (PMID = 28583207.001).
  • [ISSN] 1756-3305
  • [Journal-full-title] Parasites & vectors
  • [ISO-abbreviation] Parasit Vectors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Aedes aegypti / Denpasar / Indonesia / Kdr / Resistance
  •  go-up   go-down


46. Cocanour CS, Chang P, Huston JM, Adams CA Jr, Diaz JJ, Wessel CB, Falcione BA, Bauza GM, Forsythe RA, Rosengart MR: Management and Novel Adjuncts of Necrotizing Soft Tissue Infections. Surg Infect (Larchmt); 2017 Apr;18(3):250-272

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Management and Novel Adjuncts of Necrotizing Soft Tissue Infections.
  • Necrotizing soft tissue infections (NSTI) have been recognized for millennia and continue to impose considerable burden on both patient and society in terms of morbidity, death, and the allocation of resources.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Surg Infect (Larchmt). 2009 Oct;10(5):467-99 [19860574.001]
  • [Cites] Arch Otolaryngol Head Neck Surg. 1999 May;125(5):599 [10326824.001]
  • [Cites] J Immunol. 1996 Apr 15;156(8):3057-64 [8609429.001]
  • [Cites] J Int Med Res. 2012;40(3):1166-74 [22906291.001]
  • [Cites] J Bone Joint Surg Am. 2003 Aug;85-A(8):1454-60 [12925624.001]
  • [Cites] J Clin Invest. 1993 May;91(5):1979-86 [8486769.001]
  • [Cites] Am J Surg. 2000 May;179(5):361-6 [10930480.001]
  • [Cites] Emerg Med Clin North Am. 2008 May;26(2):431-55, ix [18406982.001]
  • [Cites] Cochrane Database Syst Rev. 2013 Sep 16;(9):CD001090 [24043371.001]
  • [Cites] J Bone Joint Surg Am. 2004 Nov;86-A(11):2497-502 [15523024.001]
  • [Cites] Surg Clin North Am. 2009 Apr;89(2):403-20, viii [19281891.001]
  • [Cites] BMJ Open. 2014 Jan 08;4(1):e003536 [24401721.001]
  • [Cites] Emerg Med J. 2004 Mar;21(2):242-3 [14988363.001]
  • [Cites] J Emerg Med. 1995 Jul-Aug;13(4):499-503 [7594369.001]
  • [Cites] Clin Infect Dis. 1998 Mar;26(3):631-8 [9524835.001]
  • [Cites] BMJ. 2008 Apr 26;336(7650):924-6 [18436948.001]
  • [Cites] Clin Infect Dis. 2004 Jul 1;39(1):38-46 [15206051.001]
  • [Cites] Crit Care. 2014 Dec 20;18(6):699 [25527094.001]
  • [Cites] Clin Infect Dis. 1999 Apr;28(4):800-7 [10825042.001]
  • [Cites] Cell Biochem Biophys. 2015 May;72 (1):259-63 [25561281.001]
  • [Cites] JAMA. 2009 Jun 17;301(23):2445-52 [19531784.001]
  • [Cites] Crit Care Med. 1999 Oct;27(10):2096-104 [10548188.001]
  • [Cites] Mycoses. 2001;44(7-8):253-60 [11714058.001]
  • [Cites] Clin Infect Dis. 2004 May 1;38(9):e87-91 [15127359.001]
  • [Cites] J Crit Care. 2012 Apr;27(2):167-71 [21737236.001]
  • [Cites] Shock. 2005 May;23(5):400-5 [15834304.001]
  • [Cites] J Oral Pathol Med. 1996 Oct;25(9):513-5 [8959561.001]
  • [Cites] Clin Infect Dis. 1995 Oct;21(4):977-80 [8645850.001]
  • [Cites] N Engl J Med. 1989 Jul 6;321(1):1-7 [2659990.001]
  • [Cites] J Crit Care. 2005 Sep;20(3):239-49 [16253792.001]
  • [Cites] Intensive Care Med. 2014 Dec;40(12):1888-96 [25217146.001]
  • [Cites] Arch Surg. 2004 Dec;139(12):1339-45 [15611459.001]
  • [Cites] J Hosp Infect. 2003 Jan;53(1):58-63 [12495686.001]
  • [Cites] Infection. 2002 Apr;30(2):81-5 [12018474.001]
  • [Cites] J Med Microbiol. 2002 Nov;51(11):971-7 [12448681.001]
  • [Cites] Blood Purif. 2004;22(3):256-60 [15148453.001]
  • [Cites] Ann Pharmacother. 1997 Sep;31(9):1034-9 [9296245.001]
  • [Cites] Rev Col Bras Cir. 2010 Dec;37(6):435-41 [21340259.001]
  • [Cites] J Am Coll Surg. 1998 Oct;187(4):416-21 [9783789.001]
  • [Cites] Curr Probl Surg. 2014 Aug;51(8):344-62 [25069713.001]
  • [Cites] Head Neck. 2010 Dec;32(12):1592-6 [20848400.001]
  • [Cites] J Intensive Care. 2013 Oct 23;1(1):4 [25705399.001]
  • [Cites] Crit Care. 2008;12 Suppl 1:S1 [19105799.001]
  • [Cites] Shock. 2005 Apr;23(4):298-304 [15803051.001]
  • [Cites] J Cardiothorac Vasc Anesth. 2005 Aug;19(4):440-5 [16085247.001]
  • [Cites] Surg Infect (Larchmt). 2008 Aug;9(4):469-74 [18399783.001]
  • [Cites] Curr Opin Infect Dis. 2004 Dec;17(6):517-25 [15640705.001]
  • [Cites] J Am Coll Surg. 1996 Jan;182(1):7-11 [8542094.001]
  • [Cites] Clin Infect Dis. 2007 Aug 15;45(4):450-8 [17638193.001]
  • [Cites] Surg Infect (Larchmt). 2009 Feb;10(1):21-8 [18991520.001]
  • [Cites] Am J Surg. 2011 Aug;202(2):139-45 [21545997.001]
  • [Cites] Crit Care Clin. 2003 Jan;19(1):55-72 [12688577.001]
  • [Cites] Clin Infect Dis. 2014 Sep 15;59(6):851-7 [24928291.001]
  • [Cites] World J Surg. 1991 Mar-Apr;15(2):240-7 [2031361.001]
  • [Cites] Cochrane Database Syst Rev. 2015 Jan 15;1:CD007937 [25879088.001]
  • [Cites] ANZ J Surg. 2001 Nov;71(11):647-9 [11736823.001]
  • [Cites] Urology. 1986 Oct;28(4):275-6 [3765234.001]
  • [Cites] Am J Surg. 2010 Dec;200(6):790-6; discussion 796-7 [21146022.001]
  • [Cites] J Burn Care Res. 2009 Sep-Oct;30(5):769-75 [19692912.001]
  • [Cites] Clin Infect Dis. 2014 Jul 15;59(2):147-59 [24947530.001]
  • [Cites] BMJ. 2008 Jul 31;337:a744 [18669566.001]
  • [Cites] Arch Surg. 2005 Feb;140(2):151-7; discussion 158 [15723996.001]
  • [Cites] Am J Surg. 1983 Jun;145(6):784-7 [6344676.001]
  • [Cites] Crit Care Med. 2007 Dec;35(12):2677-85 [18074464.001]
  • [Cites] Antimicrob Agents Chemother. 1997 Aug;41(8):1835-6 [9257774.001]
  • [Cites] Surg Infect (Larchmt). 2014 Jun;15(3):328-35 [24786980.001]
  • [Cites] ANZ J Surg. 2013 May;83(5):365-70 [22989238.001]
  • [Cites] Ann Surg. 1972 May;175(5):702-11 [4555030.001]
  • [Cites] Clin Infect Dis. 2004 Feb 15;38(4):521-8 [14765345.001]
  • [Cites] Infect Dis Clin North Am. 1996 Dec;10(4):835-55 [8958171.001]
  • [Cites] J Pediatr. 2007 Jul;151(1):79-84, 84.e1 [17586195.001]
  • [Cites] J Trauma. 1992 Jan;32(1):12-5 [1732565.001]
  • [Cites] Cochrane Database Syst Rev. 2013 Jan 31;(1):CD008075 [23440825.001]
  • [Cites] Chest. 2006 Dec;130(6):1679-86 [17166982.001]
  • [Cites] Clin Infect Dis. 2014 Jul 15;59(2):e10-52 [24973422.001]
  • [Cites] J Urol. 1976 Oct;116(4):469-71 [1053337.001]
  • [Cites] J Urol. 2005 Jun;173(6):1975-7 [15879795.001]
  • [Cites] Nephron Clin Pract. 2003;94(2):c33-9 [12845235.001]
  • [Cites] Clin Infect Dis. 2007 Mar 1;44(5):705-10 [17278065.001]
  • [Cites] South Med J. 2003 Sep;96(9):900-5 [14513988.001]
  • [Cites] Burns. 2003 Dec;29(8):857-62 [14636766.001]
  • [Cites] Arch Intern Med. 2002 Mar 11;162(5):517-22 [11871919.001]
  • [Cites] Ann Intern Med. 2007 Feb 6;146(3):193-203 [17283351.001]
  • [Cites] Epidemiol Infect. 2005 Aug;133(4):575-82 [16050501.001]
  • [Cites] Undersea Hyperb Med. 2010 Mar-Apr;37(2):115-23 [20462144.001]
  • [Cites] J Surg Res. 2012 Sep;177(1):146-51 [22487383.001]
  • [Cites] Crit Care Med. 2004 Jul;32(7):1535-41 [15241098.001]
  • [Cites] BMJ. 2008 May 3;336(7651):995-8 [18456631.001]
  • [Cites] Am J Surg. 1985 Jun;149(6):751-5 [4014552.001]
  • [Cites] ASAIO J. 2002 May-Jun;48(3):244-8 [12058997.001]
  • [Cites] J Infect. 2000 May;40(3):267-73 [10908022.001]
  • [Cites] J Am Coll Surg. 2009 Feb;208(2):279-88 [19228540.001]
  • [Cites] Am J Nephrol. 2013;38(4):275-84 [24051350.001]
  • [Cites] Crit Care Med. 2004 Aug;32(8):1662-8 [15286541.001]
  • [Cites] J Microbiol Immunol Infect. 2003 Jun;36(2):81-8 [12886957.001]
  • [Cites] Arch Surg. 1996 Aug;131(8):846-52; discussion 852-4 [8712909.001]
  • [Cites] Ann Surg. 1995 May;221(5):558-63; discussion 563-5 [7748037.001]
  • [Cites] Crit Care Med. 2007 Dec;35(12):2693-2701 [18074471.001]
  • [Cites] Clin Infect Dis. 2006 Oct 15;43(8):1060-8 [16983621.001]
  • [Cites] Infect Dis Clin North Am. 2009 Sep;23(3):571-91 [19665084.001]
  • [Cites] Antimicrob Agents Chemother. 2002 May;46(5):1581-2 [11959605.001]
  • [Cites] Crit Care. 2002 Aug;6(4):357-62 [12225613.001]
  • [Cites] Am Surg. 2002 Feb;68(2):109-16 [11842952.001]
  • [Cites] Crit Care Med. 2007 Dec;35(12):2686-92 [18074465.001]
  • [Cites] BMJ. 2005 Apr 9;330(7495):830-3 [15817551.001]
  • [Cites] Undersea Hyperb Med. 2014 Jan-Feb;41(1):59-63 [24649718.001]
  • [Cites] Epidemiol Infect. 2006 Apr;134(2):293-9 [16490133.001]
  • [Cites] ANZ J Surg. 2005 Dec;75(12):1055-8 [16398810.001]
  • [Cites] Lancet. 1994 Oct 22;344(8930):1111-5 [7934492.001]
  • [Cites] Anaesth Intensive Care. 2009 Jul;37(4):588-92 [19681416.001]
  • [Cites] Intensive Care Med. 2002 Oct;28(10):1434-9 [12373468.001]
  • [Cites] J Infect. 2004 May;48(4):330-3 [15066334.001]
  • [Cites] Int J Antimicrob Agents. 1994;4(4):297-301 [18611620.001]
  • [Cites] J Bone Joint Surg Am. 2007 Mar;89(3):631-6 [17332113.001]
  • [Cites] Clin Infect Dis. 2003 Aug 1;37(3):333-40 [12884156.001]
  • [Cites] Blood Purif. 2001;19(4):361-8; discussion 368-9 [11574732.001]
  • [Cites] Lancet. 1994 Aug 20;344(8921):556 [7914656.001]
  • [Cites] South Med J. 1997 Nov;90(11):1065-8 [9386043.001]
  • [Cites] Crit Care Med. 2009 Mar;37(3):803-10 [19237881.001]
  • [Cites] Clin Plast Surg. 1988 Jul;15(3):411-24 [3292112.001]
  • [Cites] World J Gastroenterol. 2006 Aug 28;12(32):5256-8 [16937546.001]
  • [Cites] N Z Med J. 2001 Jan 26;114(1124):3-6 [11243676.001]
  • [Cites] Scand J Infect Dis. 2003;35(9):683-9 [14620155.001]
  • [Cites] Surg Infect (Larchmt). 2011 Jun;12(3):185-90 [21767158.001]
  • [Cites] Surg Infect (Larchmt). 2008 Aug;9(4):443-50 [18759681.001]
  • [Cites] J Burn Care Res. 2008 Nov-Dec;29(6):933-8 [18997557.001]
  • [Cites] Arch Intern Med. 2006 Oct 23;166(19):2138-44 [17060545.001]
  • [Cites] Am Surg. 1952 Apr;18(4):416-31 [14915014.001]
  • [Cites] Undersea Hyperb Med. 2003 Summer;30(2):147-53 [12964858.001]
  • [Cites] Crit Care Med. 2002 Jan;30(1):100-6 [11902250.001]
  • [Cites] Clin Infect Dis. 1994 Jul;19(1):67-76 [7948560.001]
  • [Cites] Burns. 2005 Aug;31(5):623-8 [15975721.001]
  • [Cites] Clin Infect Dis. 1997 Sep;25 Suppl 2:S160-4 [9310664.001]
  • [Cites] Emerg Radiol. 2007 Mar;13(6):345-8 [17216174.001]
  • [Cites] Clin Infect Dis. 2005 Sep 1;41(5):634-53 [16080086.001]
  • [Cites] J Clin Microbiol. 1985 Jul;22(1):80-3 [4019745.001]
  • [Cites] Arch Surg. 2003 Mar;138(3):272-9; discussion 280 [12611573.001]
  • [Cites] Clin Infect Dis. 1995 May;20(5):1298-304 [7620014.001]
  • [Cites] Br J Plast Surg. 1984 Jul;37(3):354-7 [6378298.001]
  • [Cites] Clin Infect Dis. 2015 Aug 1;61(3):385-92 [25882302.001]
  • [Cites] Am J Surg. 2007 Nov;194(5):606-10 [17936421.001]
  • [Cites] Crit Care Med. 2013 Sep;41(9):2209-20 [23860248.001]
  • [Cites] Eur Arch Otorhinolaryngol. 2007 Aug;264(8):917-22 [17340128.001]
  • [Cites] J Infect. 2015 Aug;71(2):158-66 [25869539.001]
  • [Cites] Aviat Space Environ Med. 2000 Feb;71(2):119-24 [10685584.001]
  • [Cites] Am J Surg. 2000 Jan;179(1):17-21 [10737571.001]
  • [Cites] ANZ J Surg. 2008 Nov;78(11):968-72 [18959694.001]
  • [Cites] Clin Infect Dis. 1993 Jan;16(1):69-74 [8448321.001]
  • [Cites] J Infect Dis. 2007 Jan 15;195(2):202-11 [17191165.001]
  • [Cites] Ann Surg. 1996 Nov;224(5):672-83 [8916882.001]
  • [Cites] Ann Plast Surg. 2002 Oct;49(4):385-90 [12370644.001]
  • [Cites] BMJ. 2008 May 10;336(7652):1049-51 [18467413.001]
  • [Cites] Surgery. 2013 Jun;153(6):819-27 [23453328.001]
  • [Cites] Clin Infect Dis. 2006 Apr 1;42(7):e61-5 [16511748.001]
  • [Cites] J Clin Microbiol. 1998 Oct;36(10 ):2950-6 [9738049.001]
  • [Cites] Diagn Microbiol Infect Dis. 1998 Apr;30(4):251-5 [9582584.001]
  • (PMID = 28375805.001).
  • [ISSN] 1557-8674
  • [Journal-full-title] Surgical infections
  • [ISO-abbreviation] Surg Infect (Larchmt)
  • [Language] eng
  • [Publication-type] Journal Article; Review
  • [Publication-country] United States
  • [Chemical-registry-number] 0 / Anti-Infective Agents
  • [Keywords] NOTNLM ; necrotizing fasciitis (major topic) / necrotizing soft tissue infection (major topic) / sepsis (major topic)
  •  go-up   go-down


47. Toth K, Spencer JF, Ying B, Tollefson AE, Wold WSM: HAdV-C6 Is a More Relevant Challenge Virus than HAdV-C5 for Testing Antiviral Drugs with the Immunosuppressed Syrian Hamster Model. Viruses; 2017 Jun 13;9(6)
NCI CPTAC Assay Portal. NCI CPTAC Assay Portal .

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Adenovirus infections of immunocompromised patients can cause a severe multi-organ disease that often results in the patients' death.
  • Presently, there are no drugs specifically approved to treat adenovirus infections, and clinicians resort to the off-label use of antivirals that are approved to treat other DNA virus infections, most frequently cidofovir (CDV).
  • CDV, however, has considerable nephrotoxicity, thus it is recommended only for the most severe cases of adenovirus infections.
  • Further, we show for the first time that VGCV, and to a lesser extent CDV, can be used to treat respiratory adenovirus infections in the hamster model.
  • These results extend the utility of the hamster model, and demonstrate the efficacy of two drugs available for clinicians to treat adenovirus infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Virology. 2011 Mar 30;412(1):19-27 [21251688.001]
  • [Cites] J Virol. 2017 Apr 28;91(10 ): [28250128.001]
  • [Cites] Blood. 2010 Dec 16;116(25):5476-85 [20837781.001]
  • [Cites] J Gen Virol. 2009 Jan;90(Pt 1):1-20 [19088268.001]
  • [Cites] Expert Opin Pharmacother. 2015;16(14):2095-9 [26330121.001]
  • [Cites] Transpl Infect Dis. 2016 Oct;18(5):791-794 [27482652.001]
  • [Cites] Biol Blood Marrow Transplant. 2012 May;18(5):731-8 [21963623.001]
  • [Cites] Proc Natl Acad Sci U S A. 2008 May 20;105(20):7293-7 [18490659.001]
  • [Cites] Clin Microbiol Rev. 2008 Oct;21(4):704-15 [18854488.001]
  • [Cites] Methods Mol Med. 2007;130:223-35 [17401177.001]
  • [Cites] Semin Respir Crit Care Med. 2016 Aug;37(4):586-602 [27486739.001]
  • [Cites] Viruses. 2015 Mar 23;7(3):1409-28 [25807051.001]
  • [Cites] Adv Cancer Res. 2012;115:69-92 [23021242.001]
  • [Cites] Clin Infect Dis. 2006 Aug 1;43(3):331-9 [16804849.001]
  • [Cites] Cancer Gene Ther. 2009 Aug;16(8):625-37 [19197322.001]
  • [Cites] Cancer Gene Ther. 2009 Aug;16(8):644-54 [19197324.001]
  • [Cites] Antiviral Res. 2006 Sep;71(2-3):172-80 [16698093.001]
  • [Cites] Clin Microbiol Rev. 2014 Jul;27(3):441-62 [24982316.001]
  • [Cites] Antimicrob Agents Chemother. 2014 Dec;58(12):7171-81 [25224011.001]
  • [Cites] Am J Kidney Dis. 2005 May;45(5):804-17 [15861345.001]
  • [Cites] J Gene Med. 2010 May;12(5):435-45 [20440754.001]
  • [Cites] Orv Hetil. 2012 Dec 2;153(48):1896-904 [23183005.001]
  • [Cites] Biol Blood Marrow Transplant. 2017 Mar;23 (3):512-521 [28063938.001]
  • [Cites] Rev Med Virol. 2008 Nov-Dec;18(6):357-74 [18655013.001]
  • [Cites] Antiviral Res. 2014 Dec;112:38-46 [25453340.001]
  • [Cites] Clin Pharmacokinet. 2009;48(3):143-57 [19385708.001]
  • [Cites] J Clin Virol. 2016 Oct;83:1-4 [27513204.001]
  • [Cites] Cancer Res. 2006 Feb 1;66(3):1270-6 [16452178.001]
  • [Cites] Expert Rev Anti Infect Ther. 2013 Oct;11(10):1017-28 [24073835.001]
  • [Cites] Bone Marrow Transplant. 2000 Sep;26(5):511-6 [11019840.001]
  • [Cites] Virology. 2009 Nov 25;394(2):311-20 [19765790.001]
  • (PMID = 28608847.001).
  • [ISSN] 1999-4915
  • [Journal-full-title] Viruses
  • [ISO-abbreviation] Viruses
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] Switzerland
  • [Keywords] NOTNLM ; adenovirus / animal model / antiviral / hamster
  •  go-up   go-down


48. Norris P, Ralph N, Moloney C: Does metabolic syndrome predict surgical complications? A protocol for a systematic review and meta-analysis. Syst Rev; 2017 Jun 17;6(1):115

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • Surgical patients with MetS are at significantly higher risk of a range of adverse outcomes including death, morbid cardiovascular events, coma, stroke, renal failure, myocardial infarction, and surgical site infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Circulation. 2007 Sep 11;116(11 Suppl):I213-9 [17846306.001]
  • [Cites] BMJ. 2016 Oct 12;355:i4919 [27733354.001]
  • [Cites] Diabet Med. 1998 Jul;15(7):539-53 [9686693.001]
  • [Cites] Syst Rev. 2015 Jan 01;4:1 [25554246.001]
  • [Cites] Circulation. 2002 Dec 17;106(25):3143-421 [12485966.001]
  • [Cites] J Am Coll Cardiol. 2007 Aug 28;50(9):843-51 [17719470.001]
  • [Cites] J Arthroplasty. 2014 Sep;29(9):1842-5 [24851795.001]
  • [Cites] Am J Kidney Dis. 2006 Jul;48(1):134-42 [16797396.001]
  • [Cites] J Card Surg. 2014 Jan;29(1):26-34 [24283711.001]
  • [Cites] Curr Hypertens Rep. 2011 Apr;13(2):149-57 [20957457.001]
  • [Cites] J Arthroplasty. 2013 Jun;28(6):904-7 [23522489.001]
  • [Cites] Surgery. 2016 Oct;160(4):1111-7 [27498302.001]
  • [Cites] Arq Bras Cardiol. 2007 Apr;88(4):413-7 [17546270.001]
  • [Cites] JAMA. 2000 Apr 19;283(15):2008-12 [10789670.001]
  • [Cites] Circ J. 2008 Sep;72(9):1481-6 [18724026.001]
  • [Cites] Anesthesiology. 2010 Oct;113(4):859-72 [20808207.001]
  • [Cites] Circulation. 2009 Oct 20;120(16):1640-5 [19805654.001]
  • [Cites] Obes Surg. 2004 Sep;14(8):1042-50 [15487110.001]
  • [Cites] Spine (Phila Pa 1976). 2012 May 15;37(11):989-95 [22024892.001]
  • [Cites] Kidney Int Suppl. 2010 Dec;(119):S42-6 [21116317.001]
  • [Cites] Ann Surg Oncol. 2017 May;24(5):1443-1450 [27896516.001]
  • [Cites] J Arthroplasty. 2012 Apr;27(4):514-9 [21890314.001]
  • [Cites] J Int Med Res. 2010 Jan-Feb;38(1):202-7 [20233530.001]
  • [Cites] Foot Ankle Int. 2014 May;35(5):463-70 [24583475.001]
  • [Cites] Int J Cancer. 2016 Dec 15;139(12 ):2705-2713 [27560834.001]
  • [Cites] Diabetes Care. 2005 Nov;28(11):2745-9 [16249550.001]
  • [Cites] Ann Surg. 2004 Aug;240(2):205-13 [15273542.001]
  • [Cites] Coron Artery Dis. 2006 Feb;17 (1):41-4 [16374140.001]
  • [Cites] BMJ. 1997 Sep 13;315(7109):629-34 [9310563.001]
  • [Cites] Infect Control Hosp Epidemiol. 1992 Oct;13(10):606-8 [1334988.001]
  • [Cites] J Arthroplasty. 2016 Jun;31(6):1322-5 [26989028.001]
  • [Cites] J Arthroplasty. 2017 Feb;32(2):362-366 [27651122.001]
  • [Cites] Res Cardiovasc Med. 2014 Aug;3(3):e20270 [25478548.001]
  • [Cites] J Arthroplasty. 2012 Dec;27(10):1743-1749.e1 [22677144.001]
  • [Cites] Am J Med. 2006 Oct;119(10):812-9 [17000207.001]
  • [Cites] J Rheumatol. 2010 Sep;37(9):1917-22 [20634242.001]
  • [Cites] Am J Crit Care. 2009 Sep;18(5):468-73 [19723867.001]
  • [Cites] Obes Rev. 2015 Jan;16(1):1-12 [25407540.001]
  • (PMID = 28623943.001).
  • [ISSN] 2046-4053
  • [Journal-full-title] Systematic reviews
  • [ISO-abbreviation] Syst Rev
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Adverse events / Complications / Metabolic syndrome / Prevalence / Risk / Safety / Surgery
  •  go-up   go-down


49. Bilgic HB, Bakırcı S, Kose O, Unlu AH, Hacılarlıoglu S, Eren H, Weir W, Karagenc T: Prevalence of tick-borne haemoparasites in small ruminants in Turkey and diagnostic sensitivity of single-PCR and RLB. Parasit Vectors; 2017 Apr 27;10(1):211

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • The diagnostic sensitivity of these two approaches was then compared in terms of their ability to detect single species and mixed infections.
  • OT1, T. luwenshuni and T. uilenbergi in Turkey was revealed for the first time while the presence of Babesia motasi, B. crassa and T. separata in Turkish small ruminants was confirmed using molecular methods.
  • More than 80% of the mixed infections contained T. ovis and/or A. ovis.
  • The RLB approach was found to be capable of detecting mixed infections with species such as Theileria sp.
  • However, the latter approach was still capable of identifying a high proportion of individuals containing mixed-species infections.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Parassitologia. 1997 Jun;39(2):99-109 [9530692.001]
  • [Cites] Parasit Vectors. 2013 Sep 24;6(1):277 [24499621.001]
  • [Cites] Vet Parasitol. 2006 Sep 10;140(3-4):259-63 [16682122.001]
  • [Cites] Ann N Y Acad Sci. 2006 Oct;1081:498-504 [17135558.001]
  • [Cites] Transbound Emerg Dis. 2013 Nov;60 Suppl 2:113-8 [24589110.001]
  • [Cites] Parasitol Res. 2012 Jul;111(1):149-53 [22231266.001]
  • [Cites] Ticks Tick Borne Dis. 2011 Jun;2(2):94-8 [21771542.001]
  • [Cites] Vet Microbiol. 2015 Aug 5;178(3-4):246-51 [26051478.001]
  • [Cites] Parasitol Res. 2009 Jun;104(6):1417-23 [19205742.001]
  • [Cites] Transbound Emerg Dis. 2008 Aug;55(5-6):233-7 [18666967.001]
  • [Cites] Zoonoses Public Health. 2007;54(1):8-15 [17359441.001]
  • [Cites] Parasitol Res. 2008 Jul;103(2):319-23 [18421476.001]
  • [Cites] Fam Med. 2005 May;37(5):360-3 [15883903.001]
  • [Cites] Vet Parasitol. 2008 May 31;153(3-4):225-30 [18329810.001]
  • [Cites] Parasitol Res. 2009 Apr;104(5):1243-8 [19247690.001]
  • [Cites] J Clin Microbiol. 2006 Nov;44(11):4120-4 [17088370.001]
  • [Cites] Parasit Vectors. 2016 Apr 13;9:203 [27075661.001]
  • [Cites] Turkiye Parazitol Derg. 2007;31(4):268-71 [18224614.001]
  • [Cites] Vet Parasitol. 2013 Nov 15;198(1-2):72-7 [24029713.001]
  • [Cites] Vet Parasitol. 1995 Mar;57(1-3):19-41 [7597784.001]
  • [Cites] Ann N Y Acad Sci. 2000;916:271-5 [11193632.001]
  • [Cites] Trop Anim Health Prod. 2010 Oct;42(7):1327-31 [20405320.001]
  • [Cites] Trop Biomed. 2015 Jun;32(2):233-9 [26691251.001]
  • [Cites] Vector Borne Zoonotic Dis. 2015 Oct;15(10 ):580-90 [26394065.001]
  • [Cites] Parassitologia. 1997 Jun;39(2):153-6 [9530701.001]
  • [Cites] Int J Parasitol. 2004 Aug;34(9):1059-67 [15313132.001]
  • [Cites] Ticks Tick Borne Dis. 2012 Jun;3(3):147-53 [22534515.001]
  • [Cites] Vector Borne Zoonotic Dis. 2009 Oct;9(5):457-63 [18945185.001]
  • [Cites] Ann N Y Acad Sci. 1998 Jun 29;849:52-62 [9668449.001]
  • [Cites] Int J Parasitol Parasites Wildl. 2012 Nov 22;2:1-9 [24533310.001]
  • [Cites] Parasit Vectors. 2015 Dec 09;8:627 [26652614.001]
  • [Cites] Vet Microbiol. 2002 Oct 22;89(2-3):223-38 [12243899.001]
  • [Cites] Int J Parasitol. 2004 Apr;34(5):603-13 [15064125.001]
  • [Cites] Ticks Tick Borne Dis. 2013 Feb;4(1-2):148-51 [23238244.001]
  • [Cites] Biochem Med (Zagreb). 2012;22(3):276-82 [23092060.001]
  • [Cites] Vet Microbiol. 2007 Jan 31;119(2-4):375-81 [17052866.001]
  • [Cites] Vet Parasitol. 2014 Mar 1;200(3-4):276-83 [24424312.001]
  • [Cites] Vet Microbiol. 2011 Dec 15;153(3-4):293-8 [21684091.001]
  • [Cites] PCR Methods Appl. 1994 Feb;3(4):S65-75 [8173510.001]
  • [Cites] Int J Syst Evol Microbiol. 2001 Nov;51(Pt 6):2145-65 [11760958.001]
  • [Cites] J Wildl Dis. 1992 Jan;28(1):125-9 [1548791.001]
  • [Cites] Parasitol Res. 2016 May;115(5):2125-30 [26997339.001]
  • [Cites] Ticks Tick Borne Dis. 2013 Feb;4(1-2):72-7 [23246094.001]
  • [Cites] Vet Parasitol. 2008 Aug 1;155(1-2):1-9 [18472219.001]
  • [Cites] Biotechniques. 1997 Sep;23(3):504-11 [9298224.001]
  • [Cites] J Clin Microbiol. 1995 Mar;33(3):675-9 [7538510.001]
  • [Cites] Parasitol Res. 2004 Feb;92(3):189-96 [14652747.001]
  • [Cites] Parasitol Res. 2003 Nov;91(5):398-406 [14505044.001]
  • [Cites] Vet Parasitol. 2013 Jan 16;191(1-2):35-43 [22889552.001]
  • [Cites] Vet Rec. 1998 Nov 14;143(20):553-5 [9854317.001]
  • [Cites] Acta Vet Hung. 2008 Sep;56(3):281-92 [18828480.001]
  • [Cites] Rev Sci Tech. 1994 Dec;13(4):1201-26 [7711310.001]
  • [Cites] Vet Microbiol. 2007 Jun 21;122(3-4):316-22 [17336001.001]
  • [Cites] Parasitol Res. 2007 Sep;101 Suppl 2:S187-9 [17823826.001]
  • [Cites] Ann N Y Acad Sci. 2002 Oct;969:159-63 [12381583.001]
  • [Cites] Vet Res Commun. 2007 Aug;31 Suppl 1:79-84 [17682851.001]
  • [Cites] Trop Anim Health Prod. 1997 Nov;29(4 Suppl):8S-10S [9512737.001]
  • [Cites] PLoS Negl Trop Dis. 2014 Aug 07;8(8):e3067 [25101999.001]
  • [Cites] Exp Appl Acarol. 2012 May;57(1):91-104 [22371208.001]
  • [Cites] Vet Parasitol. 2012 Jul 6;187(3-4):567-71 [22365338.001]
  • [Cites] Parassitologia. 1997 Jun;39(2):161-5 [9530703.001]
  • [Cites] Vet Parasitol. 2006 May 31;138(1-2):3-10 [16513280.001]
  • [Cites] Parasitol Res. 2007 Sep;101 Suppl 2:S191-5 [17823827.001]
  • [Cites] Vet Parasitol. 2011 Feb 10;175(3-4):331-42 [21106294.001]
  • [Cites] Parasit Vectors. 2015 Jan 15;8:26 [25589064.001]
  • [Cites] J Parasitol. 2013 Feb;99(1):77-81 [22924924.001]
  • [Cites] Turkiye Parazitol Derg. 2009;33(4):273-9 [20101576.001]
  • [Cites] Parasitol Res. 2007 Mar;100(4):797-802 [17096146.001]
  • [Cites] Vet Parasitol. 2006 Apr 30;137(3-4):231-41 [16481113.001]
  • (PMID = 28449722.001).
  • [ISSN] 1756-3305
  • [Journal-full-title] Parasites & vectors
  • [ISO-abbreviation] Parasit Vectors
  • [Language] eng
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Goat / Prevalence / RLB / Sheep / Species-specific PCR / Tick-borne pathogens / Turkey
  •  go-up   go-down


50. Wesolowska-Andersen A, Everman JL, Davidson R, Rios C, Herrin R, Eng C, Janssen WJ, Liu AH, Oh SS, Kumar R, Fingerlin TE, Rodriguez-Santana J, Burchard EG, Seibold MA: Dual RNA-seq reveals viral infections in asthmatic children without respiratory illness which are associated with changes in the airway transcriptome. Genome Biol; 2017 Jan 19;18(1):12
MedlinePlus Health Information. consumer health - Asthma in Children.

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • [Title] Dual RNA-seq reveals viral infections in asthmatic children without respiratory illness which are associated with changes in the airway transcriptome.
  • Little is known about the effects of respiratory viral infections in the absence of illness.
  • Using quantitative PCR (qPCR) for common respiratory viruses and for two genes known to be highly upregulated in viral infections (CCL8/CXCL11), we screened 92 asthmatic and 69 healthy children without illness for respiratory virus infections.
  • [MeSH-major] Asthma / genetics. Host-Pathogen Interactions / genetics. RNA Virus Infections / genetics. RNA Virus Infections / virology. RNA Viruses. Respiratory Tract Infections / genetics. Respiratory Tract Infections / virology. Transcriptome

  • MedlinePlus Health Information. consumer health - Asthma.
  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Am J Respir Crit Care Med. 2009 Sep 1;180(5):388-95 [19483109.001]
  • [Cites] J Virol. 1998 Feb;72(2):1280-6 [9445028.001]
  • [Cites] Bioinformatics. 2015 Jan 15;31(2):166-9 [25260700.001]
  • [Cites] Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50 [16199517.001]
  • [Cites] BMC Bioinformatics. 2011 Aug 04;12:322 [21816037.001]
  • [Cites] PLoS One. 2015 Feb 23;10(2):e0118286 [25706956.001]
  • [Cites] Am J Respir Cell Mol Biol. 2016 Sep;55(3):323-36 [27144410.001]
  • [Cites] Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):E2329-38 [24843156.001]
  • [Cites] PLoS One. 2015 Nov 16;10(11):e0143164 [26569120.001]
  • [Cites] BMC Bioinformatics. 2009 May 27;10:161 [19473525.001]
  • [Cites] Am J Respir Crit Care Med. 2000 May;161(5):1501-7 [10806145.001]
  • [Cites] Bioinformatics. 2010 Jan 1;26(1):139-40 [19910308.001]
  • [Cites] Proc Natl Acad Sci U S A. 2016 Aug 2;113(31):8765-70 [27432971.001]
  • [Cites] PLoS One. 2015 Jun 30;10(6):e0131819 [26125632.001]
  • [Cites] J Med Virol. 2010 Jul;82(7):1282-90 [20513097.001]
  • [Cites] J Gen Virol. 2006 Jul;87(Pt 7):1805-21 [16760383.001]
  • [Cites] J Allergy Clin Immunol. 2015 Mar;135(3):663-9.e12 [25476729.001]
  • [Cites] J Pediatr. 2016 Apr;171:133-9.e1 [26787374.001]
  • [Cites] Hepatology. 2010 Aug;52(2):443-53 [20683944.001]
  • [Cites] J Clin Microbiol. 2016 Apr;54(4):1000-7 [26818672.001]
  • [Cites] J Allergy Clin Immunol. 2014 Mar;133(3):670-8.e12 [24495433.001]
  • [Cites] Genome Res. 2008 May;18(5):821-9 [18349386.001]
  • [Cites] Pediatrics. 1995 Apr;95(4):500-5 [7700748.001]
  • [Cites] J Gen Virol. 1976 Feb;30(2):263-7 [181536.001]
  • [Cites] Nat Protoc. 2008;3(6):1101-8 [18546601.001]
  • [Cites] Clin Microbiol Infect. 2016 May;22(5):458.e1-9 [26802214.001]
  • [Cites] Emerg Infect Dis. 2009 May;15(5):719-26 [19402957.001]
  • [Cites] J Allergy Clin Immunol. 2016 Oct;138(4):1042-1050 [27720018.001]
  • [Cites] Science. 1998 Dec 18;282(5397):2258-61 [9856949.001]
  • [Cites] Pediatr Infect Dis J. 2008 Dec;27(12):1103-7 [18978518.001]
  • [Cites] J Med Virol. 2016 Jan;88(1):45-50 [26100363.001]
  • [Cites] JCI Insight. 2016 Sep 8;1(14 ):e87871 [27699235.001]
  • [Cites] J Clin Virol. 2015 May;66:6-11 [25866327.001]
  • [Cites] Biotechnol Bioeng. 2014 Dec;111(12):2499-507 [24942535.001]
  • [Cites] World J Pediatr. 2016 May;12 (2):183-9 [26684315.001]
  • [Cites] J Allergy Clin Immunol. 2014 May;133(5):1301-7, 1307.e1-3 [24698319.001]
  • [Cites] Bioinformatics. 2013 Nov 1;29(21):2810-1 [23958726.001]
  • [Cites] Am J Respir Crit Care Med. 2001 Mar;163(3 Pt 2):S2-6 [11254543.001]
  • [Cites] BMC Bioinformatics. 2008 Dec 29;9:559 [19114008.001]
  • [Cites] Bioinformatics. 2010 Mar 15;26(6):841-2 [20110278.001]
  • [Cites] Bioinformatics. 2010 Apr 1;26(7):873-81 [20147302.001]
  • [Cites] J Clin Microbiol. 2015 Jul;53(7):2238-50 [25972420.001]
  • [Cites] Biol Cell. 2010 Jul 09;102(9):499-513 [20690903.001]
  • [Cites] Genome Res. 2015 Dec;25(12):1910-20 [26395152.001]
  • [Cites] J Allergy Clin Immunol. 2017 Feb;139(2):501-507 [27312820.001]
  • [Cites] Gene Ther. 2015 Oct;22(10):822-9 [26043872.001]
  • [Cites] Virol J. 2011 Jun 29;8:332 [21714915.001]
  • [Cites] Proc Natl Acad Sci U S A. 2012 Dec 4;109(49):20035-40 [23169653.001]
  • [Cites] Proc Natl Acad Sci U S A. 1978 Dec;75(12):5893-7 [282611.001]
  • [Cites] Methods Mol Biol. 2002;188:115-37 [11987537.001]
  • [Cites] Genome Med. 2014 Jan 17;6(1):1 [24433494.001]
  • [Cites] Phys Chem Chem Phys. 2015 Nov 14;17(42):27968-80 [26024367.001]
  • [Cites] J Allergy Clin Immunol. 2013 Oct;132(4):896-905.e1 [23684070.001]
  • [Cites] PLoS Pathog. 2013;9(5):e1003341 [23671415.001]
  • [Cites] Nat Rev Microbiol. 2012 Sep;10(9):618-30 [22890146.001]
  • [Cites] PLoS One. 2015 Oct 29;10(10):e0141484 [26513464.001]
  • [Cites] MBio. 2015 Sep 22;6(5):e01491-15 [26396248.001]
  • [Cites] Pediatr Infect Dis J. 2012 Dec;31(12):1221-6 [22739572.001]
  • [Cites] BMC Bioinformatics. 2009 Dec 15;10:421 [20003500.001]
  • [Cites] Bioorg Med Chem Lett. 2015 May 1;25(9):1876-9 [25857943.001]
  • [Cites] J Med Virol. 2016 Apr;88(4):578-87 [26331908.001]
  • [Cites] Nat Immunol. 2006 Mar;7(3):274-83 [16474395.001]
  • [Cites] Genome Biol. 2007;8(9):R183 [17784955.001]
  • [Cites] Am J Respir Crit Care Med. 2008 Oct 1;178(7):667-72 [18565953.001]
  • [Cites] Am J Pathol. 2012 Feb;180(2):599-607 [22189618.001]
  • [Cites] Genome Biol. 2014;15(12):550 [25516281.001]
  • (PMID = 28103897.001).
  • [ISSN] 1474-760X
  • [Journal-full-title] Genome biology
  • [ISO-abbreviation] Genome Biol.
  • [Language] eng
  • [Grant] United States / NHLBI NIH HHS / HL / R01 HL128439; United States / NIBIB NIH HHS / EB / T32 EB009383
  • [Publication-type] Journal Article
  • [Publication-country] England
  • [Keywords] NOTNLM ; Airway epithelium / Asthma / Asymptomatic / Children / Host response / Host-virus interactions / Infection / RNA-seq / Transcriptome / Virus
  •  go-up   go-down


51. Noor MT, Manoria P: Immune Dysfunction in Cirrhosis. J Clin Transl Hepatol; 2017 Mar 28;5(1):50-58

  • [Source] The source of this record is MEDLINE®, a database of the U.S. National Library of Medicine.
  • This increased bacterial translocation and consequent endotoxemia leads to increased blood stream bacterial infections that cause systemic inflammatory response syndrome, sepsis, multiorgan failure and death.
  • Prompt diagnosis and treatment of such infections are necessary for better survival.

  • [Email] Email this result item
    Email the results to the following email address:   [X] Close
  • [Cites] Trop Doct. 2010 Jul;40(3):163-4 [20478985.001]
  • [Cites] Eur J Gastroenterol Hepatol. 1999 Apr;11(4):401-3 [10321756.001]
  • [Cites] Aliment Pharmacol Ther. 2012 Jul;36(2):173-80 [22591184.001]
  • [Cites] Liver Int. 2011 Jan;31(1):140-1 [20825560.001]
  • [Cites] Clin Exp Immunol. 2009 Oct;158(1):115-24 [19737238.001]
  • [Cites] Am J Gastroenterol. 2014 Sep;109(9):1417-23 [24935272.001]
  • [Cites] Eur J Gastroenterol Hepatol. 1999 Jul;11(7):755-9 [10445796.001]
  • [Cites] J Hepatol. 2014 Jan;60(1):197-209 [23993913.001]
  • [Cites] Hepatology. 2012 May;55(5):1551-61 [22183941.001]
  • [Cites] Liver Int. 2006 Dec;26(10):1175-86 [17105582.001]
  • [Cites] Clin Gastroenterol Hepatol. 2011 Sep;9(9):727-38 [21397731.001]
  • [Cites] Clin Diagn Lab Immunol. 2002 Mar;9(2):433-9 [11874890.001]
  • [Cites] Cold Spring Harb Perspect Biol. 2012 Mar 01;4(3):null [22296764.001]
  • [Cites] Gut. 1985 Apr;26(4):325-31 [3884467.001]
  • [Cites] Gut. 1994 Nov;35(11):1648-52 [7828991.001]
  • [Cites] J Immunol. 1995 Aug 1;155(3):1606-18 [7636220.001]
  • [Cites] Hepatology. 2003 May;37(5):1043-55 [12717385.001]
  • [Cites] Nat Genet. 2005 Aug;37(8):835-43 [15995705.001]
  • [Cites] BMC Med. 2011 Sep 22;9:107 [21936959.001]
  • [Cites] Hepatology. 2008 Feb;47(2):729-36 [18167066.001]
  • [Cites] J Gastroenterol Hepatol. 2013 Aug;28 Suppl 1:38-42 [23855294.001]
  • [Cites] World J Hepatol. 2012 May 27;4(5):158-68 [22662285.001]
  • [Cites] Infect Immun. 2003 Dec;71(12):6693-700 [14638752.001]
  • [Cites] Gastroenterol Res Pract. 2010;2010:null [20706677.001]
  • [Cites] Nat Immunol. 2006 Feb;7(2):131-7 [16424890.001]
  • [Cites] Scand J Clin Lab Invest. 2012 Feb;72(1):1-13 [22060747.001]
  • [Cites] Gastroenterology. 2003 Oct;125(4):1085-93 [14517792.001]
  • [Cites] J Exp Med. 2003 Sep 15;198(6):913-23 [12975457.001]
  • [Cites] Am J Gastroenterol. 1999 Jan;94(1):200-7 [9934756.001]
  • [Cites] Acad Emerg Med. 2011 Feb;18(2):121-6 [21276124.001]
  • [Cites] J Hepatol. 2008 Jun;48(6):945-51 [18433921.001]
  • [Cites] Clin Exp Immunol. 2009 Nov;158(2):219-29 [19737142.001]
  • [Cites] Hepatology. 2003 May;37(5):1154-64 [12717397.001]
  • [Cites] Hepatology. 1993 May;17(5):828-32 [8491451.001]
  • [Cites] J Exp Med. 2006 Feb 20;203(2):265-8 [16446382.001]
  • [Cites] Am J Med. 2006 Feb;119(2):169-71 [16443429.001]
  • [Cites] Epidemiol Infect. 2000 Apr;124(2):221-5 [10813146.001]
  • [Cites] Clin Sci (Lond). 2011 Nov;121(10):415-26 [21797822.001]
  • [Cites] Lancet. 1979 Feb 10;1(8111):329-30 [84985.001]
  • [Cites] Hepatology. 1982 Jul-Aug;2(4):399-407 [7095741.001]
  • [Cites] Hepatogastroenterology. 1997 Jul-Aug;44(16):1147-51 [9261615.001]
  • [Cites] Br Med J (Clin Res Ed). 1981 Apr 18;282(6272):1262-3 [6784806.001]
  • [Cites] West J Med. 1994 Jul;161(1):64-5 [7941517.001]
  • [Cites] BMC Microbiol. 2007 Oct 23;7:94 [17956621.001]
  • [Cites] J Infect Dis. 2000 Aug;182(2):526-33 [10915084.001]
  • [Cites] J Hepatol. 2007 May;46(5):816-26 [17328986.001]
  • [Cites] J Hepatol. 1986;2(2):195-207 [2937833.001]
  • [Cites] Immunology. 2003 May;109(1):127-36 [12709026.001]
  • [Cites] World J Gastroenterol. 2014 Mar 14;20(10):2564-77 [24627592.001]
  • [Cites] J Hepatol. 2005 Feb;42(2):163-5 [15664238.001]
  • [Cites] Gastroenterology. 2012 Mar;142(3):505-512.e1 [22119930.001]
  • [Cites] J Hepatol. 2013 May;58(5):956-61 [23333526.001]
  • [Cites] Rev Med Chil. 1991 Nov;119(11):1248-53 [9723075.001]
  • [Cites] Hepatology. 1998 Nov;28(5):1187-90 [9794900.001]
  • [Cites] J Immunol. 2002 May 1;168(9):4531-7 [11970999.001]
  • [Cites] Trends Immunol. 2003 Oct;24(10):528-33 [14552836.001]
  • [Cites] J Hepatol. 2014 Dec;61(6):1385-96 [25135860.001]
  • [Cites] Hepatology. 2010 Apr;51(4):1327-33 [20087966.001]
  • [Cites] J Biol Chem. 2001 Sep 14;276(37):34686-94 [11461926.001]
  • [Cites] Gastroenterology. 2009 Jan;136(1):65-80 [19026645.001]
  • [Cites] Hepatology. 2005 Mar;41(3):422-33 [15723320.001]
  • [Cites] Gut. 1987 May;28(5):623-41 [3297941.001]
  • [Cites] Cell Mol Gastroenterol Hepatol. 2015 May 1;1(3):275-284 [26090511.001]
  • [Cites] Clin Liver Dis. 2012 Nov;16(4):687-98 [23101977.001]
  • [Cites] Liver Int. 2010 Aug;30(7):1003-11 [20492495.001]
  • [Cites] Best Pract Res Clin Gastroenterol. 2004 Apr;18(2):353-72 [15123075.001]
  • [Cites] Indian J Gastroenterol. 2016 Jan;35(1):33-9 [26873085.001]
  • [Cites] Am J Gastroenterol. 1995 Nov;90(11):2042-5 [7485020.001]
  • [Cites] Front Physiol. 2012 May 22;3:138 [22661952.001]
  • [Cites] Hepatogastroenterology. 1984 Oct;31(5):201-3 [6096238.001]
  • [Cites] Infect Immun. 2002 Jul;70(7):3433-42 [12065483.001]
  • [Cites] J Appl Res. 2006 Jan 1;6(1):43-50 [19816551.001]
  • [Cites] J Hepatol. 2011 Nov;55(5):1010-6 [21356257.001]
  • [Cites] Mol Immunol. 2004 Feb;40(12):845-59 [14698223.001]
  • [Cites] Gut. 2005 Apr;54(4):556-63 [15753544.001]
  • [Cites] Hepatology. 2006 Aug;44(2):287-98 [16871558.001]
  • [Cites] Hepatology. 2008 Jul;48(1):322-35 [18506843.001]
  • [Cites] J Hepatol. 2010 Sep;53(3):484-91 [20605050.001]
  • [Cites] Am J Gastroenterol. 2007 Jul;102(7):1510-7 [17509025.001]
  • [Cites] Semin Liver Dis. 2008 Feb;28(1):26-42 [18293275.001]
  • [Cites] Gut. 1997 Apr;40(4):544-9 [9176087.001]
  • [Cites] J Hepatol. 2005 Feb;42(2):195-201 [15664244.001]
  • [Cites] BMJ Open. 2015 Aug 21;5(8):e008033 [26297362.001]
  • [Cites] Semin Liver Dis. 1999;19(2):141-55 [10422197.001]
  • [Cites] Q J Med. 1985 Aug;56(220):431-7 [3901076.001]
  • [Cites] Biol Pharm Bull. 2005 May;28(5):886-92 [15863899.001]
  • [Cites] PLoS One. 2010 Jun 10;5(6):e11049 [20548789.001]
  • [Cites] Hepatology. 2007 Sep;46(3):831-40 [17680644.001]
  • [Cites] Clin Sci. 1957 Feb;16(1):35-51 [13414138.001]
  • [Cites] Int J Infect Dis. 2007 Nov;11(6):482-7 [17600748.001]
  • [Cites] J Hepatol. 2012 May;56(5):1207-8; author reply 1208-9 [22019578.001]
  • [Cites] Aliment Pharmacol Ther. 2010 Jun;31(11):1192-9 [20222908.001]
  • [Cites] J Clin Pathol. 1982 Sep;35(9):972-9 [7119129.001]
  • [Cites] J Hepatol. 2010 Feb;52(2):199-205 [20006396.001]
  • [Cites] Hepatology. 2000 Jan;31(1):43-8 [10613726.001]
  • [Cites] Hepatology. 1993 Nov;18(5):1139-43 [8225220.001]
  • [Cites] Hepatology. 2012 Mar;55(3):709-19 [21932384.001]
  • [Cites] Clin Exp Immunol. 2007 Jan;147(1):184-8 [17177978.001]
  • [Cites] Hepatology. 2011 Nov;54(5):1620-30 [21809356.001]
  • [Cites] World J Gastroenterol. 2009 Nov 28;15(44):5558-62 [19938194.001]
  • [Cites] J Endotoxin Res. 2001;7(5):365-73 [11753205.001]
  • [Cites] J Hepatol. 1994 Nov;21(5):792-6 [7890896.001]
  • [Cites] Liver Int. 2009 Sep;29(8):1189-93 [19508620.001]
  • [Cites] J Cell Physiol. 2005 Aug;204(2):654-65 [15828022.001]
  • [Cites] World J Gastroenterol. 2004 Feb 15;10(4):610-3 [14966928.001]
  • [Cites] J Gastroenterol Hepatol. 2012 Apr;27(4):789-96 [22188204.001]
  • [Cites] Hepatology. 2012 Apr;55(4):1154-63 [22095436.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2009 Jan;296(1):G15-22 [19033535.001]
  • [Cites] World J Gastroenterol. 2014 Nov 14;20(42):15624-31 [25400446.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2012 Jan 1;302(1):G168-75 [21940902.001]
  • [Cites] Nat Rev Gastroenterol Hepatol. 2016 Mar;13(3):131-49 [26837712.001]
  • [Cites] Am J Physiol Gastrointest Liver Physiol. 2005 Sep;289(3):G571-8 [